Difference between revisions of "Staging page"
Jump to navigation
Jump to search
m |
m |
||
Line 21: | Line 21: | ||
|- | |- | ||
|A'Hern | |A'Hern | ||
− | |Roger P | + | |Roger P. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 42: | Line 42: | ||
|Aamdal | |Aamdal | ||
|Steinar | |Steinar | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 62: | Line 62: | ||
|Aanur | |Aanur | ||
|Praveen | |Praveen | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 81: | Line 81: | ||
|- | |- | ||
|Aapro | |Aapro | ||
− | |Matti S | + | |Matti S. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 102: | Line 102: | ||
|Aaron | |Aaron | ||
|Lorne | |Lorne | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 121: | Line 121: | ||
|- | |- | ||
|Aaronson | |Aaronson | ||
− | |Neil K | + | |Neil K. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 141: | Line 141: | ||
|- | |- | ||
|Aarts | |Aarts | ||
− | |Maureen J B | + | |Maureen J. B. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 162: | Line 162: | ||
|Aasebo | |Aasebo | ||
|Ulf | |Ulf | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 182: | Line 182: | ||
|Aass | |Aass | ||
|Nina | |Nina | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 202: | Line 202: | ||
|Aastroem | |Aastroem | ||
|Lennart | |Lennart | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 222: | Line 222: | ||
|Aavall Lundqvist | |Aavall Lundqvist | ||
|Elisabeth | |Elisabeth | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 242: | Line 242: | ||
|Abacioglu | |Abacioglu | ||
|Ufuk | |Ufuk | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 262: | Line 262: | ||
|Abad | |Abad | ||
|Alberto | |Alberto | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 281: | Line 281: | ||
|- | |- | ||
|Abada | |Abada | ||
− | |Paolo B | + | |Paolo B. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 302: | Line 302: | ||
|Abadie Lacourtoisie | |Abadie Lacourtoisie | ||
|Sophie | |Sophie | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 322: | Line 322: | ||
|Abaskharoun | |Abaskharoun | ||
|Mena | |Mena | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 342: | Line 342: | ||
|Abaza | |Abaza | ||
|Yasmin | |Yasmin | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 361: | Line 361: | ||
|- | |- | ||
|Abbadessa | |Abbadessa | ||
− | |A | + | |A. |
|CBD | |CBD | ||
| | | | ||
Line 382: | Line 382: | ||
|Abbadessa | |Abbadessa | ||
|Giovanni | |Giovanni | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 402: | Line 402: | ||
|Abbal | |Abbal | ||
|Claire | |Claire | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 422: | Line 422: | ||
|Abbas | |Abbas | ||
|Abbas | |Abbas | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 442: | Line 442: | ||
|Abbas | |Abbas | ||
|Haider | |Haider | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 462: | Line 462: | ||
|Abbas | |Abbas | ||
|Mohammad | |Mohammad | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 482: | Line 482: | ||
|Abbas | |Abbas | ||
|Moncef | |Moncef | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 502: | Line 502: | ||
|Abbas | |Abbas | ||
|Richat | |Richat | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 542: | Line 542: | ||
|Abbattista | |Abbattista | ||
|Antonello | |Antonello | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 562: | Line 562: | ||
|Abbink | |Abbink | ||
|Floor | |Floor | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 582: | Line 582: | ||
|Abbott | |Abbott | ||
|Amanda | |Amanda | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 601: | Line 601: | ||
|- | |- | ||
|Abbott | |Abbott | ||
− | |R L | + | |R. L. |
|CBD | |CBD | ||
| | | | ||
Line 621: | Line 621: | ||
|- | |- | ||
|Abbott | |Abbott | ||
− | |Thomas M | + | |Thomas M. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 642: | Line 642: | ||
|Abbou | |Abbou | ||
|Clement Claude | |Clement Claude | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 661: | Line 661: | ||
|- | |- | ||
|Abboud | |Abboud | ||
− | |Camille N | + | |Camille N. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 681: | Line 681: | ||
|- | |- | ||
|Abboud | |Abboud | ||
− | |Miguel R | + | |Miguel R. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 702: | Line 702: | ||
|Abbrederis | |Abbrederis | ||
|Klaus | |Klaus | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 722: | Line 722: | ||
|Abbruzzese | |Abbruzzese | ||
|Alberto | |Alberto | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 741: | Line 741: | ||
|- | |- | ||
|Abbruzzese | |Abbruzzese | ||
− | |James L | + | |James L. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 761: | Line 761: | ||
|- | |- | ||
|Abdalla | |Abdalla | ||
− | |K | + | |K. |
|CBD | |CBD | ||
| | | | ||
Line 782: | Line 782: | ||
|Abdallah | |Abdallah | ||
|Al Ola | |Al Ola | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 822: | Line 822: | ||
|Abdeddaim | |Abdeddaim | ||
|Cyril | |Cyril | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 842: | Line 842: | ||
|Abdel Hamid | |Abdel Hamid | ||
|Abdel | |Abdel | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 862: | Line 862: | ||
|Abdel Rahman | |Abdel Rahman | ||
|Omar | |Omar | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 882: | Line 882: | ||
|Abdel Rahman | |Abdel Rahman | ||
|Sultan | |Sultan | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 902: | Line 902: | ||
|Abdel Wahab | |Abdel Wahab | ||
|Manal | |Manal | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 922: | Line 922: | ||
|Abdel Wahab | |Abdel Wahab | ||
|Omar | |Omar | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 942: | Line 942: | ||
|Abdel Wahab | |Abdel Wahab | ||
|Sherif | |Sherif | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 962: | Line 962: | ||
|Abdelfattah | |Abdelfattah | ||
|Murad | |Murad | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 982: | Line 982: | ||
|Abdelghany | |Abdelghany | ||
|Osama | |Osama | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,001: | Line 1,001: | ||
|- | |- | ||
|Abdi | |Abdi | ||
− | |Ehtesham A | + | |Ehtesham A. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,042: | Line 1,042: | ||
|Abdo | |Abdo | ||
|Andre | |Andre | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,061: | Line 1,061: | ||
|- | |- | ||
|Abdul Razak | |Abdul Razak | ||
− | |Albiruni R | + | |Albiruni R. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,081: | Line 1,081: | ||
|- | |- | ||
|Abdulkadyrov | |Abdulkadyrov | ||
− | |Kudrat M | + | |Kudrat M. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 1,101: | Line 1,101: | ||
|- | |- | ||
|Abdullaev | |Abdullaev | ||
− | |S | + | |S. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 1,121: | Line 1,121: | ||
|- | |- | ||
|Abdullah | |Abdullah | ||
− | |Shaad E | + | |Shaad E. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,142: | Line 1,142: | ||
|Abe | |Abe | ||
|Hajime | |Hajime | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,182: | Line 1,182: | ||
|Abe | |Abe | ||
|Rikiya | |Rikiya | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 1,202: | Line 1,202: | ||
|Abe | |Abe | ||
|Tetsuya | |Tetsuya | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,222: | Line 1,222: | ||
|Abe | |Abe | ||
|Yasunobu | |Yasunobu | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,242: | Line 1,242: | ||
|Abedi | |Abedi | ||
|Mehrdad | |Mehrdad | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,262: | Line 1,262: | ||
|Abel | |Abel | ||
|Edvard | |Edvard | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,282: | Line 1,282: | ||
|Abel | |Abel | ||
|Ulrich | |Ulrich | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,302: | Line 1,302: | ||
|Abella | |Abella | ||
|Eugenia | |Eugenia | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 1,322: | Line 1,322: | ||
|Abellan | |Abellan | ||
|Pascual Fernandez | |Pascual Fernandez | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,341: | Line 1,341: | ||
|- | |- | ||
|Abeloff | |Abeloff | ||
− | |Martin D | + | |Martin D. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,361: | Line 1,361: | ||
|- | |- | ||
|Abels | |Abels | ||
− | |J | + | |J. |
|CBD | |CBD | ||
| | | | ||
Line 1,381: | Line 1,381: | ||
|- | |- | ||
|Abelson | |Abelson | ||
− | |Herbert T | + | |Herbert T. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,402: | Line 1,402: | ||
|Abenhardt | |Abenhardt | ||
|Wolfgang | |Wolfgang | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,422: | Line 1,422: | ||
|Abergel | |Abergel | ||
|Armand | |Armand | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,442: | Line 1,442: | ||
|Abernethy | |Abernethy | ||
|Amy | |Amy | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 1,482: | Line 1,482: | ||
|Abgrall | |Abgrall | ||
|Jean Francois | |Jean Francois | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,502: | Line 1,502: | ||
|Abhyankar | |Abhyankar | ||
|Sunil | |Sunil | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,522: | Line 1,522: | ||
|Abi Gerges | |Abi Gerges | ||
|Dany | |Dany | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,561: | Line 1,561: | ||
|- | |- | ||
|Abidi | |Abidi | ||
− | |Muneer H | + | |Muneer H. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,581: | Line 1,581: | ||
|- | |- | ||
|Abidoye | |Abidoye | ||
− | |Oyewale O | + | |Oyewale O. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,602: | Line 1,602: | ||
|Abildgaard | |Abildgaard | ||
|Niels | |Niels | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,641: | Line 1,641: | ||
|- | |- | ||
|Ablin | |Ablin | ||
− | |Arthur R | + | |Arthur R. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,682: | Line 1,682: | ||
|Abonour | |Abonour | ||
|Rafat | |Rafat | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,701: | Line 1,701: | ||
|- | |- | ||
|Abou Alfa | |Abou Alfa | ||
− | |Ghassan K | + | |Ghassan K. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,722: | Line 1,722: | ||
|Abou Nassar | |Abou Nassar | ||
|Karim | |Karim | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,742: | Line 1,742: | ||
|Abou Rached | |Abou Rached | ||
|Antoine | |Antoine | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,762: | Line 1,762: | ||
|Aboulafia | |Aboulafia | ||
|David | |David | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,782: | Line 1,782: | ||
|Abraham | |Abraham | ||
|Aby | |Aby | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 1,802: | Line 1,802: | ||
|Abraham | |Abraham | ||
|Christine | |Christine | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 1,822: | Line 1,822: | ||
|Abraham | |Abraham | ||
|George | |George | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,842: | Line 1,842: | ||
|Abraham | |Abraham | ||
|Jacinta | |Jacinta | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 1,861: | Line 1,861: | ||
|- | |- | ||
|Abraham | |Abraham | ||
− | |Jean E | + | |Jean E. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 1,882: | Line 1,882: | ||
|Abraham | |Abraham | ||
|Julie | |Julie | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 1,902: | Line 1,902: | ||
|Abraham | |Abraham | ||
|Mirta | |Mirta | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 1,921: | Line 1,921: | ||
|- | |- | ||
|Abrahamse Testroote | |Abrahamse Testroote | ||
− | |Martine C J | + | |Martine C. J. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 1,942: | Line 1,942: | ||
|Abrahamsson | |Abrahamsson | ||
|Jonas | |Jonas | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,962: | Line 1,962: | ||
|Abrahamsson | |Abrahamsson | ||
|Per Anders | |Per Anders | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 1,982: | Line 1,982: | ||
|Abram | |Abram | ||
|Paul | |Paul | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 2,001: | Line 2,001: | ||
|- | |- | ||
|Abram | |Abram | ||
− | |Steven R | + | |Steven R. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 2,021: | Line 2,021: | ||
|- | |- | ||
|Abramov | |Abramov | ||
− | |M | + | |M. |
|CBD | |CBD | ||
| | | | ||
Line 2,041: | Line 2,041: | ||
|- | |- | ||
|Abrams | |Abrams | ||
− | |Jeffrey S | + | |Jeffrey S. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 2,061: | Line 2,061: | ||
|- | |- | ||
|Abrams | |Abrams | ||
− | |K | + | |K. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 2,081: | Line 2,081: | ||
|- | |- | ||
|Abrams | |Abrams | ||
− | |Paul G | + | |Paul G. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 2,101: | Line 2,101: | ||
|- | |- | ||
|Abrams | |Abrams | ||
− | |Ross A | + | |Ross A. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 2,121: | Line 2,121: | ||
|- | |- | ||
|Abrams | |Abrams | ||
− | |Thomas A | + | |Thomas A. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 2,141: | Line 2,141: | ||
|- | |- | ||
|Abramson | |Abramson | ||
− | |David H | + | |David H. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 2,161: | Line 2,161: | ||
|- | |- | ||
|Abramson | |Abramson | ||
− | |Jeremy S | + | |Jeremy S. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 2,182: | Line 2,182: | ||
|Abramson | |Abramson | ||
|Neil | |Neil | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 2,201: | Line 2,201: | ||
|- | |- | ||
|Abramson | |Abramson | ||
− | |Vandana G | + | |Vandana G. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 2,222: | Line 2,222: | ||
|Abrao Miziara | |Abrao Miziara | ||
|Jose Elias | |Jose Elias | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 2,242: | Line 2,242: | ||
|Abratt | |Abratt | ||
|Raymond Pierre | |Raymond Pierre | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 2,261: | Line 2,261: | ||
|- | |- | ||
|Abrey | |Abrey | ||
− | |Lauren E | + | |Lauren E. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 2,282: | Line 2,282: | ||
|Abrisqueta | |Abrisqueta | ||
|Pau | |Pau | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 2,302: | Line 2,302: | ||
|Abromowitch | |Abromowitch | ||
|Minnie | |Minnie | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 2,322: | Line 2,322: | ||
|Abruzzese | |Abruzzese | ||
|Elisabetta | |Elisabetta | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 2,341: | Line 2,341: | ||
|- | |- | ||
|Abruzzo | |Abruzzo | ||
− | |Lynne V | + | |Lynne V. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 2,361: | Line 2,361: | ||
|- | |- | ||
|Abshire | |Abshire | ||
− | |T C | + | |T. C. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 2,382: | Line 2,382: | ||
|Abt | |Abt | ||
|Markus | |Markus | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 2,422: | Line 2,422: | ||
|Abu Zahra | |Abu Zahra | ||
|Hakam | |Hakam | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 2,442: | Line 2,442: | ||
|Abuav | |Abuav | ||
|Rachel | |Rachel | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 2,461: | Line 2,461: | ||
|- | |- | ||
|Abubakr | |Abubakr | ||
− | |Yousif A | + | |Yousif A. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 2,481: | Line 2,481: | ||
|- | |- | ||
|Abulizi | |Abulizi | ||
− | |G | + | |G. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 2,502: | Line 2,502: | ||
|Accario Winslow | |Accario Winslow | ||
|Chrisann | |Chrisann | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 2,522: | Line 2,522: | ||
|Accomando | |Accomando | ||
|Emilio | |Emilio | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 2,542: | Line 2,542: | ||
|Accortanzo | |Accortanzo | ||
|Valeria | |Valeria | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 2,562: | Line 2,562: | ||
|Acha | |Acha | ||
|Tomas | |Tomas | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 2,582: | Line 2,582: | ||
|Acharya | |Acharya | ||
|Sandip | |Sandip | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 2,621: | Line 2,621: | ||
|- | |- | ||
|Achebe | |Achebe | ||
− | |Maureen M | + | |Maureen M. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 2,642: | Line 2,642: | ||
|Achille | |Achille | ||
|Emmanuel | |Emmanuel | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 2,662: | Line 2,662: | ||
|Acholonu | |Acholonu | ||
|Sandra | |Sandra | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 2,701: | Line 2,701: | ||
|- | |- | ||
|Achtelik | |Achtelik | ||
− | |W | + | |W. |
|CBD | |CBD | ||
| | | | ||
Line 2,721: | Line 2,721: | ||
|- | |- | ||
|Achtnicht | |Achtnicht | ||
− | |U | + | |U. |
|CBD | |CBD | ||
| | | | ||
Line 2,742: | Line 2,742: | ||
|Acin | |Acin | ||
|Yolene | |Yolene | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 2,762: | Line 2,762: | ||
|Acker | |Acker | ||
|Thomas | |Thomas | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 2,782: | Line 2,782: | ||
|Ackerman | |Ackerman | ||
|Charlotte | |Charlotte | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 2,822: | Line 2,822: | ||
|Ackerman | |Ackerman | ||
|Judie | |Judie | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 2,841: | Line 2,841: | ||
|- | |- | ||
|Ackerstaff | |Ackerstaff | ||
− | |Annemiek H | + | |Annemiek H. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 2,862: | Line 2,862: | ||
|Ackerstein | |Ackerstein | ||
|Aliza | |Aliza | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 2,881: | Line 2,881: | ||
|- | |- | ||
|Ackland | |Ackland | ||
− | |Stephen P | + | |Stephen P. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 2,902: | Line 2,902: | ||
|Acosta Rivera | |Acosta Rivera | ||
|Mirelis | |Mirelis | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 2,922: | Line 2,922: | ||
|Acosta | |Acosta | ||
|Mark | |Mark | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 2,941: | Line 2,941: | ||
|- | |- | ||
|Acosta | |Acosta | ||
− | |Soraida C | + | |Soraida C. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 2,961: | Line 2,961: | ||
|- | |- | ||
|Acquino Parsons | |Acquino Parsons | ||
− | |C | + | |C. |
|CBD | |CBD | ||
| | | | ||
Line 2,981: | Line 2,981: | ||
|- | |- | ||
|Acs | |Acs | ||
− | |Peter I | + | |Peter I. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,002: | Line 3,002: | ||
|Acton | |Acton | ||
|Gary | |Gary | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,022: | Line 3,022: | ||
|Adab | |Adab | ||
|Fawzi | |Fawzi | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,062: | Line 3,062: | ||
|Adachi | |Adachi | ||
|Isamu | |Isamu | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,082: | Line 3,082: | ||
|Adachi | |Adachi | ||
|Susumu | |Susumu | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,102: | Line 3,102: | ||
|Adak | |Adak | ||
|Sudeshna | |Sudeshna | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 3,121: | Line 3,121: | ||
|- | |- | ||
|Adam | |Adam | ||
− | |H | + | |H. |
|CBD | |CBD | ||
| | | | ||
Line 3,142: | Line 3,142: | ||
|Adam | |Adam | ||
|Rene | |Rene | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,162: | Line 3,162: | ||
|Adam | |Adam | ||
|Zdenek | |Zdenek | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,202: | Line 3,202: | ||
|Adami | |Adami | ||
|Bernd | |Bernd | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,222: | Line 3,222: | ||
|Adami | |Adami | ||
|Fausto | |Fausto | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,242: | Line 3,242: | ||
|Adami | |Adami | ||
|Francesca | |Francesca | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 3,262: | Line 3,262: | ||
|Adami | |Adami | ||
|Hans Olov | |Hans Olov | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,281: | Line 3,281: | ||
|- | |- | ||
|Adamkewicz | |Adamkewicz | ||
− | |Joanne I | + | |Joanne I. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 3,302: | Line 3,302: | ||
|Adamo | |Adamo | ||
|Francesco | |Francesco | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,322: | Line 3,322: | ||
|Adamo | |Adamo | ||
|Vincenzo | |Vincenzo | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,342: | Line 3,342: | ||
|Adamou | |Adamou | ||
|Adamos | |Adamos | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,381: | Line 3,381: | ||
|- | |- | ||
|Adams | |Adams | ||
− | |George L | + | |George L. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,402: | Line 3,402: | ||
|Adams | |Adams | ||
|Grenfell | |Grenfell | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,422: | Line 3,422: | ||
|Adams | |Adams | ||
|Hans Peter | |Hans Peter | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,442: | Line 3,442: | ||
|Adams | |Adams | ||
|Julian | |Julian | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,461: | Line 3,461: | ||
|- | |- | ||
|Adams | |Adams | ||
− | |M | + | |M. |
|CBD | |CBD | ||
| | | | ||
Line 3,481: | Line 3,481: | ||
|- | |- | ||
|Adams | |Adams | ||
− | |Paul T | + | |Paul T. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,501: | Line 3,501: | ||
|- | |- | ||
|Adams | |Adams | ||
− | |Richard A | + | |Richard A. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,522: | Line 3,522: | ||
|Adams | |Adams | ||
|Sylvia | |Sylvia | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 3,542: | Line 3,542: | ||
|Adamska | |Adamska | ||
|Krystyna | |Krystyna | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 3,562: | Line 3,562: | ||
|Adamski | |Adamski | ||
|Henri | |Henri | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,581: | Line 3,581: | ||
|- | |- | ||
|Adamson | |Adamson | ||
− | |Peter C | + | |Peter C. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,602: | Line 3,602: | ||
|Adamus | |Adamus | ||
|Jerzy | |Jerzy | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,621: | Line 3,621: | ||
|- | |- | ||
|Addamo | |Addamo | ||
− | |B | + | |B. |
|CBD | |CBD | ||
| | | | ||
Line 3,642: | Line 3,642: | ||
|Adde | |Adde | ||
|Magdalena | |Magdalena | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 3,662: | Line 3,662: | ||
|Addeo | |Addeo | ||
|Raffaele | |Raffaele | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,682: | Line 3,682: | ||
|Addison | |Addison | ||
|Alicia | |Alicia | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 3,702: | Line 3,702: | ||
|Adebamowo | |Adebamowo | ||
|Clement | |Clement | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,721: | Line 3,721: | ||
|- | |- | ||
|Adelman | |Adelman | ||
− | |Carrie A | + | |Carrie A. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 3,741: | Line 3,741: | ||
|- | |- | ||
|Adelson | |Adelson | ||
− | |Mark D | + | |Mark D. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,761: | Line 3,761: | ||
|- | |- | ||
|Adelstein | |Adelstein | ||
− | |David J | + | |David J. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,842: | Line 3,842: | ||
|Adenis | |Adenis | ||
|Antoine | |Antoine | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,862: | Line 3,862: | ||
|Ades | |Ades | ||
|Lionel | |Lionel | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,882: | Line 3,882: | ||
|Adeva | |Adeva | ||
|Jorge | |Jorge | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,901: | Line 3,901: | ||
|- | |- | ||
|Adewoye | |Adewoye | ||
− | |Adeboye H | + | |Adeboye H. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,921: | Line 3,921: | ||
|- | |- | ||
|Adhoute | |Adhoute | ||
− | |X | + | |X. |
|CBD | |CBD | ||
| | | | ||
Line 3,942: | Line 3,942: | ||
|Adib | |Adib | ||
|Deyaa | |Deyaa | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 3,982: | Line 3,982: | ||
|Adie | |Adie | ||
|Sam | |Sam | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,002: | Line 4,002: | ||
|Adiguzel | |Adiguzel | ||
|Ibrahim | |Ibrahim | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,021: | Line 4,021: | ||
|- | |- | ||
|Adinin | |Adinin | ||
− | |Rosnie B | + | |Rosnie B. |
|UNMATCHED | |UNMATCHED | ||
| | | | ||
Line 4,041: | Line 4,041: | ||
|- | |- | ||
|Adjei | |Adjei | ||
− | |Alex A | + | |Alex A. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,062: | Line 4,062: | ||
|Adkins | |Adkins | ||
|Douglas | |Douglas | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,081: | Line 4,081: | ||
|- | |- | ||
|Adler Reichel | |Adler Reichel | ||
− | |S | + | |S. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 4,102: | Line 4,102: | ||
|Adler | |Adler | ||
|Brian | |Brian | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,122: | Line 4,122: | ||
|Adler | |Adler | ||
|Mathias | |Mathias | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,142: | Line 4,142: | ||
|Adotevi | |Adotevi | ||
|Olivier | |Olivier | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,162: | Line 4,162: | ||
|Adrian | |Adrian | ||
|Nicole | |Nicole | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 4,182: | Line 4,182: | ||
|Adrover | |Adrover | ||
|Encarna | |Encarna | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 4,201: | Line 4,201: | ||
|- | |- | ||
|Advani | |Advani | ||
− | |Anjali S | + | |Anjali S. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 4,221: | Line 4,221: | ||
|- | |- | ||
|Advani | |Advani | ||
− | |Ranjana H | + | |Ranjana H. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 4,241: | Line 4,241: | ||
|- | |- | ||
|Advani | |Advani | ||
− | |Suresh H | + | |Suresh H. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,262: | Line 4,262: | ||
|Aeberhard | |Aeberhard | ||
|Peter | |Peter | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,281: | Line 4,281: | ||
|- | |- | ||
|Aebersold | |Aebersold | ||
− | |Daniel M | + | |Daniel M. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,302: | Line 4,302: | ||
|Aebi | |Aebi | ||
|Stefan | |Stefan | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,321: | Line 4,321: | ||
|- | |- | ||
|Aerts | |Aerts | ||
− | |Joachim G J V | + | |Joachim G. J. V. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,342: | Line 4,342: | ||
|Afable | |Afable | ||
|Manuel | |Manuel | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,361: | Line 4,361: | ||
|- | |- | ||
|Afanasyev | |Afanasyev | ||
− | |Boris V | + | |Boris V. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,382: | Line 4,382: | ||
|Afchain | |Afchain | ||
|Pauline | |Pauline | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 4,402: | Line 4,402: | ||
|Afenjar | |Afenjar | ||
|Karen | |Karen | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 4,421: | Line 4,421: | ||
|- | |- | ||
|Afflitto | |Afflitto | ||
− | |Anthony J | + | |Anthony J. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,441: | Line 4,441: | ||
|- | |- | ||
|Affronti | |Affronti | ||
− | |M L | + | |M. L. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 4,462: | Line 4,462: | ||
|Afra | |Afra | ||
|Denes | |Denes | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,481: | Line 4,481: | ||
|- | |- | ||
|Afrin | |Afrin | ||
− | |Lawrence B | + | |Lawrence B. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,502: | Line 4,502: | ||
|Aft | |Aft | ||
|Rebecca | |Rebecca | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 4,521: | Line 4,521: | ||
|- | |- | ||
|Aftab | |Aftab | ||
− | |Dana T | + | |Dana T. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 4,542: | Line 4,542: | ||
|Aftimos | |Aftimos | ||
|Philippe | |Philippe | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,562: | Line 4,562: | ||
|Agajanian | |Agajanian | ||
|Richy | |Richy | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,581: | Line 4,581: | ||
|- | |- | ||
|Agaram | |Agaram | ||
− | |Narasimhan P | + | |Narasimhan P. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,622: | Line 4,622: | ||
|Agarwal | |Agarwal | ||
|Jaiprakash | |Jaiprakash | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,641: | Line 4,641: | ||
|- | |- | ||
|Agarwal | |Agarwal | ||
− | |Mohan B | + | |Mohan B. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,662: | Line 4,662: | ||
|Agarwal | |Agarwal | ||
|Neeraj | |Neeraj | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,682: | Line 4,682: | ||
|Agarwal | |Agarwal | ||
|Prasheen | |Prasheen | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,702: | Line 4,702: | ||
|Agarwal | |Agarwal | ||
|Rishu | |Rishu | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 4,722: | Line 4,722: | ||
|Agarwal | |Agarwal | ||
|Shefali | |Shefali | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 4,741: | Line 4,741: | ||
|- | |- | ||
|Agarwal | |Agarwal | ||
− | |Suresh K | + | |Suresh K. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,761: | Line 4,761: | ||
|- | |- | ||
|Agarwala | |Agarwala | ||
− | |A | + | |A. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 4,781: | Line 4,781: | ||
|- | |- | ||
|Agarwala | |Agarwala | ||
− | |Sanjiv S | + | |Sanjiv S. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,802: | Line 4,802: | ||
|Agate | |Agate | ||
|Laura | |Laura | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 4,822: | Line 4,822: | ||
|Agathocleous | |Agathocleous | ||
|Agathoclis | |Agathoclis | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,842: | Line 4,842: | ||
|Agbalika | |Agbalika | ||
|Felix | |Felix | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,862: | Line 4,862: | ||
|Agelaki | |Agelaki | ||
|Sophia | |Sophia | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 4,882: | Line 4,882: | ||
|Agelidou | |Agelidou | ||
|Athina | |Athina | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 4,902: | Line 4,902: | ||
|Agelidou | |Agelidou | ||
|Maria | |Maria | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 4,922: | Line 4,922: | ||
|Ageno | |Ageno | ||
|Walter | |Walter | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,942: | Line 4,942: | ||
|Ager | |Ager | ||
|Phyllis Joyce | |Phyllis Joyce | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 4,962: | Line 4,962: | ||
|Agerbaek | |Agerbaek | ||
|Mads | |Mads | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 4,982: | Line 4,982: | ||
|Aggarwal | |Aggarwal | ||
|Charu | |Charu | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 5,002: | Line 5,002: | ||
|Aggarwal | |Aggarwal | ||
|Sanjay | |Sanjay | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,022: | Line 5,022: | ||
|Aggerholm | |Aggerholm | ||
|Anni | |Anni | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 5,041: | Line 5,041: | ||
|- | |- | ||
|Agha | |Agha | ||
− | |Mounzer E | + | |Mounzer E. |
|UNMATCHED | |UNMATCHED | ||
| | | | ||
Line 5,061: | Line 5,061: | ||
|- | |- | ||
|Aghajanian | |Aghajanian | ||
− | |Carol A | + | |Carol A. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 5,081: | Line 5,081: | ||
|- | |- | ||
|Aghemo | |Aghemo | ||
− | |E | + | |E. |
|CBD | |CBD | ||
| | | | ||
Line 5,102: | Line 5,102: | ||
|Agis | |Agis | ||
|Hermine | |Hermine | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 5,122: | Line 5,122: | ||
|Aglietta | |Aglietta | ||
|Massimo | |Massimo | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,142: | Line 5,142: | ||
|Agnelli | |Agnelli | ||
|Giancarlo | |Giancarlo | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,161: | Line 5,161: | ||
|- | |- | ||
|Agnelli | |Agnelli | ||
− | |L | + | |L. |
|CBD | |CBD | ||
| | | | ||
Line 5,182: | Line 5,182: | ||
|Agodoa | |Agodoa | ||
|Irene | |Irene | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 5,202: | Line 5,202: | ||
|Agopian | |Agopian | ||
|Julie | |Julie | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 5,222: | Line 5,222: | ||
|Agostara | |Agostara | ||
|Biagio | |Biagio | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,242: | Line 5,242: | ||
|Agostinelli | |Agostinelli | ||
|Claudio | |Claudio | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,262: | Line 5,262: | ||
|Agostini | |Agostini | ||
|Cecile | |Cecile | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 5,282: | Line 5,282: | ||
|Agrawal | |Agrawal | ||
|Manish | |Manish | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,301: | Line 5,301: | ||
|- | |- | ||
|Agrawal | |Agrawal | ||
− | |Rajiv K | + | |Rajiv K. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,322: | Line 5,322: | ||
|Agrawal | |Agrawal | ||
|Samir | |Samir | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,342: | Line 5,342: | ||
|Agrawal | |Agrawal | ||
|Shruti | |Shruti | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 5,361: | Line 5,361: | ||
|- | |- | ||
|Agresta | |Agresta | ||
− | |Samuel V | + | |Samuel V. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,382: | Line 5,382: | ||
|Agricola | |Agricola | ||
|Karen | |Karen | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 5,402: | Line 5,402: | ||
|Aguado Fraile | |Aguado Fraile | ||
|Elia | |Elia | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 5,421: | Line 5,421: | ||
|- | |- | ||
|Aguado | |Aguado | ||
− | |M Jose | + | |M. Jose |
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,441: | Line 5,441: | ||
|- | |- | ||
|Aguggini | |Aguggini | ||
− | |S | + | |S. |
|CBD | |CBD | ||
| | | | ||
Line 5,481: | Line 5,481: | ||
|- | |- | ||
|Aguiar | |Aguiar | ||
− | |Ricardo C T | + | |Ricardo C. T. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,502: | Line 5,502: | ||
|Aguilera | |Aguilera | ||
|Nadia | |Nadia | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 5,522: | Line 5,522: | ||
|Aguilo | |Aguilo | ||
|Rafael | |Rafael | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,542: | Line 5,542: | ||
|Agulnik | |Agulnik | ||
|Jason | |Jason | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,561: | Line 5,561: | ||
|- | |- | ||
|Agulnik | |Agulnik | ||
− | |Mark B | + | |Mark B. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,581: | Line 5,581: | ||
|- | |- | ||
|Agunwamba | |Agunwamba | ||
− | |Blessing U | + | |Blessing U. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 5,602: | Line 5,602: | ||
|Agura | |Agura | ||
|Edward | |Edward | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,621: | Line 5,621: | ||
|- | |- | ||
|Agus | |Agus | ||
− | |David B | + | |David B. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,661: | Line 5,661: | ||
|- | |- | ||
|Ah See | |Ah See | ||
− | |Antoinne K | + | |Antoinne K. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,702: | Line 5,702: | ||
|Ahern | |Ahern | ||
|Charlotte | |Charlotte | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 5,722: | Line 5,722: | ||
|Ahlberg | |Ahlberg | ||
|Lucia | |Lucia | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 5,742: | Line 5,742: | ||
|Ahlborn | |Ahlborn | ||
|Miriam | |Miriam | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 5,761: | Line 5,761: | ||
|- | |- | ||
|Ahlgren | |Ahlgren | ||
− | |Goeran M | + | |Goeran M. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,781: | Line 5,781: | ||
|- | |- | ||
|Ahlgren | |Ahlgren | ||
− | |James D | + | |James D. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,802: | Line 5,802: | ||
|Ahlgren | |Ahlgren | ||
|Johan | |Johan | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,822: | Line 5,822: | ||
|Ahlgren | |Ahlgren | ||
|Tomas | |Tomas | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,842: | Line 5,842: | ||
|Ahlman | |Ahlman | ||
|Hakan | |Hakan | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,862: | Line 5,862: | ||
|Ahlmann | |Ahlmann | ||
|Martina | |Martina | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 5,881: | Line 5,881: | ||
|- | |- | ||
|Ahluwalia | |Ahluwalia | ||
− | |Manmeet S | + | |Manmeet S. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,901: | Line 5,901: | ||
|- | |- | ||
|Ahmad | |Ahmad | ||
− | |Chaudhary E | + | |Chaudhary E. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 5,922: | Line 5,922: | ||
|Ahmad | |Ahmad | ||
|Rizvana | |Rizvana | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 5,962: | Line 5,962: | ||
|Ahmadi | |Ahmadi | ||
|Jamshid | |Jamshid | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 5,982: | Line 5,982: | ||
|Ahmadi | |Ahmadi | ||
|Tahamtan | |Tahamtan | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 6,001: | Line 6,001: | ||
|- | |- | ||
|Ahmann | |Ahmann | ||
− | |David L | + | |David L. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 6,021: | Line 6,021: | ||
|- | |- | ||
|Ahmann | |Ahmann | ||
− | |Frederick R | + | |Frederick R. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 6,041: | Line 6,041: | ||
|- | |- | ||
|Ahmann | |Ahmann | ||
− | |Gregory J | + | |Gregory J. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 6,062: | Line 6,062: | ||
|Ahmed | |Ahmed | ||
|Asra | |Asra | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 6,081: | Line 6,081: | ||
|- | |- | ||
|Ahmed | |Ahmed | ||
− | |Atif A | + | |Atif A. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 6,122: | Line 6,122: | ||
|Ahmed | |Ahmed | ||
|Nazma | |Nazma | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 6,142: | Line 6,142: | ||
|Ahmed | |Ahmed | ||
|Sairah | |Sairah | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 6,162: | Line 6,162: | ||
|Ahn | |Ahn | ||
|Chul | |Chul | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 6,181: | Line 6,181: | ||
|- | |- | ||
|Ahn | |Ahn | ||
− | |Daniel H | + | |Daniel H. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 6,221: | Line 6,221: | ||
|- | |- | ||
|Ahn | |Ahn | ||
− | |Inhye E | + | |Inhye E. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 6,242: | Line 6,242: | ||
|Ahn | |Ahn | ||
|Jae Sook | |Jae Sook | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 6,262: | Line 6,262: | ||
|Ahn | |Ahn | ||
|Jin Hee | |Jin Hee | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 6,282: | Line 6,282: | ||
|Ahn | |Ahn | ||
|Jin Seok | |Jin Seok | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 6,302: | Line 6,302: | ||
|Ahn | |Ahn | ||
|Joong Bae | |Joong Bae | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 6,322: | Line 6,322: | ||
|Ahn | |Ahn | ||
|Myung Ju | |Myung Ju | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 6,381: | Line 6,381: | ||
|- | |- | ||
|Ahn | |Ahn | ||
− | |Yeon S | + | |Yeon S. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 6,402: | Line 6,402: | ||
|Ahn | |Ahn | ||
|Yong Chan | |Yong Chan | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 6,422: | Line 6,422: | ||
|Ahren | |Ahren | ||
|Bo | |Bo | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 6,441: | Line 6,441: | ||
|- | |- | ||
|Ahrens | |Ahrens | ||
− | |S | + | |S. |
|CBD | |CBD | ||
| | | | ||
Line 6,461: | Line 6,461: | ||
|- | |- | ||
|Ahsan | |Ahsan | ||
− | |S | + | |S. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 6,482: | Line 6,482: | ||
|Ahsan | |Ahsan | ||
|Sama | |Sama | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 6,502: | Line 6,502: | ||
|Ahuja | |Ahuja | ||
|Harish | |Harish | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 6,522: | Line 6,522: | ||
|Ai | |Ai | ||
|Ping | |Ping | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 6,542: | Line 6,542: | ||
|Ai | |Ai | ||
|Weiyun | |Weiyun | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 6,602: | Line 6,602: | ||
|Aiello | |Aiello | ||
|Maria | |Maria | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 6,622: | Line 6,622: | ||
|Aieta | |Aieta | ||
|Michele | |Michele | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 6,662: | Line 6,662: | ||
|Aihara | |Aihara | ||
|Tomohiko | |Tomohiko | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 6,682: | Line 6,682: | ||
|Aikata | |Aikata | ||
|Hiroshi | |Hiroshi | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 6,742: | Line 6,742: | ||
|Ailawadhi | |Ailawadhi | ||
|Sikander | |Sikander | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 6,762: | Line 6,762: | ||
|Aimone | |Aimone | ||
|Paola | |Paola | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 6,782: | Line 6,782: | ||
|Airatovich Gafanov | |Airatovich Gafanov | ||
|Rustem | |Rustem | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 6,802: | Line 6,802: | ||
|Aird | |Aird | ||
|William | |William | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 6,841: | Line 6,841: | ||
|- | |- | ||
|Airoma | |Airoma | ||
− | |G | + | |G. |
|CBD | |CBD | ||
| | | | ||
Line 6,862: | Line 6,862: | ||
|Aisa | |Aisa | ||
|Yoshinobu | |Yoshinobu | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 6,881: | Line 6,881: | ||
|- | |- | ||
|Aisner | |Aisner | ||
− | |D L | + | |D. L. |
|CBD | |CBD | ||
| | | | ||
Line 6,901: | Line 6,901: | ||
|- | |- | ||
|Aisner | |Aisner | ||
− | |Joseph A | + | |Joseph A. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 6,921: | Line 6,921: | ||
|- | |- | ||
|Aisner | |Aisner | ||
− | |Seena C | + | |Seena C. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 6,941: | Line 6,941: | ||
|- | |- | ||
|Aitchison | |Aitchison | ||
− | |Michael A | + | |Michael A. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 6,962: | Line 6,962: | ||
|Aitini | |Aitini | ||
|Enrico | |Enrico | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 6,981: | Line 6,981: | ||
|- | |- | ||
|Aitken | |Aitken | ||
− | |Casey N | + | |Casey N. |
|UNMATCHED | |UNMATCHED | ||
| | | | ||
Line 7,002: | Line 7,002: | ||
|Aivado | |Aivado | ||
|Manuel | |Manuel | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,061: | Line 7,061: | ||
|- | |- | ||
|Ajani | |Ajani | ||
− | |Jaffer A | + | |Jaffer A. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,102: | Line 7,102: | ||
|Akabane | |Akabane | ||
|Hiromitsu | |Hiromitsu | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,122: | Line 7,122: | ||
|Akaike | |Akaike | ||
|Makoto | |Makoto | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,142: | Line 7,142: | ||
|Akaike | |Akaike | ||
|Tomoko | |Tomoko | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 7,162: | Line 7,162: | ||
|Akamaru | |Akamaru | ||
|Yusuke | |Yusuke | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,182: | Line 7,182: | ||
|Akamatsu | |Akamatsu | ||
|Hiroaki | |Hiroaki | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,222: | Line 7,222: | ||
|Akapame | |Akapame | ||
|Sydney | |Sydney | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,242: | Line 7,242: | ||
|Akard | |Akard | ||
|Luke | |Luke | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,262: | Line 7,262: | ||
|Akaza | |Akaza | ||
|Hideyuki | |Hideyuki | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,282: | Line 7,282: | ||
|Akazawa | |Akazawa | ||
|Kohei | |Kohei | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,302: | Line 7,302: | ||
|Akazawa | |Akazawa | ||
|Rio | |Rio | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 7,322: | Line 7,322: | ||
|Akbulut | |Akbulut | ||
|Hakan | |Hakan | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,342: | Line 7,342: | ||
|Akdas | |Akdas | ||
|Atif | |Atif | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,362: | Line 7,362: | ||
|Aker | |Aker | ||
|Memet | |Memet | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,382: | Line 7,382: | ||
|Akerley | |Akerley | ||
|Wallace | |Wallace | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,402: | Line 7,402: | ||
|Akerman | |Akerman | ||
|Maans | |Maans | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,422: | Line 7,422: | ||
|Akewanlop | |Akewanlop | ||
|Charuwan | |Charuwan | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 7,461: | Line 7,461: | ||
|- | |- | ||
|Akilov | |Akilov | ||
− | |Oleg E | + | |Oleg E. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,502: | Line 7,502: | ||
|Akimov | |Akimov | ||
|Mikhail | |Mikhail | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,522: | Line 7,522: | ||
|Akin | |Akin | ||
|Cem | |Cem | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,542: | Line 7,542: | ||
|Akinaga | |Akinaga | ||
|Shiro | |Shiro | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,562: | Line 7,562: | ||
|Akita | |Akita | ||
|Hirotoshi | |Hirotoshi | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,582: | Line 7,582: | ||
|Akiya | |Akiya | ||
|Toshikazu | |Toshikazu | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,602: | Line 7,602: | ||
|Akiyama | |Akiyama | ||
|Hideki | |Hideki | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,641: | Line 7,641: | ||
|- | |- | ||
|Akkermans Vogelaar | |Akkermans Vogelaar | ||
− | |Janine M | + | |Janine M. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 7,662: | Line 7,662: | ||
|Akopov | |Akopov | ||
|Audrey | |Audrey | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 7,722: | Line 7,722: | ||
|Akram | |Akram | ||
|Muhammed | |Muhammed | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,742: | Line 7,742: | ||
|Aksnes | |Aksnes | ||
|Anne Kirsti | |Anne Kirsti | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 7,762: | Line 7,762: | ||
|Aktan | |Aktan | ||
|Gursel | |Gursel | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,782: | Line 7,782: | ||
|Aktan | |Aktan | ||
|Melih | |Melih | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,802: | Line 7,802: | ||
|Aktas | |Aktas | ||
|Bahriye | |Bahriye | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 7,822: | Line 7,822: | ||
|Akusawa | |Akusawa | ||
|Hiroshi | |Hiroshi | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,841: | Line 7,841: | ||
|- | |- | ||
|Al Akash | |Al Akash | ||
− | |Samhar I | + | |Samhar I. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 7,862: | Line 7,862: | ||
|Al Ali | |Al Ali | ||
|Haifa Kathrin | |Haifa Kathrin | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 7,882: | Line 7,882: | ||
|Al Batran | |Al Batran | ||
|Salah Eddin | |Salah Eddin | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,902: | Line 7,902: | ||
|Al Booz | |Al Booz | ||
|Hoda | |Hoda | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 7,922: | Line 7,922: | ||
|Al Dewik | |Al Dewik | ||
|Nader | |Nader | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,942: | Line 7,942: | ||
|Al Fayoumi | |Al Fayoumi | ||
|Suliman | |Suliman | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 7,982: | Line 7,982: | ||
|Al Kali | |Al Kali | ||
|Aref | |Aref | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,022: | Line 8,022: | ||
|Al Rajabi | |Al Rajabi | ||
|Raed | |Raed | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,042: | Line 8,042: | ||
|Al Sakaff | |Al Sakaff | ||
|Nedal | |Nedal | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,062: | Line 8,062: | ||
|al Sarraf | |al Sarraf | ||
|Muhyi | |Muhyi | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,082: | Line 8,082: | ||
|Al Sawaf | |Al Sawaf | ||
|Othman | |Othman | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,102: | Line 8,102: | ||
|Al Shukri | |Al Shukri | ||
|Salman | |Salman | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,121: | Line 8,121: | ||
|- | |- | ||
|Al Toubah | |Al Toubah | ||
− | |Taymeyah E | + | |Taymeyah E. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 8,142: | Line 8,142: | ||
|Al Tweigeri | |Al Tweigeri | ||
|Taher | |Taher | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,162: | Line 8,162: | ||
|Al Zoubi | |Al Zoubi | ||
|Ammar | |Ammar | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,181: | Line 8,181: | ||
|- | |- | ||
|Alabiso | |Alabiso | ||
− | |O | + | |O. |
|CBD | |CBD | ||
| | | | ||
Line 8,201: | Line 8,201: | ||
|- | |- | ||
|Alakel | |Alakel | ||
− | |N | + | |N. |
|CBD | |CBD | ||
| | | | ||
Line 8,222: | Line 8,222: | ||
|Alakl | |Alakl | ||
|May | |May | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 8,241: | Line 8,241: | ||
|- | |- | ||
|Alam | |Alam | ||
− | |A | + | |A. |
|CBD | |CBD | ||
| | | | ||
Line 8,262: | Line 8,262: | ||
|Alam | |Alam | ||
|Rafeul | |Rafeul | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,282: | Line 8,282: | ||
|Alam | |Alam | ||
|Yasmin | |Yasmin | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 8,301: | Line 8,301: | ||
|- | |- | ||
|Alama | |Alama | ||
− | |A | + | |A. |
|CBD | |CBD | ||
| | | | ||
Line 8,322: | Line 8,322: | ||
|Alamoudi | |Alamoudi | ||
|Sameer | |Sameer | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,342: | Line 8,342: | ||
|Alamouti | |Alamouti | ||
|Sepideh | |Sepideh | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 8,362: | Line 8,362: | ||
|Alanko | |Alanko | ||
|Tuomo | |Tuomo | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,422: | Line 8,422: | ||
|Alarcon | |Alarcon | ||
|Jesus | |Jesus | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,462: | Line 8,462: | ||
|Alatorre Alexander | |Alatorre Alexander | ||
|Jorge | |Jorge | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,482: | Line 8,482: | ||
|Alattar | |Alattar | ||
|Mona Lisa | |Mona Lisa | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 8,502: | Line 8,502: | ||
|Alavi | |Alavi | ||
|Jane | |Jane | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 8,522: | Line 8,522: | ||
|Alba | |Alba | ||
|Emilio | |Emilio | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,541: | Line 8,541: | ||
|- | |- | ||
|Albain | |Albain | ||
− | |Kathy S | + | |Kathy S. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 8,561: | Line 8,561: | ||
|- | |- | ||
|Albala | |Albala | ||
− | |Maurice M | + | |Maurice M. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,582: | Line 8,582: | ||
|Albanell | |Albanell | ||
|Juan | |Juan | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,602: | Line 8,602: | ||
|Albano | |Albano | ||
|Edythe | |Edythe | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 8,622: | Line 8,622: | ||
|Albano | |Albano | ||
|Francesco | |Francesco | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,642: | Line 8,642: | ||
|Alberici | |Alberici | ||
|Federico | |Federico | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,662: | Line 8,662: | ||
|Alberola | |Alberola | ||
|Vincente | |Vincente | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,681: | Line 8,681: | ||
|- | |- | ||
|Albers | |Albers | ||
− | |Gregory W | + | |Gregory W. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,701: | Line 8,701: | ||
|- | |- | ||
|Albers | |Albers | ||
− | |Mary E | + | |Mary E. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 8,722: | Line 8,722: | ||
|Albers | |Albers | ||
|Peter | |Peter | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,741: | Line 8,741: | ||
|- | |- | ||
|Albert | |Albert | ||
− | |Catherine M | + | |Catherine M. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 8,762: | Line 8,762: | ||
|Albert | |Albert | ||
|Donald | |Donald | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,782: | Line 8,782: | ||
|Albert | |Albert | ||
|Istvan | |Istvan | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,801: | Line 8,801: | ||
|- | |- | ||
|Albert | |Albert | ||
− | |Michael H | + | |Michael H. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,821: | Line 8,821: | ||
|- | |- | ||
|Albert | |Albert | ||
− | |Paul S | + | |Paul S. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,842: | Line 8,842: | ||
|Albert | |Albert | ||
|Ute Susann | |Ute Susann | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 8,881: | Line 8,881: | ||
|- | |- | ||
|Albertini | |Albertini | ||
− | |Mark R | + | |Mark R. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,902: | Line 8,902: | ||
|Alberto | |Alberto | ||
|Pierre | |Pierre | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,921: | Line 8,921: | ||
|- | |- | ||
|Alberts | |Alberts | ||
− | |David S | + | |David S. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,941: | Line 8,941: | ||
|- | |- | ||
|Alberts | |Alberts | ||
− | |Steven R | + | |Steven R. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 8,962: | Line 8,962: | ||
|Albertsen | |Albertsen | ||
|Birgitte Klug | |Birgitte Klug | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 8,981: | Line 8,981: | ||
|- | |- | ||
|Albertson | |Albertson | ||
− | |Tina M | + | |Tina M. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 9,002: | Line 9,002: | ||
|Albertsson | |Albertsson | ||
|Maria | |Maria | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 9,022: | Line 9,022: | ||
|Albiges | |Albiges | ||
|Laurence | |Laurence | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,042: | Line 9,042: | ||
|Albitar | |Albitar | ||
|Maher | |Maher | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,061: | Line 9,061: | ||
|- | |- | ||
|Albo | |Albo | ||
− | |Vincent C | + | |Vincent C. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,081: | Line 9,081: | ||
|- | |- | ||
|Albright | |Albright | ||
− | |A L | + | |A. L. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 9,101: | Line 9,101: | ||
|- | |- | ||
|Albright | |Albright | ||
− | |Robert E | + | |Robert E. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,122: | Line 9,122: | ||
|Albritton | |Albritton | ||
|Karen | |Karen | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 9,142: | Line 9,142: | ||
|Albuquerque | |Albuquerque | ||
|Marco | |Marco | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,162: | Line 9,162: | ||
|Alcaide | |Alcaide | ||
|Julia | |Julia | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 9,182: | Line 9,182: | ||
|Alcaide | |Alcaide | ||
|Miguel | |Miguel | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,202: | Line 9,202: | ||
|Alcaraz | |Alcaraz | ||
|Antonio | |Antonio | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,222: | Line 9,222: | ||
|Alcedo | |Alcedo | ||
|Juan Carlos | |Juan Carlos | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,242: | Line 9,242: | ||
|Alcindor | |Alcindor | ||
|Thierry | |Thierry | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,262: | Line 9,262: | ||
|Aldaoud | |Aldaoud | ||
|Ali | |Ali | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,281: | Line 9,281: | ||
|- | |- | ||
|Aldape | |Aldape | ||
− | |Kenneth D | + | |Kenneth D. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,301: | Line 9,301: | ||
|- | |- | ||
|Alderdice | |Alderdice | ||
− | |M | + | |M. |
|CBD | |CBD | ||
| | | | ||
Line 9,322: | Line 9,322: | ||
|Alderete | |Alderete | ||
|Daniel | |Daniel | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,342: | Line 9,342: | ||
|Alderson | |Alderson | ||
|Derek | |Derek | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,362: | Line 9,362: | ||
|Alderuccio | |Alderuccio | ||
|Juan Pablo | |Juan Pablo | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,382: | Line 9,382: | ||
|Aldrighetti | |Aldrighetti | ||
|Daniela | |Daniela | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 9,402: | Line 9,402: | ||
|Aldrighetti | |Aldrighetti | ||
|Luca | |Luca | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,422: | Line 9,422: | ||
|Aledo | |Aledo | ||
|Alexander | |Alexander | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,441: | Line 9,441: | ||
|- | |- | ||
|Aledort | |Aledort | ||
− | |Louis M | + | |Louis M. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,462: | Line 9,462: | ||
|Alegakis | |Alegakis | ||
|Athanasios | |Athanasios | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,482: | Line 9,482: | ||
|Alegre | |Alegre | ||
|Adrian | |Adrian | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,502: | Line 9,502: | ||
|Aleinikova | |Aleinikova | ||
|Olga | |Olga | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 9,522: | Line 9,522: | ||
|Alekar | |Alekar | ||
|Shilpa | |Shilpa | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 9,542: | Line 9,542: | ||
|Aleksandrovic | |Aleksandrovic | ||
|Jasna | |Jasna | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 9,562: | Line 9,562: | ||
|Alekseev | |Alekseev | ||
|Boris Yakovlevich | |Boris Yakovlevich | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,582: | Line 9,582: | ||
|Alekseev | |Alekseev | ||
|Sergey | |Sergey | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,602: | Line 9,602: | ||
|Alekseeva | |Alekseeva | ||
|Yulia | |Yulia | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 9,621: | Line 9,621: | ||
|- | |- | ||
|Aleman | |Aleman | ||
− | |Berthe M P | + | |Berthe M. P. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 9,642: | Line 9,642: | ||
|Aleman | |Aleman | ||
|Karen | |Karen | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 9,681: | Line 9,681: | ||
|- | |- | ||
|Alese | |Alese | ||
− | |Olatunji B | + | |Olatunji B. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 9,701: | Line 9,701: | ||
|- | |- | ||
|Alessandri | |Alessandri | ||
− | |S | + | |S. |
|CBD | |CBD | ||
| | | | ||
Line 9,722: | Line 9,722: | ||
|Alessandrino | |Alessandrino | ||
|Emilio Paolo | |Emilio Paolo | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,742: | Line 9,742: | ||
|Alessandroni | |Alessandroni | ||
|Paolo | |Paolo | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,762: | Line 9,762: | ||
|Alexander | |Alexander | ||
|Eben | |Eben | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,782: | Line 9,782: | ||
|Alexander | |Alexander | ||
|Sarah | |Sarah | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 9,802: | Line 9,802: | ||
|Alexandre | |Alexandre | ||
|Jerome | |Jerome | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,822: | Line 9,822: | ||
|Alexandris | |Alexandris | ||
|Ekaterine | |Ekaterine | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 9,842: | Line 9,842: | ||
|Alexandru | |Alexandru | ||
|Aurelia | |Aurelia | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 9,862: | Line 9,862: | ||
|Alexanian | |Alexanian | ||
|Raymond | |Raymond | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,881: | Line 9,881: | ||
|- | |- | ||
|Alexeeva | |Alexeeva | ||
− | |Julia A | + | |Julia A. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 9,902: | Line 9,902: | ||
|Alexis Vigier | |Alexis Vigier | ||
|Magda | |Magda | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 9,922: | Line 9,922: | ||
|Alexopoulos | |Alexopoulos | ||
|Athanasios | |Athanasios | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,941: | Line 9,941: | ||
|- | |- | ||
|Alexopoulos | |Alexopoulos | ||
− | |Constantinos G | + | |Constantinos G. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 9,962: | Line 9,962: | ||
|Alfaro | |Alfaro | ||
|Elizabeth | |Elizabeth | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 9,982: | Line 9,982: | ||
|Alfaro | |Alfaro | ||
|Vicente | |Vicente | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,002: | Line 10,002: | ||
|Alfieri | |Alfieri | ||
|Sergio | |Sergio | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,022: | Line 10,022: | ||
|Alfonsi | |Alfonsi | ||
|Marc | |Marc | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,042: | Line 10,042: | ||
|Algarra | |Algarra | ||
|Lorenzo | |Lorenzo | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,061: | Line 10,061: | ||
|- | |- | ||
|Algazi | |Algazi | ||
− | |Alain P | + | |Alain P. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,082: | Line 10,082: | ||
|Algeri | |Algeri | ||
|Renato | |Renato | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,102: | Line 10,102: | ||
|Algul | |Algul | ||
|Hana | |Hana | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 10,141: | Line 10,141: | ||
|- | |- | ||
|Ali | |Ali | ||
− | |Arif N | + | |Arif N. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,162: | Line 10,162: | ||
|Ali | |Ali | ||
|Haris | |Haris | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,182: | Line 10,182: | ||
|Ali | |Ali | ||
|Haythem | |Haythem | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,202: | Line 10,202: | ||
|Ali | |Ali | ||
|Kulsam | |Kulsam | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,222: | Line 10,222: | ||
|Ali | |Ali | ||
|Marco | |Marco | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,242: | Line 10,242: | ||
|Ali | |Ali | ||
|Nasim | |Nasim | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,262: | Line 10,262: | ||
|Ali | |Ali | ||
|Ridvan | |Ridvan | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,282: | Line 10,282: | ||
|Ali | |Ali | ||
|Saad | |Saad | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,302: | Line 10,302: | ||
|Ali | |Ali | ||
|Sahra | |Sahra | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 10,322: | Line 10,322: | ||
|Ali | |Ali | ||
|Shamshad | |Shamshad | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,342: | Line 10,342: | ||
|Ali | |Ali | ||
|Shyanne | |Shyanne | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 10,361: | Line 10,361: | ||
|- | |- | ||
|Ali | |Ali | ||
− | |Siraj M | + | |Siraj M. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,382: | Line 10,382: | ||
|Aliberti | |Aliberti | ||
|Camillo | |Camillo | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,402: | Line 10,402: | ||
|Aliberti | |Aliberti | ||
|Sandra | |Sandra | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 10,422: | Line 10,422: | ||
|Alietti | |Alietti | ||
|Alessandra | |Alessandra | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 10,442: | Line 10,442: | ||
|Alimam | |Alimam | ||
|Samah | |Samah | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 10,462: | Line 10,462: | ||
|Alimena | |Alimena | ||
|Giuliana | |Giuliana | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 10,482: | Line 10,482: | ||
|Alinari | |Alinari | ||
|Lapo | |Lapo | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,502: | Line 10,502: | ||
|Aljijakli | |Aljijakli | ||
|Ahmad | |Ahmad | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,521: | Line 10,521: | ||
|- | |- | ||
|Aljitawi | |Aljitawi | ||
− | |Omar S | + | |Omar S. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,542: | Line 10,542: | ||
|Aljumaily | |Aljumaily | ||
|Raid | |Raid | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,562: | Line 10,562: | ||
|Alkan | |Alkan | ||
|Serhan | |Serhan | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,622: | Line 10,622: | ||
|Alkuzweny | |Alkuzweny | ||
|Baha | |Baha | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,642: | Line 10,642: | ||
|Allaham | |Allaham | ||
|Wassim | |Wassim | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,661: | Line 10,661: | ||
|- | |- | ||
|Allal | |Allal | ||
− | |Abdelkarim S | + | |Abdelkarim S. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,681: | Line 10,681: | ||
|- | |- | ||
|Allan | |Allan | ||
− | |John N | + | |John N. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,702: | Line 10,702: | ||
|Allan | |Allan | ||
|Karen | |Karen | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 10,721: | Line 10,721: | ||
|- | |- | ||
|Allan | |Allan | ||
− | |Norman C | + | |Norman C. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,742: | Line 10,742: | ||
|Alland | |Alland | ||
|Leila | |Leila | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 10,762: | Line 10,762: | ||
|Allangba | |Allangba | ||
|Olivier | |Olivier | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,782: | Line 10,782: | ||
|Allard | |Allard | ||
|Christian | |Christian | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,801: | Line 10,801: | ||
|- | |- | ||
|Allegra | |Allegra | ||
− | |Carmen J | + | |Carmen J. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,822: | Line 10,822: | ||
|Allegrini | |Allegrini | ||
|Giacomo | |Giacomo | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,841: | Line 10,841: | ||
|- | |- | ||
|Allen Mersh | |Allen Mersh | ||
− | |T G | + | |T. G. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 10,861: | Line 10,861: | ||
|- | |- | ||
|Allen | |Allen | ||
− | |Aaron M | + | |Aaron M. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,881: | Line 10,881: | ||
|- | |- | ||
|Allen | |Allen | ||
− | |Andrew R | + | |Andrew R. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,902: | Line 10,902: | ||
|Allen | |Allen | ||
|Carl | |Carl | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,921: | Line 10,921: | ||
|- | |- | ||
|Allen | |Allen | ||
− | |Jeffrey C | + | |Jeffrey C. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 10,941: | Line 10,941: | ||
|- | |- | ||
|Allen | |Allen | ||
− | |Jennifer L | + | |Jennifer L. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 10,961: | Line 10,961: | ||
|- | |- | ||
|Allen | |Allen | ||
− | |Jill N | + | |Jill N. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 10,982: | Line 10,982: | ||
|Allen | |Allen | ||
|John | |John | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 11,001: | Line 11,001: | ||
|- | |- | ||
|Allen | |Allen | ||
− | |L | + | |L. |
|CBD | |CBD | ||
| | | | ||
Line 11,021: | Line 11,021: | ||
|- | |- | ||
|Allen | |Allen | ||
− | |Lee F | + | |Lee F. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 11,041: | Line 11,041: | ||
|- | |- | ||
|Allen | |Allen | ||
− | |Mary S | + | |Mary S. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 11,061: | Line 11,061: | ||
|- | |- | ||
|Allen | |Allen | ||
− | |Peter J | + | |Peter J. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 11,081: | Line 11,081: | ||
|- | |- | ||
|Allen | |Allen | ||
− | |Roberta S | + | |Roberta S. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 11,101: | Line 11,101: | ||
|- | |- | ||
|Allen | |Allen | ||
− | |Steven L | + | |Steven L. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 11,122: | Line 11,122: | ||
|Allepuz | |Allepuz | ||
|Alex | |Alex | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 11,142: | Line 11,142: | ||
|Allerton | |Allerton | ||
|Rozenn | |Rozenn | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 11,161: | Line 11,161: | ||
|- | |- | ||
|Allevi | |Allevi | ||
− | |G | + | |G. |
|CBD | |CBD | ||
| | | | ||
Line 11,182: | Line 11,182: | ||
|Allewelt | |Allewelt | ||
|Heather | |Heather | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 11,202: | Line 11,202: | ||
|Allgeier | |Allgeier | ||
|Anouk | |Anouk | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 11,222: | Line 11,222: | ||
|Allietta | |Allietta | ||
|Nathalie | |Nathalie | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 11,242: | Line 11,242: | ||
|Allione | |Allione | ||
|Bernardino | |Bernardino | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 11,262: | Line 11,262: | ||
|Allis | |Allis | ||
|Simona | |Simona | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 11,282: | Line 11,282: | ||
|Allison | |Allison | ||
|James | |James | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 11,301: | Line 11,301: | ||
|- | |- | ||
|Allison | |Allison | ||
− | |Mary Ann K | + | |Mary Ann K. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 11,322: | Line 11,322: | ||
|Allman | |Allman | ||
|David | |David | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 11,342: | Line 11,342: | ||
|Allmark | |Allmark | ||
|Christine | |Christine | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 11,362: | Line 11,362: | ||
|Allmer | |Allmer | ||
|Christine | |Christine | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 11,381: | Line 11,381: | ||
|- | |- | ||
|Alloisio | |Alloisio | ||
− | |M | + | |M. |
|CBD | |CBD | ||
| | | | ||
Line 11,402: | Line 11,402: | ||
|Allolio | |Allolio | ||
|Bruno | |Bruno | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 11,422: | Line 11,422: | ||
|Allotey | |Allotey | ||
|David | |David | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 11,442: | Line 11,442: | ||
|Allouache | |Allouache | ||
|Djelila | |Djelila | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 11,481: | Line 11,481: | ||
|- | |- | ||
|Allred | |Allred | ||
− | |Alicia J | + | |Alicia J. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 11,501: | Line 11,501: | ||
|- | |- | ||
|Allred | |Allred | ||
− | |D Craig | + | |D. Craig |
− | | | + | |M |
| | | | ||
| | | | ||
Line 11,521: | Line 11,521: | ||
|- | |- | ||
|Allred | |Allred | ||
− | |Jacob B | + | |Jacob B. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 11,541: | Line 11,541: | ||
|- | |- | ||
|Allsup | |Allsup | ||
− | |David J | + | |David J. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 11,561: | Line 11,561: | ||
|- | |- | ||
|Allum | |Allum | ||
− | |William H | + | |William H. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 11,581: | Line 11,581: | ||
|- | |- | ||
|Ally | |Ally | ||
− | |Mina S | + | |Mina S. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 11,602: | Line 11,602: | ||
|Alm | |Alm | ||
|Gunnar | |Gunnar | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 11,622: | Line 11,622: | ||
|Almeida | |Almeida | ||
|Antonio | |Antonio | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 11,641: | Line 11,641: | ||
|- | |- | ||
|Almeida | |Almeida | ||
− | |M S S | + | |M. S. S. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 11,662: | Line 11,662: | ||
|Almenar | |Almenar | ||
|Daniel | |Daniel | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 11,682: | Line 11,682: | ||
|Almenar | |Almenar | ||
|Sergio | |Sergio | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 11,701: | Line 11,701: | ||
|- | |- | ||
|Almond | |Almond | ||
− | |Jennifer P | + | |Jennifer P. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 11,742: | Line 11,742: | ||
|Aloj | |Aloj | ||
|Luigi | |Luigi | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 11,762: | Line 11,762: | ||
|Alonso Carrion | |Alonso Carrion | ||
|Lorenzo | |Lorenzo | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 11,782: | Line 11,782: | ||
|Alonso Garcia | |Alonso Garcia | ||
|Miriam | |Miriam | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 11,802: | Line 11,802: | ||
|Alonso Gordoa | |Alonso Gordoa | ||
|Teresa | |Teresa | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 11,822: | Line 11,822: | ||
|Alonso Orduna | |Alonso Orduna | ||
|Vicente | |Vicente | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 11,842: | Line 11,842: | ||
|Alonso | |Alonso | ||
|Carmen | |Carmen | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 11,862: | Line 11,862: | ||
|Alonso | |Alonso | ||
|Guillermo | |Guillermo | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 11,882: | Line 11,882: | ||
|Alonso | |Alonso | ||
|Liuba | |Liuba | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 11,902: | Line 11,902: | ||
|Alonso | |Alonso | ||
|Maria Carmen | |Maria Carmen | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 11,922: | Line 11,922: | ||
|Alonso | |Alonso | ||
|Mirta Garcia | |Mirta Garcia | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 11,942: | Line 11,942: | ||
|Alonso | |Alonso | ||
|Natalia | |Natalia | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 11,962: | Line 11,962: | ||
|Alonso | |Alonso | ||
|Silvia | |Silvia | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 11,981: | Line 11,981: | ||
|- | |- | ||
|Alonzo | |Alonzo | ||
− | |Todd A | + | |Todd A. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,001: | Line 12,001: | ||
|- | |- | ||
|Alousi | |Alousi | ||
− | |Amin M | + | |Amin M. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,021: | Line 12,021: | ||
|- | |- | ||
|Alpen | |Alpen | ||
− | |B | + | |B. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 12,042: | Line 12,042: | ||
|Alquati | |Alquati | ||
|Palmiro | |Palmiro | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,062: | Line 12,062: | ||
|Alsayed | |Alsayed | ||
|Yazan | |Yazan | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,082: | Line 12,082: | ||
|Alsina Maqueda | |Alsina Maqueda | ||
|Maria | |Maria | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 12,102: | Line 12,102: | ||
|Alsina | |Alsina | ||
|Melissa | |Melissa | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 12,122: | Line 12,122: | ||
|Altavilla | |Altavilla | ||
|Giuseppe | |Giuseppe | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,142: | Line 12,142: | ||
|Altenhofer | |Altenhofer | ||
|Petra | |Petra | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 12,161: | Line 12,161: | ||
|- | |- | ||
|Alter | |Alter | ||
− | |Robert S | + | |Robert S. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,181: | Line 12,181: | ||
|- | |- | ||
|Alterio | |Alterio | ||
− | |D | + | |D. |
|CBD | |CBD | ||
| | | | ||
Line 12,201: | Line 12,201: | ||
|- | |- | ||
|Altermatt | |Altermatt | ||
− | |Hans J | + | |Hans J. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,222: | Line 12,222: | ||
|Altes | |Altes | ||
|Albert | |Albert | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,241: | Line 12,241: | ||
|- | |- | ||
|Althaus | |Althaus | ||
− | |Betsy L | + | |Betsy L. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 12,261: | Line 12,261: | ||
|- | |- | ||
|Althausen | |Althausen | ||
− | |Alex F | + | |Alex F. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,282: | Line 12,282: | ||
|Altieri | |Altieri | ||
|Vincenzo | |Vincenzo | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,301: | Line 12,301: | ||
|- | |- | ||
|Altinbas | |Altinbas | ||
− | |M | + | |M. |
|CBD | |CBD | ||
| | | | ||
Line 12,322: | Line 12,322: | ||
|Altinmakas | |Altinmakas | ||
|Emre | |Emre | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,342: | Line 12,342: | ||
|Altintas | |Altintas | ||
|Sevilay | |Sevilay | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 12,362: | Line 12,362: | ||
|Altman | |Altman | ||
|Arnold | |Arnold | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,381: | Line 12,381: | ||
|- | |- | ||
|Altman | |Altman | ||
− | |Jessica K | + | |Jessica K. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 12,401: | Line 12,401: | ||
|- | |- | ||
|Altman | |Altman | ||
− | |Stanley J | + | |Stanley J. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,422: | Line 12,422: | ||
|Altmann | |Altmann | ||
|Bettina | |Bettina | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 12,442: | Line 12,442: | ||
|Altorjai | |Altorjai | ||
|Gabriela | |Gabriela | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 12,461: | Line 12,461: | ||
|- | |- | ||
|Altorki | |Altorki | ||
− | |Nasser K | + | |Nasser K. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,482: | Line 12,482: | ||
|Altug | |Altug | ||
|Sedat | |Sedat | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,502: | Line 12,502: | ||
|Altwein | |Altwein | ||
|Jens Erik | |Jens Erik | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,522: | Line 12,522: | ||
|Alu | |Alu | ||
|Massimiliano | |Massimiliano | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,541: | Line 12,541: | ||
|- | |- | ||
|Alumkal | |Alumkal | ||
− | |Joshi J | + | |Joshi J. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,561: | Line 12,561: | ||
|- | |- | ||
|Alva | |Alva | ||
− | |Ajjai S | + | |Ajjai S. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,582: | Line 12,582: | ||
|Alvarado | |Alvarado | ||
|Gladys | |Gladys | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 12,602: | Line 12,602: | ||
|Alvarado | |Alvarado | ||
|Yesid | |Yesid | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,622: | Line 12,622: | ||
|Alvarez Cabellos | |Alvarez Cabellos | ||
|Ruth | |Ruth | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 12,642: | Line 12,642: | ||
|Alvarez de Celis | |Alvarez de Celis | ||
|Isabel | |Isabel | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 12,662: | Line 12,662: | ||
|Alvarez Larran | |Alvarez Larran | ||
|Alberto | |Alberto | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,682: | Line 12,682: | ||
|Alvarez Secord | |Alvarez Secord | ||
|Angeles | |Angeles | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 12,702: | Line 12,702: | ||
|Alvarez Twose | |Alvarez Twose | ||
|Ivan | |Ivan | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,721: | Line 12,721: | ||
|- | |- | ||
|Alvarez Vicent | |Alvarez Vicent | ||
− | |J J | + | |J. J. |
|CBD | |CBD | ||
| | | | ||
Line 12,742: | Line 12,742: | ||
|Alvarez | |Alvarez | ||
|Ana | |Ana | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 12,782: | Line 12,782: | ||
|Alvarez | |Alvarez | ||
|Elena | |Elena | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 12,802: | Line 12,802: | ||
|Alvarez | |Alvarez | ||
|Isabel | |Isabel | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 12,822: | Line 12,822: | ||
|Alvarez | |Alvarez | ||
|Ivan | |Ivan | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,842: | Line 12,842: | ||
|Alvarez | |Alvarez | ||
|Jose Valero | |Jose Valero | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,861: | Line 12,861: | ||
|- | |- | ||
|Alvarez | |Alvarez | ||
− | |Ofelia A | + | |Ofelia A. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 12,882: | Line 12,882: | ||
|Alvarez | |Alvarez | ||
|Pablo | |Pablo | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,901: | Line 12,901: | ||
|- | |- | ||
|Alvarez | |Alvarez | ||
− | |Ronald D | + | |Ronald D. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,921: | Line 12,921: | ||
|- | |- | ||
|Alvarnas | |Alvarnas | ||
− | |Joseph C | + | |Joseph C. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,942: | Line 12,942: | ||
|Alvegaard | |Alvegaard | ||
|Thor | |Thor | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,962: | Line 12,962: | ||
|Aly | |Aly | ||
|Abdalla | |Abdalla | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 12,982: | Line 12,982: | ||
|Alyasova | |Alyasova | ||
|Anna | |Anna | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 13,001: | Line 13,001: | ||
|- | |- | ||
|Alyea | |Alyea | ||
− | |Edwin P | + | |Edwin P. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,022: | Line 13,022: | ||
|Alzate | |Alzate | ||
|Stefanie | |Stefanie | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 13,042: | Line 13,042: | ||
|Alzieu | |Alzieu | ||
|Claude | |Claude | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,062: | Line 13,062: | ||
|Alzouebi | |Alzouebi | ||
|Mymoona | |Mymoona | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 13,082: | Line 13,082: | ||
|Amabile | |Amabile | ||
|Marilina | |Marilina | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 13,101: | Line 13,101: | ||
|- | |- | ||
|Amado | |Amado | ||
− | |Rafael G | + | |Rafael G. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,121: | Line 13,121: | ||
|- | |- | ||
|Amador Barciela | |Amador Barciela | ||
− | |Maria L | + | |Maria L. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 13,141: | Line 13,141: | ||
|- | |- | ||
|Amador | |Amador | ||
− | |Rosa M | + | |Rosa M. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 13,162: | Line 13,162: | ||
|Amadori | |Amadori | ||
|Dino | |Dino | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,182: | Line 13,182: | ||
|Amadori | |Amadori | ||
|Sergio | |Sergio | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,202: | Line 13,202: | ||
|Amaducci | |Amaducci | ||
|Laura | |Laura | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 13,222: | Line 13,222: | ||
|Amagai | |Amagai | ||
|Kenji | |Kenji | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,242: | Line 13,242: | ||
|Amam | |Amam | ||
|Josif | |Josif | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,261: | Line 13,261: | ||
|- | |- | ||
|Amann | |Amann | ||
− | |G | + | |G. |
|CBD | |CBD | ||
| | | | ||
Line 13,302: | Line 13,302: | ||
|Amant | |Amant | ||
|Frederic | |Frederic | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,322: | Line 13,322: | ||
|Amar | |Amar | ||
|Avraham | |Avraham | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,341: | Line 13,341: | ||
|- | |- | ||
|Amaravadi | |Amaravadi | ||
− | |Ravi K | + | |Ravi K. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,382: | Line 13,382: | ||
|Amato | |Amato | ||
|Giovanni | |Giovanni | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,401: | Line 13,401: | ||
|- | |- | ||
|Amato | |Amato | ||
− | |Robert J | + | |Robert J. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,421: | Line 13,421: | ||
|- | |- | ||
|Amato | |Amato | ||
− | |S | + | |S. |
|CBD | |CBD | ||
| | | | ||
Line 13,441: | Line 13,441: | ||
|- | |- | ||
|Amatruda | |Amatruda | ||
− | |Thomas T | + | |Thomas T. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,462: | Line 13,462: | ||
|Amatu | |Amatu | ||
|Alessio | |Alessio | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,482: | Line 13,482: | ||
|Ambarkhane | |Ambarkhane | ||
|Sumeet | |Sumeet | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,501: | Line 13,501: | ||
|- | |- | ||
|Ambinder | |Ambinder | ||
− | |Richard F | + | |Richard F. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,521: | Line 13,521: | ||
|- | |- | ||
|Ambo | |Ambo | ||
− | |Y | + | |Y. |
|CBD | |CBD | ||
| | | | ||
Line 13,541: | Line 13,541: | ||
|- | |- | ||
|Ambros | |Ambros | ||
− | |Peter F | + | |Peter F. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,562: | Line 13,562: | ||
|Ambrose | |Ambrose | ||
|David | |David | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,582: | Line 13,582: | ||
|Ambrosetti | |Ambrosetti | ||
|Achille | |Achille | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,602: | Line 13,602: | ||
|Ambrosini | |Ambrosini | ||
|Giovanni | |Giovanni | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,622: | Line 13,622: | ||
|Ambrosini | |Ambrosini | ||
|Grazia | |Grazia | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 13,642: | Line 13,642: | ||
|Ambrosini | |Ambrosini | ||
|Maria Teresa | |Maria Teresa | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 13,662: | Line 13,662: | ||
|Ambrosio | |Ambrosio | ||
|Francesca | |Francesca | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 13,702: | Line 13,702: | ||
|Amellal | |Amellal | ||
|Nadia | |Nadia | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 13,722: | Line 13,722: | ||
|Amendola | |Amendola | ||
|Angela | |Angela | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 13,742: | Line 13,742: | ||
|Amenedo Gancedo | |Amenedo Gancedo | ||
|Margarita | |Margarita | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 13,761: | Line 13,761: | ||
|- | |- | ||
|Ames | |Ames | ||
− | |Frederick C | + | |Frederick C. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,782: | Line 13,782: | ||
|Ames | |Ames | ||
|Patricia | |Patricia | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 13,802: | Line 13,802: | ||
|Ameye | |Ameye | ||
|Lieveke | |Lieveke | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 13,822: | Line 13,822: | ||
|Amiel | |Amiel | ||
|Jean Louis | |Jean Louis | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,861: | Line 13,861: | ||
|- | |- | ||
|Amin | |Amin | ||
− | |Amanda L | + | |Amanda L. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 13,882: | Line 13,882: | ||
|Amin | |Amin | ||
|Asim | |Asim | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,922: | Line 13,922: | ||
|Amin | |Amin | ||
|Himal | |Himal | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,941: | Line 13,941: | ||
|- | |- | ||
|Amin | |Amin | ||
− | |Mahul B | + | |Mahul B. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 13,962: | Line 13,962: | ||
|Aminossadati | |Aminossadati | ||
|Behnaz | |Behnaz | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 14,001: | Line 14,001: | ||
|- | |- | ||
|Amista | |Amista | ||
− | |P | + | |P. |
|CBD | |CBD | ||
| | | | ||
Line 14,022: | Line 14,022: | ||
|Amler | |Amler | ||
|Susanne | |Susanne | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 14,042: | Line 14,042: | ||
|Ammassari | |Ammassari | ||
|Adriana | |Adriana | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 14,062: | Line 14,062: | ||
|Amonkar | |Amonkar | ||
|Mayur | |Mayur | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,082: | Line 14,082: | ||
|Amorim | |Amorim | ||
|Gilberto | |Gilberto | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,102: | Line 14,102: | ||
|Amoroso | |Amoroso | ||
|Domenico | |Domenico | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,122: | Line 14,122: | ||
|Amoroso | |Amoroso | ||
|Mariangela | |Mariangela | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 14,142: | Line 14,142: | ||
|Amoroso | |Amoroso | ||
|Vito | |Vito | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,161: | Line 14,161: | ||
|- | |- | ||
|Amos | |Amos | ||
− | |Claire L | + | |Claire L. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 14,181: | Line 14,181: | ||
|- | |- | ||
|Amott | |Amott | ||
− | |S J | + | |S. J. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 14,202: | Line 14,202: | ||
|Amoura | |Amoura | ||
|Zahir | |Zahir | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,221: | Line 14,221: | ||
|- | |- | ||
|Amrein | |Amrein | ||
− | |Philip C | + | |Philip C. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,242: | Line 14,242: | ||
|Amthauer | |Amthauer | ||
|Holger | |Holger | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,262: | Line 14,262: | ||
|Amundsen | |Amundsen | ||
|Tore | |Tore | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,282: | Line 14,282: | ||
|Amunni | |Amunni | ||
|Gianni | |Gianni | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,302: | Line 14,302: | ||
|Amutio | |Amutio | ||
|Elena | |Elena | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 14,321: | Line 14,321: | ||
|- | |- | ||
|Amylon | |Amylon | ||
− | |Michael D | + | |Michael D. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,342: | Line 14,342: | ||
|Amzal | |Amzal | ||
|Billy | |Billy | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,381: | Line 14,381: | ||
|- | |- | ||
|An | |An | ||
− | |J Y | + | |J. Y. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 14,462: | Line 14,462: | ||
|Anagnostopoulos | |Anagnostopoulos | ||
|Achilles | |Achilles | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,482: | Line 14,482: | ||
|Anagnostopoulos | |Anagnostopoulos | ||
|Athanasios | |Athanasios | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,502: | Line 14,502: | ||
|Anagnostopoulos | |Anagnostopoulos | ||
|Ioannis | |Ioannis | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,522: | Line 14,522: | ||
|Anagnostopoulos | |Anagnostopoulos | ||
|Nikolaos | |Nikolaos | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,542: | Line 14,542: | ||
|Anagnostopoulou | |Anagnostopoulou | ||
|Ourania | |Ourania | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 14,562: | Line 14,562: | ||
|Anaissie | |Anaissie | ||
|Elias | |Elias | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,582: | Line 14,582: | ||
|Anak | |Anak | ||
|Oezlem | |Oezlem | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 14,602: | Line 14,602: | ||
|Anand | |Anand | ||
|Aseem | |Aseem | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,642: | Line 14,642: | ||
|Ananthakrishnan | |Ananthakrishnan | ||
|Revathi | |Revathi | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 14,662: | Line 14,662: | ||
|Anasetti | |Anasetti | ||
|Claudio | |Claudio | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,682: | Line 14,682: | ||
|Anastasi | |Anastasi | ||
|John | |John | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,702: | Line 14,702: | ||
|Anastasia | |Anastasia | ||
|Antonella | |Antonella | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 14,722: | Line 14,722: | ||
|Anastasopoulou | |Anastasopoulou | ||
|Anastasia | |Anastasia | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 14,742: | Line 14,742: | ||
|Ancell | |Ancell | ||
|Kristin | |Kristin | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 14,782: | Line 14,782: | ||
|Anciaux | |Anciaux | ||
|Nicole | |Nicole | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 14,802: | Line 14,802: | ||
|Ancliff | |Ancliff | ||
|Philip | |Philip | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,822: | Line 14,822: | ||
|Ancona | |Ancona | ||
|Ermanno | |Ermanno | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,842: | Line 14,842: | ||
|Ancukiewicz | |Ancukiewicz | ||
|Marek | |Marek | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,862: | Line 14,862: | ||
|Andel | |Andel | ||
|Johannes | |Johannes | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,882: | Line 14,882: | ||
|Andergassen | |Andergassen | ||
|Ulrich | |Ulrich | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,902: | Line 14,902: | ||
|Anderl | |Anderl | ||
|Janet | |Janet | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 14,922: | Line 14,922: | ||
|Anderlini | |Anderlini | ||
|Paolo | |Paolo | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,941: | Line 14,941: | ||
|- | |- | ||
|Anders | |Anders | ||
− | |Carey K | + | |Carey K. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 14,961: | Line 14,961: | ||
|- | |- | ||
|Anders | |Anders | ||
− | |Robert A | + | |Robert A. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 14,981: | Line 14,981: | ||
|- | |- | ||
|Andersen | |Andersen | ||
− | |Barbara L | + | |Barbara L. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 15,001: | Line 15,001: | ||
|- | |- | ||
|Andersen | |Andersen | ||
− | |E | + | |E. |
|CBD | |CBD | ||
| | | | ||
Line 15,021: | Line 15,021: | ||
|- | |- | ||
|Andersen | |Andersen | ||
− | |J C | + | |J. C. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 15,041: | Line 15,041: | ||
|- | |- | ||
|Andersen | |Andersen | ||
− | |James S | + | |James S. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,061: | Line 15,061: | ||
|- | |- | ||
|Andersen | |Andersen | ||
− | |Janet W | + | |Janet W. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 15,081: | Line 15,081: | ||
|- | |- | ||
|Andersen | |Andersen | ||
− | |Jay C | + | |Jay C. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,102: | Line 15,102: | ||
|Andersen | |Andersen | ||
|Joern Erik | |Joern Erik | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,122: | Line 15,122: | ||
|Andersen | |Andersen | ||
|John | |John | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,142: | Line 15,142: | ||
|Andersen | |Andersen | ||
|Jorn | |Jorn | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,162: | Line 15,162: | ||
|Andersen | |Andersen | ||
|Knud West | |Knud West | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,182: | Line 15,182: | ||
|Andersen | |Andersen | ||
|Niels Frost | |Niels Frost | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,201: | Line 15,201: | ||
|- | |- | ||
|Andersen | |Andersen | ||
− | |Niels S | + | |Niels S. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,221: | Line 15,221: | ||
|- | |- | ||
|Andersen | |Andersen | ||
− | |Willie A | + | |Willie A. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,242: | Line 15,242: | ||
|Anderson | |Anderson | ||
|Abraham | |Abraham | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,282: | Line 15,282: | ||
|Anderson | |Anderson | ||
|Barry | |Barry | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,302: | Line 15,302: | ||
|Anderson | |Anderson | ||
|Cathy | |Cathy | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 15,321: | Line 15,321: | ||
|- | |- | ||
|Anderson | |Anderson | ||
− | |Charles K | + | |Charles K. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,341: | Line 15,341: | ||
|- | |- | ||
|Anderson | |Anderson | ||
− | |Clay M | + | |Clay M. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,361: | Line 15,361: | ||
|- | |- | ||
|Anderson | |Anderson | ||
− | |Daniel M | + | |Daniel M. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,381: | Line 15,381: | ||
|- | |- | ||
|Anderson | |Anderson | ||
− | |David R | + | |David R. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,402: | Line 15,402: | ||
|Anderson | |Anderson | ||
|Harald | |Harald | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,421: | Line 15,421: | ||
|- | |- | ||
|Anderson | |Anderson | ||
− | |Heather A | + | |Heather A. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 15,441: | Line 15,441: | ||
|- | |- | ||
|Anderson | |Anderson | ||
− | |J | + | |J. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 15,461: | Line 15,461: | ||
|- | |- | ||
|Anderson | |Anderson | ||
− | |James R | + | |James R. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,481: | Line 15,481: | ||
|- | |- | ||
|Anderson | |Anderson | ||
− | |Jeanne E | + | |Jeanne E. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 15,502: | Line 15,502: | ||
|Anderson | |Anderson | ||
|Jeffrey | |Jeffrey | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,521: | Line 15,521: | ||
|- | |- | ||
|Anderson | |Anderson | ||
− | |Jennifer J | + | |Jennifer J. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 15,541: | Line 15,541: | ||
|- | |- | ||
|Anderson | |Anderson | ||
− | |John B | + | |John B. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,561: | Line 15,561: | ||
|- | |- | ||
|Anderson | |Anderson | ||
− | |Karen S | + | |Karen S. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 15,581: | Line 15,581: | ||
|- | |- | ||
|Anderson | |Anderson | ||
− | |Kenneth C | + | |Kenneth C. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,601: | Line 15,601: | ||
|- | |- | ||
|Anderson | |Anderson | ||
− | |Larry D | + | |Larry D. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,622: | Line 15,622: | ||
|Anderson | |Anderson | ||
|Lisa | |Lisa | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 15,662: | Line 15,662: | ||
|Anderson | |Anderson | ||
|Mary Ann | |Mary Ann | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 15,681: | Line 15,681: | ||
|- | |- | ||
|Anderson | |Anderson | ||
− | |Michael J | + | |Michael J. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,721: | Line 15,721: | ||
|- | |- | ||
|Anderson | |Anderson | ||
− | |Nicole D | + | |Nicole D. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 15,742: | Line 15,742: | ||
|Anderson | |Anderson | ||
|Patricia | |Patricia | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 15,761: | Line 15,761: | ||
|- | |- | ||
|Anderson | |Anderson | ||
− | |Peter M | + | |Peter M. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,781: | Line 15,781: | ||
|- | |- | ||
|Anderson | |Anderson | ||
− | |Richard T | + | |Richard T. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,801: | Line 15,801: | ||
|- | |- | ||
|Anderson | |Anderson | ||
− | |Russell D | + | |Russell D. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,822: | Line 15,822: | ||
|Anderson | |Anderson | ||
|Sibyl | |Sibyl | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 15,841: | Line 15,841: | ||
|- | |- | ||
|Anderson | |Anderson | ||
− | |Stewart J | + | |Stewart J. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,882: | Line 15,882: | ||
|Anderson | |Anderson | ||
|Tara | |Tara | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 15,902: | Line 15,902: | ||
|Anderson | |Anderson | ||
|Thomas | |Thomas | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,921: | Line 15,921: | ||
|- | |- | ||
|Andersson | |Andersson | ||
− | |Borje S | + | |Borje S. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 15,962: | Line 15,962: | ||
|Andersson | |Andersson | ||
|Michael | |Michael | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,002: | Line 16,002: | ||
|Andersson | |Andersson | ||
|Ronny | |Ronny | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,022: | Line 16,022: | ||
|Andersson | |Andersson | ||
|Swen Olof | |Swen Olof | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,042: | Line 16,042: | ||
|Ando | |Ando | ||
|Jiro | |Jiro | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,062: | Line 16,062: | ||
|Ando | |Ando | ||
|Kiyoshi | |Kiyoshi | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,082: | Line 16,082: | ||
|Ando | |Ando | ||
|Masahiko | |Masahiko | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,102: | Line 16,102: | ||
|Ando | |Ando | ||
|Masahiro | |Masahiro | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,122: | Line 16,122: | ||
|Ando | |Ando | ||
|Masashi | |Masashi | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,142: | Line 16,142: | ||
|Ando | |Ando | ||
|Nobutoshi | |Nobutoshi | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,162: | Line 16,162: | ||
|Ando | |Ando | ||
|Yuichi | |Yuichi | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,181: | Line 16,181: | ||
|- | |- | ||
|Andoh | |Andoh | ||
− | |J | + | |J. |
|CBD | |CBD | ||
| | | | ||
Line 16,202: | Line 16,202: | ||
|Andorsky | |Andorsky | ||
|David | |David | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,222: | Line 16,222: | ||
|Andrade | |Andrade | ||
|Luciana | |Luciana | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 16,242: | Line 16,242: | ||
|Andre | |Andre | ||
|Fabrice | |Fabrice | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,261: | Line 16,261: | ||
|- | |- | ||
|Andre | |Andre | ||
− | |Marc P E | + | |Marc P. E. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,282: | Line 16,282: | ||
|Andre | |Andre | ||
|Niko | |Niko | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,302: | Line 16,302: | ||
|Andre | |Andre | ||
|Thierry | |Thierry | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,321: | Line 16,321: | ||
|- | |- | ||
|Andre | |Andre | ||
− | |Valerie A M | + | |Valerie A. M. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 16,342: | Line 16,342: | ||
|Andreadis | |Andreadis | ||
|Charalambos | |Charalambos | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,362: | Line 16,362: | ||
|Andreas | |Andreas | ||
|Stefan | |Stefan | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,382: | Line 16,382: | ||
|Andreasson | |Andreasson | ||
|Bjoern | |Bjoern | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,402: | Line 16,402: | ||
|Andreeff | |Andreeff | ||
|Michael | |Michael | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,421: | Line 16,421: | ||
|- | |- | ||
|Andreescu | |Andreescu | ||
− | |Astrid C | + | |Astrid C. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 16,442: | Line 16,442: | ||
|Andreesen | |Andreesen | ||
|Reinhard | |Reinhard | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,462: | Line 16,462: | ||
|Andreetta | |Andreetta | ||
|Claudia | |Claudia | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 16,502: | Line 16,502: | ||
|Andreola | |Andreola | ||
|Giovanna | |Giovanna | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 16,522: | Line 16,522: | ||
|Andreoli | |Andreoli | ||
|Laura | |Laura | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 16,542: | Line 16,542: | ||
|Andreopoulos | |Andreopoulos | ||
|Demetrios | |Demetrios | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,562: | Line 16,562: | ||
|Andreou | |Andreou | ||
|Cal | |Cal | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,602: | Line 16,602: | ||
|Andresen Daniil | |Andresen Daniil | ||
|Corina | |Corina | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 16,622: | Line 16,622: | ||
|Andreuccetti | |Andreuccetti | ||
|Michele | |Michele | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,642: | Line 16,642: | ||
|Andrews | |Andrews | ||
|Chris | |Chris | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,661: | Line 16,661: | ||
|- | |- | ||
|Andrews | |Andrews | ||
− | |Glen I | + | |Glen I. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,681: | Line 16,681: | ||
|- | |- | ||
|Andrews | |Andrews | ||
− | |Michael B | + | |Michael B. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,702: | Line 16,702: | ||
|Andrews | |Andrews | ||
|Stephen | |Stephen | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,721: | Line 16,721: | ||
|- | |- | ||
|Andrews | |Andrews | ||
− | |Vivienne E | + | |Vivienne E. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 16,742: | Line 16,742: | ||
|Andric | |Andric | ||
|Zoran | |Zoran | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,761: | Line 16,761: | ||
|- | |- | ||
|Andrien | |Andrien | ||
− | |J M | + | |J. M. |
|CBD | |CBD | ||
| | | | ||
Line 16,782: | Line 16,782: | ||
|Andrieu | |Andrieu | ||
|Jean Marie | |Jean Marie | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,801: | Line 16,801: | ||
|- | |- | ||
|Andriole | |Andriole | ||
− | |Gerald L | + | |Gerald L. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,821: | Line 16,821: | ||
|- | |- | ||
|Andritsos | |Andritsos | ||
− | |Leslie A | + | |Leslie A. |
|UNMATCHED | |UNMATCHED | ||
| | | | ||
Line 16,842: | Line 16,842: | ||
|Androulakis | |Androulakis | ||
|Ioannis | |Ioannis | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,862: | Line 16,862: | ||
|Androulakis | |Androulakis | ||
|Nikolaos | |Nikolaos | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,881: | Line 16,881: | ||
|- | |- | ||
|Andrulis | |Andrulis | ||
− | |Irene L | + | |Irene L. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 16,901: | Line 16,901: | ||
|- | |- | ||
|Andtbacka | |Andtbacka | ||
− | |Robert H I | + | |Robert H. I. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,922: | Line 16,922: | ||
|Ang | |Ang | ||
|Agnes | |Agnes | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 16,942: | Line 16,942: | ||
|Ang | |Ang | ||
|Kie Kian | |Kie Kian | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 16,962: | Line 16,962: | ||
|Ang | |Ang | ||
|Mei Kim | |Mei Kim | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 16,982: | Line 16,982: | ||
|Ang | |Ang | ||
|Peng Tiam | |Peng Tiam | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,022: | Line 17,022: | ||
|Angele | |Angele | ||
|Martin | |Martin | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,042: | Line 17,042: | ||
|Angeli | |Angeli | ||
|Alberto | |Alberto | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,061: | Line 17,061: | ||
|- | |- | ||
|Angelopoulou | |Angelopoulou | ||
− | |Maria K | + | |Maria K. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 17,082: | Line 17,082: | ||
|Angelot Delettre | |Angelot Delettre | ||
|Fanny | |Fanny | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 17,102: | Line 17,102: | ||
|Angelsen | |Angelsen | ||
|Anders | |Anders | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,122: | Line 17,122: | ||
|Angelucci | |Angelucci | ||
|Emanuele | |Emanuele | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,142: | Line 17,142: | ||
|Angermund | |Angermund | ||
|Ralf | |Ralf | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,162: | Line 17,162: | ||
|Anghel | |Anghel | ||
|Rodica | |Rodica | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 17,181: | Line 17,181: | ||
|- | |- | ||
|Angiolillo | |Angiolillo | ||
− | |Anne L | + | |Anne L. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 17,202: | Line 17,202: | ||
|Anglaret | |Anglaret | ||
|Bruno | |Bruno | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,222: | Line 17,222: | ||
|Anglin | |Anglin | ||
|Peter | |Peter | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,242: | Line 17,242: | ||
|Angra | |Angra | ||
|Natasha | |Natasha | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 17,262: | Line 17,262: | ||
|Angrilli | |Angrilli | ||
|Francesco | |Francesco | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,281: | Line 17,281: | ||
|- | |- | ||
|Angyalfi | |Angyalfi | ||
− | |Steve J | + | |Steve J. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,321: | Line 17,321: | ||
|- | |- | ||
|Anker | |Anker | ||
− | |Christopher J | + | |Christopher J. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,342: | Line 17,342: | ||
|Anker | |Anker | ||
|Gun | |Gun | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 17,362: | Line 17,362: | ||
|Annamalai | |Annamalai | ||
|Lakshmanan | |Lakshmanan | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,381: | Line 17,381: | ||
|- | |- | ||
|Anne | |Anne | ||
− | |P Rani | + | |P. Rani |
− | | | + | |F |
| | | | ||
| | | | ||
Line 17,402: | Line 17,402: | ||
|Annechini | |Annechini | ||
|Giorgia | |Giorgia | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 17,421: | Line 17,421: | ||
|- | |- | ||
|Annecke | |Annecke | ||
− | |K | + | |K. |
|CBD | |CBD | ||
| | | | ||
Line 17,441: | Line 17,441: | ||
|- | |- | ||
|Annett | |Annett | ||
− | |Robert D | + | |Robert D. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,462: | Line 17,462: | ||
|Annibali | |Annibali | ||
|Ombretta | |Ombretta | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 17,482: | Line 17,482: | ||
|Annino | |Annino | ||
|Luciana | |Luciana | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 17,502: | Line 17,502: | ||
|Annunziata | |Annunziata | ||
|Annalisa | |Annalisa | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 17,522: | Line 17,522: | ||
|Annunziata | |Annunziata | ||
|Mario | |Mario | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,542: | Line 17,542: | ||
|Anota | |Anota | ||
|Amelie | |Amelie | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 17,562: | Line 17,562: | ||
|Ansari | |Ansari | ||
|Hassan | |Hassan | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,582: | Line 17,582: | ||
|Ansari | |Ansari | ||
|Marc | |Marc | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,601: | Line 17,601: | ||
|- | |- | ||
|Ansari | |Ansari | ||
− | |Rafat H | + | |Rafat H. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,621: | Line 17,621: | ||
|- | |- | ||
|Ansell | |Ansell | ||
− | |Peter J | + | |Peter J. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,641: | Line 17,641: | ||
|- | |- | ||
|Ansell | |Ansell | ||
− | |Stephen M | + | |Stephen M. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,662: | Line 17,662: | ||
|Anselmo | |Anselmo | ||
|Anna Paola | |Anna Paola | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 17,681: | Line 17,681: | ||
|- | |- | ||
|Ansfield | |Ansfield | ||
− | |Fred J | + | |Fred J. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,702: | Line 17,702: | ||
|Ansstas | |Ansstas | ||
|George | |George | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,722: | Line 17,722: | ||
|Antal | |Antal | ||
|Joyce | |Joyce | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 17,741: | Line 17,741: | ||
|- | |- | ||
|Anter | |Anter | ||
− | |A H | + | |A. H. |
|CBD | |CBD | ||
| | | | ||
Line 17,761: | Line 17,761: | ||
|- | |- | ||
|Anthes | |Anthes | ||
− | |M | + | |M. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 17,782: | Line 17,782: | ||
|Anthoney | |Anthoney | ||
|Alan | |Alan | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,802: | Line 17,802: | ||
|Anthony | |Anthony | ||
|Alan | |Alan | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,821: | Line 17,821: | ||
|- | |- | ||
|Anthony | |Anthony | ||
− | |Stephen P | + | |Stephen P. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,842: | Line 17,842: | ||
|Antimi | |Antimi | ||
|Mauro | |Mauro | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,861: | Line 17,861: | ||
|- | |- | ||
|Antin | |Antin | ||
− | |Joseph H | + | |Joseph H. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,902: | Line 17,902: | ||
|Antman | |Antman | ||
|Karen | |Karen | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 17,922: | Line 17,922: | ||
|Antolin Novoa | |Antolin Novoa | ||
|Silvia | |Silvia | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 17,941: | Line 17,941: | ||
|- | |- | ||
|Anton Torres | |Anton Torres | ||
− | |A | + | |A. |
|CBD | |CBD | ||
| | | | ||
Line 17,962: | Line 17,962: | ||
|Anton | |Anton | ||
|Antonio | |Antonio | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 17,981: | Line 17,981: | ||
|- | |- | ||
|Antonarakis | |Antonarakis | ||
− | |Emmanuel S | + | |Emmanuel S. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,001: | Line 18,001: | ||
|- | |- | ||
|Antonelli | |Antonelli | ||
− | |G | + | |G. |
|CBD | |CBD | ||
| | | | ||
Line 18,021: | Line 18,021: | ||
|- | |- | ||
|Antonescu | |Antonescu | ||
− | |Cristina R | + | |Cristina R. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 18,041: | Line 18,041: | ||
|- | |- | ||
|Antonia | |Antonia | ||
− | |Scott J | + | |Scott J. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,061: | Line 18,061: | ||
|- | |- | ||
|Antonini | |Antonini | ||
− | |Ninja F | + | |Ninja F. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 18,082: | Line 18,082: | ||
|Antonioli | |Antonioli | ||
|Elisabetta | |Elisabetta | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 18,102: | Line 18,102: | ||
|Antoniotti | |Antoniotti | ||
|Carlotta | |Carlotta | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 18,122: | Line 18,122: | ||
|Antoniou | |Antoniou | ||
|Dimosthenis | |Dimosthenis | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,142: | Line 18,142: | ||
|Antoniou | |Antoniou | ||
|Nicos | |Nicos | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,162: | Line 18,162: | ||
|Antonuzzo | |Antonuzzo | ||
|Lorenzo | |Lorenzo | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,202: | Line 18,202: | ||
|Anttila | |Anttila | ||
|Pekka | |Pekka | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,222: | Line 18,222: | ||
|Antunes | |Antunes | ||
|Luis | |Luis | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,242: | Line 18,242: | ||
|Antunovic | |Antunovic | ||
|Petar | |Petar | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,262: | Line 18,262: | ||
|Anz | |Anz | ||
|Bertrand | |Bertrand | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,282: | Line 18,282: | ||
|Aogi | |Aogi | ||
|Kenjiro | |Kenjiro | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,322: | Line 18,322: | ||
|Aoki | |Aoki | ||
|Daisuke | |Daisuke | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,342: | Line 18,342: | ||
|Aoki | |Aoki | ||
|Hiroshi | |Hiroshi | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,382: | Line 18,382: | ||
|Aoki | |Aoki | ||
|Yoichi | |Yoichi | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,402: | Line 18,402: | ||
|Aondio | |Aondio | ||
|Gian Marco | |Gian Marco | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,422: | Line 18,422: | ||
|Aotani | |Aotani | ||
|Eriko | |Eriko | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 18,441: | Line 18,441: | ||
|- | |- | ||
|Aoudjhane | |Aoudjhane | ||
− | |A | + | |A. |
|CBD | |CBD | ||
| | | | ||
Line 18,462: | Line 18,462: | ||
|Aoudjhane | |Aoudjhane | ||
|Malek | |Malek | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,481: | Line 18,481: | ||
|- | |- | ||
|Aoyama | |Aoyama | ||
− | |H | + | |H. |
|CBD | |CBD | ||
| | | | ||
Line 18,502: | Line 18,502: | ||
|Aoyama | |Aoyama | ||
|Norio | |Norio | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,562: | Line 18,562: | ||
|Apanovitch | |Apanovitch | ||
|Anne Marie | |Anne Marie | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 18,582: | Line 18,582: | ||
|Aparicio | |Aparicio | ||
|Jorge | |Jorge | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,602: | Line 18,602: | ||
|Aparicio | |Aparicio | ||
|Samuel | |Samuel | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,622: | Line 18,622: | ||
|Aparicio | |Aparicio | ||
|Thomas | |Thomas | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,642: | Line 18,642: | ||
|Apfelbeck | |Apfelbeck | ||
|Ute | |Ute | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 18,662: | Line 18,662: | ||
|Apffelstaedt | |Apffelstaedt | ||
|Justus | |Justus | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,682: | Line 18,682: | ||
|Aplenc | |Aplenc | ||
|Richard | |Richard | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,701: | Line 18,701: | ||
|- | |- | ||
|Apolo | |Apolo | ||
− | |Andrea B | + | |Andrea B. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,722: | Line 18,722: | ||
|Apolone | |Apolone | ||
|Giovanni | |Giovanni | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,742: | Line 18,742: | ||
|Aponte | |Aponte | ||
|John | |John | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,762: | Line 18,762: | ||
|Apostolou | |Apostolou | ||
|Theofanis | |Theofanis | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,782: | Line 18,782: | ||
|Appel | |Appel | ||
|Tabea | |Tabea | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 18,802: | Line 18,802: | ||
|Appel | |Appel | ||
|Wiebke | |Wiebke | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 18,821: | Line 18,821: | ||
|- | |- | ||
|Appelbaum | |Appelbaum | ||
− | |Frederick R | + | |Frederick R. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,861: | Line 18,861: | ||
|- | |- | ||
|Apperley | |Apperley | ||
− | |Jane F | + | |Jane F. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 18,882: | Line 18,882: | ||
|Appiani | |Appiani | ||
|Carlos | |Carlos | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,901: | Line 18,901: | ||
|- | |- | ||
|Appleman | |Appleman | ||
− | |Leonard J | + | |Leonard J. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,922: | Line 18,922: | ||
|Aprea | |Aprea | ||
|Pasquale | |Pasquale | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,942: | Line 18,942: | ||
|Aprile | |Aprile | ||
|Giuseppe | |Giuseppe | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,961: | Line 18,961: | ||
|- | |- | ||
|Apte | |Apte | ||
− | |Ron N | + | |Ron N. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 18,981: | Line 18,981: | ||
|- | |- | ||
|Aqui | |Aqui | ||
− | |Nicole A | + | |Nicole A. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 19,021: | Line 19,021: | ||
|- | |- | ||
|Arachchillage | |Arachchillage | ||
− | |Deepa R J | + | |Deepa R. J. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 19,061: | Line 19,061: | ||
|- | |- | ||
|Aragon Ching | |Aragon Ching | ||
− | |Jeanny B | + | |Jeanny B. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 19,082: | Line 19,082: | ||
|Arahmani | |Arahmani | ||
|Amal | |Amal | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 19,122: | Line 19,122: | ||
|Arai | |Arai | ||
|Kuniyoshi | |Kuniyoshi | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 19,182: | Line 19,182: | ||
|Arai | |Arai | ||
|Sally | |Sally | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 19,202: | Line 19,202: | ||
|Arai | |Arai | ||
|Yasuaki | |Yasuaki | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 19,222: | Line 19,222: | ||
|Arai | |Arai | ||
|Yoichi | |Yoichi | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 19,242: | Line 19,242: | ||
|Arakelyan | |Arakelyan | ||
|Nina | |Nina | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 19,261: | Line 19,261: | ||
|- | |- | ||
|Araki | |Araki | ||
− | |K | + | |K. |
|CBD | |CBD | ||
| | | | ||
Line 19,282: | Line 19,282: | ||
|Araki | |Araki | ||
|Nobuhito | |Nobuhito | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 19,301: | Line 19,301: | ||
|- | |- | ||
|Arana Yi | |Arana Yi | ||
− | |C | + | |C. |
|CBD | |CBD | ||
| | | | ||
Line 19,321: | Line 19,321: | ||
|- | |- | ||
|Arance | |Arance | ||
− | |Ana M | + | |Ana M. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 19,342: | Line 19,342: | ||
|Aranda | |Aranda | ||
|Enrique | |Enrique | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 19,362: | Line 19,362: | ||
|Aranda | |Aranda | ||
|Ignacio | |Ignacio | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 19,381: | Line 19,381: | ||
|- | |- | ||
|Aranda | |Aranda | ||
− | |J | + | |J. |
|CBD | |CBD | ||
| | | | ||
Line 19,402: | Line 19,402: | ||
|Arango Hisijara | |Arango Hisijara | ||
|Israel | |Israel | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 19,421: | Line 19,421: | ||
|- | |- | ||
|Arango Ossa | |Arango Ossa | ||
− | |Juan E | + | |Juan E. |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 19,442: | Line 19,442: | ||
|Arasteh | |Arasteh | ||
|Keikawus | |Keikawus | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 19,462: | Line 19,462: | ||
|Araujo | |Araujo | ||
|Carla | |Carla | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 19,481: | Line 19,481: | ||
|- | |- | ||
|Araujo | |Araujo | ||
− | |John C | + | |John C. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 19,502: | Line 19,502: | ||
|Aravantinos | |Aravantinos | ||
|Gerasimos | |Gerasimos | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 19,522: | Line 19,522: | ||
|Arazy | |Arazy | ||
|Melina | |Melina | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 19,542: | Line 19,542: | ||
|Arbogast | |Arbogast | ||
|Daria | |Daria | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 19,561: | Line 19,561: | ||
|- | |- | ||
|Arbuck | |Arbuck | ||
− | |Susan G | + | |Susan G. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 19,581: | Line 19,581: | ||
|- | |- | ||
|Arbushites | |Arbushites | ||
− | |Michael C | + | |Michael C. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 19,602: | Line 19,602: | ||
|Arcaini | |Arcaini | ||
|Luca | |Luca | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 19,622: | Line 19,622: | ||
|Arcamone | |Arcamone | ||
|Manuela | |Manuela | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 19,642: | Line 19,642: | ||
|Arcangeli | |Arcangeli | ||
|Annarosa | |Annarosa | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 19,662: | Line 19,662: | ||
|Arcangeli | |Arcangeli | ||
|Giuseppina | |Giuseppina | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 19,682: | Line 19,682: | ||
|Arcangeli | |Arcangeli | ||
|Valentina | |Valentina | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 19,702: | Line 19,702: | ||
|Arcari | |Arcari | ||
|Annalisa | |Annalisa | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 19,721: | Line 19,721: | ||
|- | |- | ||
|Arcasoy | |Arcasoy | ||
− | |Murat O | + | |Murat O. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 19,742: | Line 19,742: | ||
|Arce Lara | |Arce Lara | ||
|Carlos | |Carlos | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 19,761: | Line 19,761: | ||
|- | |- | ||
|Arce Salinas | |Arce Salinas | ||
− | |Claudia H | + | |Claudia H. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 19,781: | Line 19,781: | ||
|- | |- | ||
|Arceci | |Arceci | ||
− | |Robert J | + | |Robert J. |
− | | | + | |M |
| | | | ||
| | | | ||
Line 19,802: | Line 19,802: | ||
|Arcenas | |Arcenas | ||
|Anthony | |Anthony | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 19,822: | Line 19,822: | ||
|Arcese | |Arcese | ||
|William | |William | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 19,862: | Line 19,862: | ||
|Archambault | |Archambault | ||
|Robert | |Robert | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 19,882: | Line 19,882: | ||
|Archer | |Archer | ||
|Caroline | |Caroline | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 19,901: | Line 19,901: | ||
|- | |- | ||
|Archer | |Archer | ||
− | |J Hunter | + | |J. Hunter |
|Not yet determined | |Not yet determined | ||
| | | | ||
Line 19,922: | Line 19,922: | ||
|Archer | |Archer | ||
|Laura | |Laura | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 19,942: | Line 19,942: | ||
|Archer | |Archer | ||
|Venice | |Venice | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 19,962: | Line 19,962: | ||
|Archimbaud | |Archimbaud | ||
|Eric | |Eric | ||
− | | | + | |M |
| | | | ||
| | | | ||
Line 19,981: | Line 19,981: | ||
|- | |- | ||
|Arcila | |Arcila | ||
− | |Maria E | + | |Maria E. |
− | | | + | |F |
| | | | ||
| | | | ||
Line 20,002: | Line 20,002: | ||
|Arcusa | |Arcusa | ||
|Angels | |Angels | ||
− | | | + | |F |
| | | | ||
| | | | ||
Line 20,019: | Line 20,019: | ||
|52 | |52 | ||
|1 | |1 | ||
− | |||
|- | |- | ||
} | } |
Revision as of 14:52, 14 January 2023
}
Surname | Forename | Gender | Site | City | Region | Country | First active year | Last active year | Study group(s) | Sponsor(s) | Conditions | Total publications | Senior publications | Phase 3 RCTs | FDA pivotal studies | Co-authorships | Co-authors | Vital status |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A'Hern | Roger P. | M | United Kingdom | 1987 | 2015 | London Gynaecological Oncology Group; TOPIC Trial Group | Breast cancer; Ovarian cancer; Prostate cancer | 5 | 0 | 4 | 0 | 100 | 83 | 1 | ||||
Aamdal | Steinar | M | Norway | 1989 | 2015 | EORTC; Nordic Melanoma Cooperative Group | Melanoma; Small cell lung cancer | 7 | 2 | 6 | 0 | 87 | 84 | 1 | ||||
Aanur | Praveen | M | USA | 2016 | 2021 | Malignant pleural mesothelioma | 1 | 0 | 1 | 1 | 20 | 20 | 1 | |||||
Aapro | Matti S. | F | Belgium; Switzerland | 1984 | 2018 | EORTC; International Collaborative Cancer Group | Breast cancer; Endometrial cancer | 5 | 3 | 5 | 1 | 109 | 108 | 1 | ||||
Aaron | Lorne | M | 2006 | 2012 | Prostate cancer | 1 | 0 | 1 | 0 | 7 | 7 | 1 | ||||||
Aaronson | Neil K. | M | 1992 | 2001 | EORTC | Melanoma; Prostate cancer | 2 | 0 | 2 | 0 | 26 | 26 | 1 | |||||
Aarts | Maureen J. B. | F | Netherlands | 2006 | 2017 | BOOG; Dutch WIN-O Consortium | Breast cancer; Renal cell carcinoma | 3 | 0 | 2 | 0 | 38 | 30 | 1 | ||||
Aasebo | Ulf | M | Norway | 1989 | 2013 | Non-small cell lung cancer; Small cell lung cancer | 7 | 1 | 7 | 0 | 65 | 44 | 1 | |||||
Aass | Nina | F | Norway | 1996 | 2012 | EORTC; MRC | Renal cell carcinoma; Testicular cancer | 5 | 1 | 4 | 0 | 48 | 34 | 1 | ||||
Aastroem | Lennart | M | Sweden | 2014 | 2022 | SPCG | Prostate cancer | 2 | 0 | 2 | 0 | 21 | 21 | 1 | ||||
Aavall Lundqvist | Elisabeth | F | Sweden | 1999 | 2017 | AGO; Gynecologic Cancer Intergroup | Ovarian cancer | 4 | 0 | 4 | 0 | 64 | 52 | 1 | ||||
Abacioglu | Ufuk | M | 2000 | 2012 | Glioblastoma | 1 | 0 | 1 | 0 | 11 | 11 | 1 | ||||||
Abad | Alberto | M | Spain | 1989 | 2012 | TTD | Colorectal cancer; Non-small cell lung cancer | 3 | 1 | 3 | 0 | 53 | 44 | 1 | ||||
Abada | Paolo B. | M | USA | 2010 | 2019 | Hepatocellular carcinoma | 2 | 0 | 2 | 1 | 42 | 38 | 1 | |||||
Abadie Lacourtoisie | Sophie | F | France | 2006 | 2019 | GINECO | Breast cancer | 3 | 0 | 1 | 0 | 55 | 36 | 1 | ||||
Abaskharoun | Mena | F | USA | 2018 | 2022 | Melanoma | 1 | 0 | 0 | 1 | 21 | 21 | 1 | |||||
Abaza | Yasmin | F | USA | 2002 | 2017 | Acute promyelocytic leukemia | 1 | 1 | 0 | 0 | 26 | 26 | 1 | |||||
Abbadessa | A. | CBD | 2007 | 2007 | CNS lymphoma | 1 | 0 | 0 | 0 | 17 | 17 | 1 | ||||||
Abbadessa | Giovanni | M | USA | 2012 | 2018 | Hepatocellular carcinoma | 1 | 0 | 1 | 0 | 29 | 29 | 1 | |||||
Abbal | Claire | F | Switzerland | 2006 | 2015 | GRAALL | B-cell acute lymphoblastic leukemia | 1 | 0 | 1 | 0 | 19 | 19 | 1 | ||||
Abbas | Abbas | M | 2002 | 2010 | Esophageal adenocarcinoma | 1 | 0 | 0 | 0 | 8 | 8 | 1 | ||||||
Abbas | Haider | M | United Kingdom | 2009 | 2014 | COG | Esophageal cancer | 1 | 0 | 1 | 0 | 20 | 20 | 1 | ||||
Abbas | Mohammad | M | 2008 | 2012 | Multiple myeloma | 1 | 0 | 0 | 0 | 14 | 14 | 1 | ||||||
Abbas | Moncef | M | 2002 | 2011 | FFCD | Colorectal cancer | 1 | 0 | 1 | 0 | 18 | 18 | 1 | |||||
Abbas | Richat | M | USA | 2006 | 2011 | B-cell acute lymphoblastic leukemia; Chronic myeloid leukemia | 1 | 0 | 0 | 1 | 14 | 14 | 1 | |||||
Abbas | Tahir | Not yet determined | Canada | 2016 | 2020 | NCIC-CTG | Colorectal cancer | 1 | 0 | 0 | 0 | 20 | 20 | 1 | ||||
Abbattista | Antonello | M | Italy | 2014 | 2019 | Non-small cell lung cancer | 3 | 0 | 0 | 1 | 50 | 28 | 1 | |||||
Abbink | Floor | F | Netherlands | 2011 | 2019 | Chronic myeloid leukemia pediatric | 1 | 0 | 0 | 1 | 15 | 15 | 1 | |||||
Abbott | Amanda | F | USA | 2012 | 2019 | Gastrointestinal stromal tumor | 1 | 0 | 0 | 0 | 15 | 15 | 1 | |||||
Abbott | R. L. | CBD | 1982 | 1989 | Bladder cancer | 1 | 0 | 1 | 0 | 14 | 14 | 1 | ||||||
Abbott | Thomas M. | M | 1979 | 1989 | SWOG | Ovarian cancer | 1 | 0 | 1 | 0 | 8 | 8 | 1 | |||||
Abbou | Clement Claude | M | France | 1986 | 1993 | Prostate cancer | 1 | 0 | 1 | 1 | 14 | 14 | 1 | |||||
Abboud | Camille N. | F | USA | 1993 | 2016 | ECOG | Acute myeloid leukemia | 2 | 0 | 1 | 0 | 49 | 49 | 1 | ||||
Abboud | Miguel R. | M | Lebanon | 2017 | 2019 | Sickle cell anemia | 1 | 0 | 1 | 0 | 21 | 21 | 1 | |||||
Abbrederis | Klaus | M | 1994 | 2003 | Chronic myeloid leukemia | 1 | 0 | 1 | 0 | 25 | 25 | 1 | ||||||
Abbruzzese | Alberto | M | 2003 | 2009 | Bladder cancer | 1 | 0 | 1 | 0 | 11 | 11 | 1 | ||||||
Abbruzzese | James L. | M | 1988 | 2010 | SWOG | Colorectal cancer; Esophageal adenocarcinoma; Hepatocellular carcinoma; Pancreatic cancer | 5 | 3 | 2 | 0 | 47 | 44 | 1 | |||||
Abdalla | K. | CBD | Brazil | 2011 | 2017 | Gastric cancer | 1 | 0 | 1 | 0 | 18 | 18 | 1 | |||||
Abdallah | Al Ola | M | USA | 2018 | 2021 | Multiple myeloma | 2 | 0 | 0 | 1 | 55 | 38 | 1 | |||||
Abdallah | Rehab | Not yet determined | USA | 2015 | 2021 | Prostate cancer | 1 | 0 | 0 | 0 | 27 | 27 | 1 | |||||
Abdeddaim | Cyril | M | France | 2017 | 2020 | Endometrial cancer | 1 | 0 | 0 | 1 | 14 | 14 | 1 | |||||
Abdel Hamid | Abdel | M | United Kingdom | 2007 | 2012 | Thyroid cancer differentiated | 1 | 0 | 1 | 0 | 27 | 27 | 1 | |||||
Abdel Rahman | Omar | M | Egypt | 2010 | 2013 | Hepatocellular carcinoma | 1 | 1 | 0 | 0 | 5 | 5 | 1 | |||||
Abdel Rahman | Sultan | M | Germany | 1997 | 2018 | EORTC; European Society for Hyperthermic Oncology | Soft tissue sarcoma | 2 | 0 | 1 | 0 | 40 | 26 | 1 | ||||
Abdel Wahab | Manal | F | 2010 | 2013 | Hepatocellular carcinoma | 1 | 0 | 0 | 0 | 5 | 5 | 1 | ||||||
Abdel Wahab | Omar | M | USA | 2002 | 2019 | ECOG | Acute myeloid leukemia; Chronic myelomonocytic leukemia; Erdheim-Chester disease; Essential thrombocythemia; Hairy cell leukemia; Langerhans cell histiocytosis; Polycythemia vera; Rosai-Dorfman-Destombes disease | 6 | 1 | 1 | 1 | 124 | 114 | 1 | ||||
Abdel Wahab | Sherif | M | 2010 | 2013 | Hepatocellular carcinoma | 1 | 0 | 0 | 0 | 5 | 5 | 1 | ||||||
Abdelfattah | Murad | M | 2001 | 2009 | Colorectal cancer | 1 | 0 | 0 | 0 | 12 | 12 | 1 | ||||||
Abdelghany | Osama | M | USA | 2011 | 2020 | Endometrial cancer | 2 | 0 | 0 | 0 | 46 | 24 | 1 | |||||
Abdi | Ehtesham A. | M | Australia | 1994 | 2021 | ALLG; IBCSG | Breast cancer; Diffuse large B-cell lymphoma | 4 | 0 | 3 | 0 | 95 | 72 | 1 | ||||
Abdiche | Menouar Samir | Not yet determined | France | 2008 | 2020 | GETUG | Prostate cancer | 1 | 0 | 1 | 0 | 17 | 17 | 1 | ||||
Abdo | Andre | M | Brazil | 2017 | 2021 | Chronic myeloid leukemia | 1 | 0 | 1 | 1 | 25 | 25 | 1 | |||||
Abdul Razak | Albiruni R. | M | Canada | 2015 | 2020 | Soft tissue sarcoma | 1 | 0 | 1 | 0 | 20 | 20 | 1 | |||||
Abdulkadyrov | Kudrat M. | F | Russian Federation | 2004 | 2019 | Chronic lymphocytic leukemia; Chronic myeloid leukemia; Essential thrombocythemia; Multiple myeloma | 6 | 0 | 4 | 2 | 117 | 76 | 1 | |||||
Abdullaev | S. | Not yet determined | USA | 2014 | 2022 | Colorectal cancer | 1 | 0 | 0 | 1 | 18 | 18 | 1 | |||||
Abdullah | Shaad E. | M | United Kingdom | 2017 | 2021 | Uveal melanoma | 1 | 0 | 1 | 1 | 27 | 27 | 1 | |||||
Abe | Hajime | M | 2002 | 2010 | Breast cancer | 1 | 0 | 1 | 0 | 20 | 20 | 1 | ||||||
Abe | Osahiko | UNMATCHED | 1981 | 1994 | Breast cancer | 2 | 0 | 2 | 0 | 23 | 17 | 1 | ||||||
Abe | Rikiya | F | 1996 | 2009 | Adjuvant CEF Research Group for Breast Cancer | Breast cancer | 2 | 0 | 2 | 0 | 27 | 24 | 1 | |||||
Abe | Tetsuya | M | Japan | 2008 | 2015 | JCOG | Non-small cell lung cancer | 1 | 1 | 1 | 0 | 19 | 19 | 1 | ||||
Abe | Yasunobu | M | Japan | 2012 | 2016 | Adult T-cell leukemia-lymphoma | 1 | 0 | 0 | 0 | 17 | 17 | 1 | |||||
Abedi | Mehrdad | M | USA | 2010 | 2021 | B-cell acute lymphoblastic leukemia; Follicular lymphoma | 2 | 0 | 0 | 1 | 37 | 37 | 1 | |||||
Abel | Edvard | M | Sweden | 2013 | 2020 | Head and neck cancer | 1 | 0 | 1 | 0 | 14 | 14 | 1 | |||||
Abel | Ulrich | M | 1990 | 2012 | Diffuse large B-cell lymphoma; Pancreatic cancer | 2 | 0 | 2 | 0 | 40 | 40 | 1 | ||||||
Abella | Eugenia | F | 2001 | 2013 | GELCAB; GELTAMO; GESIDA; PETHEMA | Chronic lymphocytic leukemia; HIV-associated lymphoma | 4 | 0 | 0 | 0 | 68 | 42 | 1 | |||||
Abellan | Pascual Fernandez | M | 1999 | 2008 | GEM; PETHEMA | Multiple myeloma | 1 | 0 | 1 | 0 | 16 | 16 | 1 | |||||
Abeloff | Martin D. | M | USA | 1979 | 2009 | Breast Cancer Intergroup of North America; CALGB; ECOG; SWOG | Breast cancer; Small cell lung cancer | 10 | 4 | 10 | 0 | 89 | 59 | 1 | ||||
Abels | J. | CBD | 1983 | 1989 | EORTC | Acute myeloid leukemia | 2 | 0 | 2 | 0 | 22 | 15 | 1 | |||||
Abelson | Herbert T. | M | 1982 | 1986 | Osteosarcoma | 1 | 0 | 1 | 0 | 14 | 14 | 1 | ||||||
Abenhardt | Wolfgang | M | Germany | 1997 | 2017 | GCLLSG | Breast cancer; Chronic lymphocytic leukemia | 4 | 0 | 4 | 0 | 52 | 37 | 1 | ||||
Abergel | Armand | M | France | 1995 | 2019 | FFCD | Hepatocellular carcinoma | 3 | 0 | 3 | 0 | 48 | 42 | 1 | ||||
Abernethy | Amy | F | USA | 2013 | 2017 | Melanoma | 1 | 0 | 1 | 1 | 22 | 22 | 1 | |||||
Abeyakoon | Sarath | UNMATCHED | 1996 | 2003 | Head and neck cancer | 1 | 0 | 1 | 0 | 10 | 10 | 1 | ||||||
Abgrall | Jean Francois | M | France | 1991 | 1997 | Intergroupe Francais des Leucemies Myeloides Chroniques | Chronic myeloid leukemia | 1 | 0 | 1 | 0 | 11 | 11 | 1 | ||||
Abhyankar | Sunil | M | USA | 2018 | 2018 | BMT CTN | Graft versus host disease | 1 | 0 | 0 | 0 | 21 | 21 | 1 | ||||
Abi Gerges | Dany | M | Lebanon | 2008 | 2014 | Breast cancer | 1 | 0 | 1 | 0 | 19 | 19 | 1 | |||||
Abianui | Abongnwen | Not yet determined | Canada | 2018 | 2018 | Venous thromboembolism | 1 | 0 | 1 | 0 | 26 | 26 | 1 | |||||
Abidi | Muneer H. | M | USA | 2004 | 2020 | SWOG | Hodgkin lymphoma; Multiple myeloma | 6 | 0 | 3 | 1 | 82 | 48 | 1 | ||||
Abidoye | Oyewale O. | M | USA | 2014 | 2016 | Bladder cancer | 2 | 0 | 0 | 2 | 64 | 43 | 1 | |||||
Abildgaard | Niels | M | 2002 | 2013 | Multiple myeloma | 2 | 0 | 2 | 0 | 48 | 37 | 1 | ||||||
Abir | Esshagh | Not yet determined | 1965 | 1965 | B-cell acute lymphoblastic leukemia | 1 | 0 | 0 | 0 | 19 | 19 | 1 | ||||||
Ablin | Arthur R. | M | 1988 | 1988 | CCG | T-cell acute lymphoblastic leukemia pediatric | 1 | 0 | 0 | 0 | 11 | 11 | 1 | |||||
Aboelhassan | Rasha | Not yet determined | Egypt | 2013 | 2019 | Malignant pleural mesothelioma | 1 | 0 | 0 | 0 | 25 | 25 | 1 | |||||
Abonour | Rafat | M | USA | 2004 | 2018 | ECOG | Multiple myeloma | 3 | 0 | 1 | 1 | 53 | 50 | 1 | ||||
Abou Alfa | Ghassan K. | M | USA | 2001 | 2021 | CALGB | Cholangiocarcinoma; Hepatocellular carcinoma; Pancreatic cancer | 13 | 11 | 7 | 4 | 267 | 191 | 1 | ||||
Abou Nassar | Karim | M | Canada | 2013 | 2019 | Follicular lymphoma; Venous thromboembolism | 2 | 0 | 1 | 1 | 44 | 44 | 1 | |||||
Abou Rached | Antoine | M | France | 1990 | 1995 | Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire | Hepatocellular carcinoma | 1 | 0 | 1 | 0 | 5 | 5 | 1 | ||||
Aboulafia | David | M | 1993 | 2009 | AIDS Malignancy Consortium | HIV-associated lymphoma; Kaposi sarcoma | 3 | 0 | 2 | 0 | 33 | 29 | 1 | |||||
Abraham | Aby | F | 1998 | 2010 | Acute promyelocytic leukemia | 1 | 0 | 0 | 0 | 11 | 11 | 1 | ||||||
Abraham | Christine | F | France | 2003 | 2019 | Prostate cancer | 1 | 0 | 1 | 0 | 27 | 27 | 1 | |||||
Abraham | George | M | India | 2012 | 2019 | Head and neck cancer | 1 | 0 | 1 | 0 | 50 | 50 | 1 | |||||
Abraham | Jacinta | F | United Kingdom | 2008 | 2018 | Breast cancer | 1 | 0 | 1 | 0 | 37 | 37 | 1 | |||||
Abraham | Jean E. | F | United Kingdom | 2001 | 2019 | tAnGo trial collaborators | Breast cancer | 4 | 0 | 4 | 0 | 102 | 66 | 1 | ||||
Abraham | Julie | F | France | 2014 | 2021 | Diffuse large B-cell lymphoma | 1 | 0 | 1 | 0 | 24 | 24 | 1 | |||||
Abraham | Mirta | F | 1996 | 2013 | Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group | Breast cancer | 1 | 0 | 1 | 0 | 37 | 37 | 1 | |||||
Abrahamse Testroote | Martine C. J. | F | Netherlands | 2006 | 2014 | HOVON | Chronic lymphocytic leukemia | 1 | 0 | 1 | 0 | 14 | 14 | 1 | ||||
Abrahamsson | Jonas | M | Sweden | 2004 | 2019 | Nordic Society of Paediatric Haematology and Oncology (NOPHO) | Acute myeloid leukemia; B-cell acute lymphoblastic leukemia pediatric | 2 | 0 | 2 | 0 | 18 | 17 | 1 | ||||
Abrahamsson | Per Anders | M | 2001 | 2007 | Atrasentan Phase III Study Group Institutions | Prostate cancer | 1 | 0 | 1 | 0 | 8 | 8 | 1 | |||||
Abram | Paul | M | 1998 | 2004 | Breast cancer | 1 | 0 | 1 | 0 | 10 | 10 | 1 | ||||||
Abram | Steven R. | M | USA | 2007 | 2018 | Glioblastoma | 1 | 0 | 1 | 0 | 68 | 68 | 1 | |||||
Abramov | M. | CBD | Russian Federation | 2011 | 2017 | Gastric cancer | 1 | 0 | 1 | 0 | 18 | 18 | 1 | |||||
Abrams | Jeffrey S. | M | USA | 1982 | 2018 | CALGB; NCIC-CTG | Breast cancer; Melanoma | 9 | 1 | 6 | 2 | 145 | 85 | 1 | ||||
Abrams | K. | Not yet determined | 1988 | 1994 | Colorectal cancer | 1 | 0 | 1 | 0 | 4 | 4 | 1 | ||||||
Abrams | Paul G. | M | 1984 | 1984 | Follicular lymphoma | 1 | 0 | 0 | 0 | 11 | 11 | 1 | ||||||
Abrams | Ross A. | M | USA | 1987 | 2011 | Radiation Therapy Oncology Group; RTOG | Cholangiocarcinoma; Pancreatic cancer; Prostate cancer | 3 | 0 | 2 | 1 | 36 | 27 | 1 | ||||
Abrams | Thomas A. | M | USA | 2006 | 2018 | Cholangiocarcinoma; Gallbladder cancer; Hepatocellular carcinoma | 3 | 0 | 0 | 0 | 59 | 40 | 1 | |||||
Abramson | David H. | M | USA | 2010 | 2014 | Uveal melanoma | 1 | 0 | 0 | 0 | 27 | 27 | 1 | |||||
Abramson | Jeremy S. | M | USA | 2005 | 2022 | Alliance; Blood Cancer Research Partnership of the Leukemia and Lymphoma Society; CALGB | Chronic lymphocytic leukemia; Diffuse large B-cell lymphoma; Hodgkin lymphoma; Primary mediastinal B-cell lymphoma; Transformed lymphoma | 8 | 3 | 5 | 3 | 156 | 140 | 1 | ||||
Abramson | Neil | M | USA | 1979 | 2001 | ECOG; NSABP | Breast cancer; Multiple myeloma | 5 | 0 | 6 | 0 | 63 | 40 | 1 | ||||
Abramson | Vandana G. | F | USA | 2010 | 2022 | NCIC-CTG | Breast cancer; CNS carcinoma; Thyroid cancer | 6 | 1 | 2 | 2 | 131 | 98 | 1 | ||||
Abrao Miziara | Jose Elias | M | Brazil | 2006 | 2015 | Non-small cell lung cancer; Non-small cell lung cancer nonsquamous | 3 | 0 | 3 | 0 | 62 | 52 | 1 | |||||
Abratt | Raymond Pierre | M | South Africa | 1995 | 2011 | GLOB 2 group | Non-small cell lung cancer; Prostate cancer | 6 | 3 | 6 | 0 | 58 | 53 | 1 | ||||
Abrey | Lauren E. | F | Switzerland; USA | 1992 | 2018 | Autologous HSCT; CNS lymphoma; Glioblastoma; High-grade glioma pediatric; Stem cell mobilization | 9 | 4 | 1 | 1 | 101 | 76 | 1 | |||||
Abrisqueta | Pau | M | Spain | 2005 | 2021 | Chronic lymphocytic leukemia; Diffuse large B-cell lymphoma | 5 | 1 | 2 | 1 | 111 | 87 | 1 | |||||
Abromowitch | Minnie | F | 1979 | 2012 | COG | B-cell acute lymphoblastic leukemia; B-cell acute lymphoblastic leukemia pediatric | 3 | 1 | 3 | 0 | 30 | 27 | 1 | |||||
Abruzzese | Elisabetta | F | Italy | 2004 | 2018 | EORTC; FIL; GIMEMA; LYSA | B-cell acute lymphoblastic leukemia; Chronic myeloid leukemia; Hodgkin lymphoma | 7 | 0 | 5 | 1 | 174 | 122 | 1 | ||||
Abruzzo | Lynne V. | F | USA | 2015 | 2020 | Chronic lymphocytic leukemia; Hodgkin lymphoma | 2 | 0 | 0 | 0 | 29 | 29 | 1 | |||||
Abshire | T. C. | Not yet determined | USA | 2000 | 2000 | POG | B-cell acute lymphoblastic leukemia pediatric | 1 | 1 | 0 | 0 | 4 | 4 | 1 | ||||
Abt | Markus | M | Switzerland | 1998 | 2005 | Colon cancer | 1 | 0 | 1 | 1 | 25 | 25 | 1 | |||||
Abu Samra | Maisun | Not yet determined | Germany | 2010 | 2019 | Acute myeloid leukemia | 1 | 0 | 1 | 0 | 32 | 32 | 1 | |||||
Abu Zahra | Hakam | M | Canada | 1984 | 1998 | NCIC-CTG | Breast cancer | 2 | 0 | 2 | 2 | 38 | 31 | 1 | ||||
Abuav | Rachel | F | USA | 2009 | 2009 | Cutaneous T-cell lymphoma | 1 | 0 | 0 | 1 | 13 | 13 | 1 | |||||
Abubakr | Yousif A. | M | 2002 | 2008 | Colorectal cancer | 2 | 0 | 3 | 0 | 30 | 29 | 1 | ||||||
Abulizi | G. | Not yet determined | China | 2017 | 2021 | Ovarian cancer | 1 | 0 | 1 | 0 | 33 | 33 | 1 | |||||
Accario Winslow | Chrisann | F | 2001 | 2009 | Gynecologic Cancer Intergroup | Ovarian cancer | 1 | 0 | 1 | 0 | 15 | 15 | 1 | |||||
Accomando | Emilio | M | Italy | 1987 | 1992 | Head and neck cancer | 1 | 0 | 1 | 0 | 24 | 24 | 1 | |||||
Accortanzo | Valeria | F | Italy | 1996 | 2016 | GONO | Breast cancer | 1 | 0 | 1 | 0 | 18 | 18 | 1 | ||||
Acha | Tomas | M | Spain | 2001 | 2015 | Wilms tumor | 1 | 0 | 1 | 0 | 13 | 13 | 1 | |||||
Acharya | Sandip | M | India | 2009 | 2018 | Chronic myeloid leukemia | 2 | 0 | 1 | 1 | 36 | 32 | 1 | |||||
Acharyya | Suddhasatta | Not yet determined | USA | 2018 | 2021 | Non-small cell lung cancer | 1 | 0 | 0 | 0 | 20 | 20 | 1 | |||||
Achebe | Maureen M. | F | USA | 2017 | 2021 | Sickle cell anemia | 2 | 0 | 1 | 0 | 32 | 23 | 1 | |||||
Achille | Emmanuel | M | 1996 | 2007 | GERCOR | Colon cancer; Colorectal cancer | 3 | 0 | 2 | 0 | 41 | 22 | 1 | |||||
Acholonu | Sandra | F | 2008 | 2008 | Allogeneic HSCT; Hodgkin lymphoma | 1 | 0 | 0 | 0 | 17 | 17 | 1 | ||||||
Achour | Eddine | UNMATCHED | 2001 | 2001 | CNS lymphoma; Stem cell mobilization | 1 | 0 | 0 | 0 | 11 | 11 | 1 | ||||||
Achtelik | W. | CBD | 1994 | 2001 | DeCOG | Melanoma | 1 | 0 | 1 | 0 | 15 | 15 | 1 | |||||
Achtnicht | U. | CBD | 1985 | 1992 | Renal cell carcinoma | 1 | 0 | 1 | 0 | 8 | 8 | 1 | ||||||
Acin | Yolene | F | France | 2009 | 2015 | Gastrointestinal stromal tumor; Pancreatic cancer | 2 | 0 | 1 | 0 | 33 | 29 | 1 | |||||
Acker | Thomas | M | 2002 | 2012 | “Aktion Bronchialkarzinom” (ABC Study Group) | Small cell lung cancer | 1 | 0 | 1 | 0 | 15 | 15 | 1 | |||||
Ackerman | Charlotte | F | United Kingdom | 2007 | 2016 | Bladder cancer | 1 | 0 | 1 | 0 | 18 | 18 | 1 | |||||
Ackerman | Ilana | Not yet determined | Australia | 2022 | 2022 | Venous thromboembolism | 1 | 0 | 1 | 0 | 45 | 45 | 1 | |||||
Ackerman | Judie | F | 2001 | 2006 | Pancreatic cancer | 1 | 0 | 1 | 0 | 10 | 10 | 1 | ||||||
Ackerstaff | Annemiek H. | F | 2000 | 2010 | Head and neck cancer | 1 | 0 | 1 | 0 | 12 | 12 | 1 | ||||||
Ackerstein | Aliza | F | 1998 | 1998 | Allogeneic HSCT; Chronic lymphocytic leukemia | 1 | 0 | 0 | 0 | 14 | 14 | 1 | ||||||
Ackland | Stephen P. | M | Australia | 1990 | 2012 | AGITG; ANZ BCTG; Australasian Gastro-Intestinal Trials Group; Trans-Tasman Radiation Oncology Group; TROG | Breast cancer; Colorectal cancer; Esophageal cancer; Rectal cancer | 8 | 1 | 8 | 1 | 109 | 97 | 1 | ||||
Acosta Rivera | Mirelis | F | USA | 2012 | 2020 | Hepatocellular carcinoma | 1 | 0 | 0 | 1 | 20 | 20 | 1 | |||||
Acosta | Mark | M | USA | 2010 | 2010 | Cutaneous T-cell lymphoma | 1 | 0 | 1 | 1 | 8 | 8 | 1 | |||||
Acosta | Soraida C. | Not yet determined | Cuba | 2006 | 2016 | Non-small cell lung cancer | 1 | 0 | 1 | 0 | 33 | 33 | 1 | |||||
Acquino Parsons | C. | CBD | 1995 | 2001 | Endometrial cancer | 1 | 0 | 0 | 0 | 6 | 6 | 1 | ||||||
Acs | Peter I. | M | 2008 | 2013 | Diffuse large B-cell lymphoma | 1 | 0 | 0 | 0 | 5 | 5 | 1 | ||||||
Acton | Gary | M | USA | 2010 | 2015 | Acute myeloid leukemia | 1 | 0 | 1 | 0 | 35 | 35 | 1 | |||||
Adab | Fawzi | M | United Kingdom | 2002 | 2017 | CRUK | Pancreatic cancer; Prostate cancer | 2 | 0 | 2 | 0 | 65 | 65 | 1 | ||||
Adachi | Hisanobu | Not yet determined | 2005 | 2013 | Bladder cancer; Upper tract urothelial carcinoma | 1 | 0 | 0 | 0 | 22 | 22 | 1 | ||||||
Adachi | Isamu | M | Japan | 1993 | 1996 | Breast cancer | 1 | 1 | 0 | 0 | 6 | 6 | 1 | |||||
Adachi | Susumu | M | 2001 | 2008 | Malignant pleural mesothelioma | 2 | 0 | 1 | 0 | 23 | 21 | 1 | ||||||
Adak | Sudeshna | F | USA | 1991 | 2001 | ECOG | Non-small cell lung cancer; Small cell lung cancer | 2 | 0 | 2 | 0 | 12 | 11 | 1 | ||||
Adam | H. | CBD | 1982 | 1994 | SAKK | Breast cancer | 1 | 0 | 1 | 0 | 17 | 17 | 1 | |||||
Adam | Rene | M | France | 1994 | 2017 | SARAH Trial Group | Colorectal cancer; Hepatocellular carcinoma | 2 | 0 | 2 | 0 | 52 | 52 | 1 | ||||
Adam | Zdenek | M | 2001 | 2013 | Multiple myeloma | 4 | 1 | 1 | 0 | 45 | 24 | 1 | ||||||
Adamchuk | Hryhoriy | Not yet determined | Ukraine | 2008 | 2019 | Breast cancer | 1 | 0 | 1 | 0 | 24 | 24 | 1 | |||||
Adami | Bernd | M | 2001 | 2009 | Colorectal cancer | 1 | 0 | 0 | 0 | 12 | 12 | 1 | ||||||
Adami | Fausto | M | Italy | 1999 | 2017 | Light-chain (AL) amyloidosis; POEMS syndrome | 2 | 0 | 0 | 0 | 17 | 16 | 1 | |||||
Adami | Francesca | F | Italy | 1996 | 2016 | GONO | Breast cancer | 1 | 0 | 1 | 0 | 18 | 18 | 1 | ||||
Adami | Hans Olov | M | Sweden; USA | 1989 | 2018 | SPCG | Prostate cancer | 6 | 0 | 1 | 0 | 78 | 22 | 1 | ||||
Adamkewicz | Joanne I. | F | USA | 2018 | 2018 | Inherited coagulopathy | 1 | 0 | 1 | 0 | 16 | 16 | 1 | |||||
Adamo | Francesco | M | 1995 | 2006 | EORTC; FIL; GIMEMA | Acute myeloid leukemia; Hodgkin lymphoma | 2 | 0 | 1 | 0 | 37 | 36 | 1 | |||||
Adamo | Vincenzo | M | 1983 | 2005 | Italian Lung Cancer Project; Italian Multicentre Breast Study with Epirubicin | Breast cancer; Colon cancer; Non-small cell lung cancer; Ovarian cancer | 5 | 0 | 4 | 0 | 138 | 121 | 1 | |||||
Adamou | Adamos | M | 1992 | 2009 | HeCOG; HORG | Breast cancer | 2 | 0 | 2 | 0 | 35 | 34 | 1 | |||||
Adams | Bonne | Not yet determined | USA | 2017 | 2022 | Vascular sarcoma | 1 | 0 | 1 | 0 | 15 | 15 | 1 | |||||
Adams | George L. | M | 1989 | 2003 | Head and neck cancer; Nasopharyngeal carcinoma | 2 | 0 | 3 | 0 | 17 | 14 | 1 | ||||||
Adams | Grenfell | M | 1984 | 2004 | NCIC-CTG | Diffuse large B-cell lymphoma; Hodgkin lymphoma | 2 | 0 | 1 | 0 | 28 | 27 | 1 | |||||
Adams | Hans Peter | M | 1995 | 2003 | AGO | Ovarian cancer | 1 | 0 | 1 | 0 | 16 | 16 | 1 | |||||
Adams | Julian | M | USA | 2001 | 2004 | Follicular lymphoma; Mantle cell lymphoma; Multiple myeloma | 3 | 0 | 0 | 1 | 49 | 34 | 1 | |||||
Adams | M. | CBD | 1995 | 2002 | ICON | Ovarian cancer | 1 | 0 | 1 | 0 | 20 | 20 | 1 | |||||
Adams | Paul T. | M | USA | 2007 | 2015 | NSABP | Breast cancer | 2 | 0 | 1 | 0 | 39 | 21 | 1 | ||||
Adams | Richard A. | M | United Kingdom | 2005 | 2021 | MRC | Anal cancer; Colorectal cancer | 5 | 2 | 5 | 0 | 99 | 79 | 1 | ||||
Adams | Sylvia | F | USA | 2015 | 2021 | Breast cancer | 3 | 0 | 1 | 1 | 47 | 22 | 1 | |||||
Adamska | Krystyna | F | Poland | 2008 | 2014 | Canadian Brain Tumor Consortium; CENTRIC study team; EORTC | Glioblastoma | 1 | 0 | 1 | 0 | 36 | 36 | 1 | ||||
Adamski | Henri | M | 2011 | 2011 | Cutaneous squamous cell carcinoma | 1 | 0 | 0 | 0 | 19 | 19 | 1 | ||||||
Adamson | Peter C. | M | USA | 2008 | 2020 | Children's Oncology Group; COG; European Intergroup for Childhood Non-Hodgkin Lymphoma | Anaplastic large cell lymphoma pediatric; B-cell acute lymphoblastic leukemia pediatric; Non-Hodgkin lymphoma pediatric | 3 | 0 | 2 | 3 | 50 | 50 | 1 | ||||
Adamus | Jerzy | M | 1974 | 1982 | Melanoma | 1 | 0 | 1 | 0 | 25 | 25 | 1 | ||||||
Addamo | B. | CBD | 1998 | 2004 | AML Study Group Ulm | Acute myeloid leukemia | 1 | 0 | 1 | 0 | 24 | 24 | 1 | |||||
Adde | Magdalena | F | Sweden | 2001 | 2006 | Burkitt lymphoma; Diffuse large B-cell lymphoma; HIV-associated lymphoma | 2 | 1 | 0 | 0 | 15 | 15 | 1 | |||||
Addeo | Raffaele | M | Italy | 2003 | 2009 | Bladder cancer | 1 | 1 | 1 | 0 | 11 | 11 | 1 | |||||
Addison | Alicia | F | USA | 2013 | 2015 | Mantle cell lymphoma | 1 | 0 | 0 | 0 | 24 | 24 | 1 | |||||
Adebamowo | Clement | M | Nigeria | 2004 | 2016 | Breast cancer | 1 | 0 | 1 | 0 | 29 | 29 | 1 | |||||
Adelman | Carrie A. | F | United Kingdom | 2020 | 2020 | Prostate cancer | 2 | 0 | 0 | 0 | 38 | 23 | 1 | |||||
Adelson | Mark D. | M | USA | 1985 | 1999 | GOG | Endometrial cancer; Ovarian cancer | 2 | 0 | 2 | 0 | 18 | 18 | 1 | ||||
Adelstein | David J. | M | USA | 1988 | 2018 | RTOG; SWOG | Diffuse large B-cell lymphoma; Head and neck cancer; Oropharyngeal cancer | 6 | 4 | 4 | 0 | 62 | 56 | 1 | ||||
Ademokun | Debo | Not yet determined | United Kingdom | 2008 | 2019 | National Cancer Research Institute Haemato-oncology Clinical Studies Group | Multiple myeloma | 1 | 0 | 2 | 0 | 21 | 21 | 1 | ||||
Ademuyiwa | Foluso | Not yet determined | USA | 2013 | 2017 | Breast cancer | 1 | 0 | 0 | 0 | 33 | 33 | 1 | |||||
Adeniran | Adebowale | Not yet determined | USA | 2016 | 2021 | SWOG | Papillary renal cell carcinoma | 1 | 0 | 0 | 0 | 19 | 19 | 1 | ||||
Adenis | Antoine | M | France | 1992 | 2022 | EORTC; FFCD; FNCLCC; French Sarcoma Group; GI Group of the French Anti-Cancer Centers; PAZOGIST study group of the French Sarcoma Groupe-Groupe d'Etude des Tumeurs Osseuses (GSF-GETO); UNICANCER | Anal cancer; Colorectal cancer; Esophageal cancer; Esophageal squamous cell carcinoma; Gastrointestinal stromal tumor; Pancreatic cancer | 18 | 2 | 12 | 5 | 322 | 225 | 1 | ||||
Ades | Lionel | M | France | 1993 | 2022 | EAPLG; European APL Group; French Belgian Swiss APL group; Groupe Francophone des Myelodysplasies; PETHEMA | Acute myeloid leukemia; Acute promyelocytic leukemia; Chronic myelomonocytic leukemia; Myelodysplastic syndrome | 8 | 7 | 6 | 1 | 182 | 121 | 1 | ||||
Adeva | Jorge | M | Spain | 2017 | 2021 | Cholangiocarcinoma | 2 | 0 | 1 | 1 | 51 | 28 | 1 | |||||
Adewoye | Adeboye H. | M | USA | 2012 | 2017 | Chronic lymphocytic leukemia | 1 | 0 | 1 | 0 | 22 | 22 | 1 | |||||
Adhoute | X. | CBD | France | 2003 | 2015 | FFCD | Colorectal cancer | 1 | 0 | 1 | 0 | 23 | 23 | 1 | ||||
Adib | Deyaa | M | USA | 2015 | 2020 | Follicular lymphoma | 1 | 0 | 0 | 1 | 20 | 20 | 1 | |||||
Adibi | Mehrad | Not yet determined | USA | 2017 | 2020 | Upper tract urothelial carcinoma | 1 | 0 | 0 | 0 | 35 | 35 | 1 | |||||
Adie | Sam | M | Australia | 2022 | 2022 | Venous thromboembolism | 1 | 0 | 1 | 0 | 45 | 45 | 1 | |||||
Adiguzel | Ibrahim | M | 2007 | 2011 | Small cell lung cancer | 1 | 0 | 0 | 0 | 9 | 9 | 1 | ||||||
Adinin | Rosnie B. | UNMATCHED | 2001 | 2008 | Breast cancer | 1 | 0 | 1 | 0 | 10 | 10 | 1 | ||||||
Adjei | Alex A. | M | USA | 1999 | 2017 | ECOG-ACRIN; NCCTG | Non-small cell lung cancer | 2 | 0 | 2 | 0 | 38 | 38 | 1 | ||||
Adkins | Douglas | M | USA | 2004 | 2021 | Head and neck cancer; Soft tissue sarcoma; Thyroid cancer | 3 | 0 | 1 | 2 | 54 | 54 | 1 | |||||
Adler Reichel | S. | Not yet determined | Germany | 2001 | 2016 | Multiple myeloma | 1 | 0 | 1 | 0 | 34 | 34 | 1 | |||||
Adler | Brian | M | 1992 | 2003 | Sickle cell anemia | 1 | 0 | 1 | 0 | 26 | 26 | 1 | ||||||
Adler | Mathias | M | Germany | 1991 | 2011 | CONKO; GHSG | Hodgkin lymphoma; Pancreatic cancer | 3 | 0 | 2 | 0 | 66 | 59 | 1 | ||||
Adotevi | Olivier | M | France | 2014 | 2018 | Anal cancer | 1 | 0 | 0 | 0 | 26 | 26 | 1 | |||||
Adrian | Nicole | F | Germany | 2012 | 2016 | Diffuse large B-cell lymphoma | 1 | 0 | 0 | 0 | 12 | 12 | 1 | |||||
Adrover | Encarna | F | Spain | 1999 | 2015 | GEICAM | Breast cancer | 5 | 0 | 5 | 0 | 122 | 74 | 1 | ||||
Advani | Anjali S. | F | USA | 2006 | 2019 | CALGB; SWOG | Acute myeloid leukemia; B-cell acute lymphoblastic leukemia; B-cell acute lymphoblastic leukemia pediatric; Diffuse large B-cell lymphoma; Follicular lymphoma; Myelodysplastic syndrome | 7 | 3 | 1 | 1 | 112 | 91 | 1 | ||||
Advani | Ranjana H. | F | USA | 1995 | 2022 | ECOG; WMCTG | Acute myeloid leukemia; Anaplastic large cell lymphoma; Cutaneous T-cell lymphoma; Diffuse large B-cell lymphoma; Hodgkin lymphoma; Hodgkin lymphoma nodular lymphocyte-predominant; Mantle cell lymphoma; Mediastinal gray-zone lymphoma; Peripheral T-cell lymphoma; Primary mediastinal B-cell lymphoma; Waldenstroem macroglobulinemia | 38 | 6 | 5 | 5 | 607 | 314 | 1 | ||||
Advani | Suresh H. | M | 1996 | 2005 | Breast cancer | 1 | 0 | 1 | 0 | 10 | 10 | 1 | ||||||
Aeberhard | Peter | M | 1981 | 2008 | SAKK | Colon cancer | 2 | 0 | 2 | 0 | 12 | 9 | 1 | |||||
Aebersold | Daniel M. | M | 1994 | 2011 | SAKK | Head and neck cancer | 1 | 1 | 1 | 0 | 10 | 10 | 1 | |||||
Aebi | Stefan | M | Switzerland | 1993 | 2021 | BOOG Dutch Breast Cancer Trialists' Group; Breast International Group; GEICAM Spanish Breast Cancer Group; International Breast Cancer Study Group; NRG Oncology; SAKK | Breast cancer | 9 | 2 | 5 | 0 | 179 | 83 | 1 | ||||
Aerts | Joachim G. J. V. | M | Netherlands | 2007 | 2021 | Malignant pleural mesothelioma; Non-small cell lung cancer; Non-small cell lung cancer nonsquamous; Non-small cell lung cancer squamous; Small cell lung cancer | 9 | 1 | 6 | 1 | 152 | 125 | 1 | |||||
Afable | Manuel | M | 2012 | 2012 | Myelodysplastic syndrome | 1 | 0 | 0 | 0 | 16 | 16 | 1 | ||||||
Afanasyev | Boris V. | M | Russian Federation | 2003 | 2020 | SPRINT trial investigators and in collaboration with the European Mantle Cell Lymphoma Network | Acute myeloid leukemia; Chronic lymphocytic leukemia; Mantle cell lymphoma; Myelodysplastic syndrome | 4 | 0 | 3 | 2 | 95 | 95 | 1 | ||||
Afchain | Pauline | F | 2004 | 2009 | Colorectal cancer | 1 | 0 | 1 | 0 | 16 | 16 | 1 | ||||||
Afenjar | Karen | F | France | 2008 | 2019 | Breast cancer; Gastric cancer | 3 | 0 | 2 | 0 | 62 | 47 | 1 | |||||
Afflitto | Anthony J. | M | USA | 2013 | 2018 | Hepatocellular carcinoma | 1 | 0 | 0 | 0 | 20 | 20 | 1 | |||||
Affronti | M. L. | Not yet determined | 1992 | 2006 | Breast cancer | 1 | 0 | 1 | 0 | 11 | 11 | 1 | ||||||
Afra | Denes | M | 1988 | 2008 | EORTC | Anaplastic glioma | 1 | 0 | 1 | 0 | 9 | 9 | 1 | |||||
Afrin | Lawrence B. | M | USA | 2009 | 2017 | Systemic mastocytosis | 1 | 0 | 1 | 0 | 25 | 25 | 1 | |||||
Aft | Rebecca | F | USA | 2013 | 2017 | Breast cancer | 1 | 0 | 0 | 0 | 33 | 33 | 1 | |||||
Aftab | Dana T. | F | USA | 2013 | 2016 | Renal cell carcinoma | 1 | 0 | 1 | 1 | 22 | 22 | 1 | |||||
Aftimos | Philippe | M | Belgium | 2017 | 2022 | Breast cancer | 2 | 0 | 2 | 1 | 57 | 54 | 1 | |||||
Agajanian | Richy | M | USA | 2012 | 2016 | Multiple myeloma | 1 | 0 | 0 | 0 | 16 | 16 | 1 | |||||
Agaram | Narasimhan P. | M | USA | 2014 | 2018 | Alliance | Desmoid tumor | 1 | 0 | 1 | 0 | 24 | 24 | 1 | ||||
Agarwal | Archi | Not yet determined | India | 2012 | 2019 | Head and neck cancer | 1 | 0 | 1 | 0 | 50 | 50 | 1 | |||||
Agarwal | Jaiprakash | M | India | 2000 | 2019 | Head and neck cancer | 3 | 1 | 3 | 0 | 87 | 54 | 1 | |||||
Agarwal | Mohan B. | M | India | 2007 | 2011 | Chronic myeloid leukemia | 1 | 0 | 1 | 1 | 19 | 19 | 1 | |||||
Agarwal | Neeraj | M | USA | 2006 | 2022 | SWOG | Bladder cancer; Prostate cancer; Renal cell carcinoma | 15 | 2 | 8 | 3 | 299 | 211 | 1 | ||||
Agarwal | Prasheen | M | USA | 2004 | 2007 | Chronic myeloid leukemia | 2 | 0 | 0 | 0 | 32 | 25 | 1 | |||||
Agarwal | Rishu | F | Australia | 2015 | 2018 | Mantle cell lymphoma | 1 | 0 | 0 | 0 | 16 | 16 | 1 | |||||
Agarwal | Shefali | F | USA | 2013 | 2020 | Epithelioid sarcoma; Follicular lymphoma; Ovarian cancer | 3 | 0 | 1 | 3 | 71 | 71 | 1 | |||||
Agarwal | Suresh K. | M | USA | 2012 | 2019 | Acute myeloid leukemia; Chronic lymphocytic leukemia; Multiple myeloma | 4 | 0 | 0 | 3 | 71 | 60 | 1 | |||||
Agarwala | A. | Not yet determined | 2002 | 2011 | Non-small cell lung cancer | 1 | 0 | 1 | 0 | 14 | 14 | 1 | ||||||
Agarwala | Sanjiv S. | M | USA | 1974 | 2017 | ECOG; EORTC | Head and neck cancer; Melanoma | 16 | 5 | 13 | 3 | 268 | 198 | 1 | ||||
Agate | Laura | F | 2014 | 2014 | Thyroid cancer differentiated; Thyroid cancer medullary | 1 | 0 | 0 | 0 | 14 | 14 | 1 | ||||||
Agathocleous | Agathoclis | M | United Kingdom | 2010 | 2010 | Follicular lymphoma | 1 | 1 | 0 | 0 | 11 | 11 | 1 | |||||
Agbalika | Felix | M | 2007 | 2007 | Castleman disease | 1 | 0 | 0 | 0 | 12 | 12 | 1 | ||||||
Agelaki | Sophia | F | Greece | 2001 | 2017 | HORG | Breast cancer; Colorectal cancer; Non-small cell lung cancer; Small cell lung cancer | 5 | 0 | 4 | 0 | 65 | 39 | 1 | ||||
Agelidou | Athina | F | Greece | 1999 | 2011 | HORG | Non-small cell lung cancer; Small cell lung cancer | 8 | 0 | 7 | 0 | 99 | 47 | 1 | ||||
Agelidou | Maria | F | Greece | 2000 | 2013 | HORG | Non-small cell lung cancer; Small cell lung cancer | 6 | 0 | 5 | 0 | 79 | 42 | 1 | ||||
Ageno | Walter | M | Italy | 2008 | 2018 | Venous thromboembolism | 3 | 0 | 3 | 0 | 30 | 30 | 1 | |||||
Ager | Phyllis Joyce | F | 1984 | 1990 | NSABP | Breast cancer | 1 | 0 | 1 | 1 | 19 | 19 | 1 | |||||
Agerbaek | Mads | M | Denmark | 2002 | 2021 | EORTC; German Association of Urologic Oncology; Groupe d'Etude des Tumeurs Urogenitales; National Cancer Institute of Canada Clinical Trials Group; National Cancer Research Institute Bladder Cancer Study Group | Bladder cancer | 2 | 0 | 2 | 1 | 56 | 55 | 1 | ||||
Aggarwal | Charu | F | USA | 2011 | 2015 | Non-small cell lung cancer | 1 | 0 | 0 | 0 | 26 | 26 | 1 | |||||
Aggarwal | Sanjay | M | USA | 2012 | 2016 | Multiple myeloma | 2 | 0 | 1 | 1 | 37 | 37 | 1 | |||||
Aggerholm | Anni | F | 2004 | 2010 | Acute myeloid leukemia; Chronic myelomonocytic leukemia; Myelodysplastic syndrome | 1 | 0 | 0 | 0 | 19 | 19 | 1 | ||||||
Agha | Mounzer E. | UNMATCHED | USA | 2008 | 2022 | Multiple myeloma | 3 | 0 | 1 | 1 | 104 | 100 | 1 | |||||
Aghajanian | Carol A. | F | USA | 2005 | 2021 | GOG | Endometrial cancer; Leiomyosarcoma; Low-grade serous ovarian cancer; Ovarian cancer | 19 | 3 | 11 | 6 | 375 | 215 | 1 | ||||
Aghemo | E. | CBD | Italy | 2010 | 2016 | Multiple myeloma | 1 | 0 | 0 | 0 | 29 | 29 | 1 | |||||
Agis | Hermine | F | Austria | 2000 | 2006 | Chronic myeloid leukemia | 1 | 0 | 1 | 1 | 31 | 31 | 1 | |||||
Aglietta | Massimo | M | Italy | 1998 | 2022 | Italian Group for the Study of Gastrointestinal Cancer | Colorectal cancer; Multiple myeloma; Osteosarcoma; Soft tissue sarcoma | 8 | 1 | 4 | 2 | 138 | 119 | 1 | ||||
Agnelli | Giancarlo | M | Italy | 2010 | 2020 | Venous thromboembolism | 6 | 3 | 6 | 0 | 81 | 51 | 1 | |||||
Agnelli | L. | CBD | Italy | 2013 | 2013 | Plasma cell leukemia | 1 | 0 | 0 | 0 | 29 | 29 | 1 | |||||
Agodoa | Irene | F | USA | 2017 | 2021 | Sickle cell anemia | 1 | 0 | 1 | 0 | 11 | 11 | 1 | |||||
Agopian | Julie | F | France | 2009 | 2017 | Systemic mastocytosis | 1 | 0 | 1 | 0 | 25 | 25 | 1 | |||||
Agostara | Biagio | M | 1997 | 2010 | GOIM; Gruppo Oncologico Italia Meridionale | Breast cancer; Colorectal cancer; Non-small cell lung cancer | 3 | 0 | 3 | 0 | 53 | 46 | 1 | |||||
Agostinelli | Claudio | M | Italy | 2006 | 2017 | Diffuse large B-cell lymphoma | 1 | 0 | 1 | 0 | 25 | 25 | 1 | |||||
Agostini | Cecile | F | 2000 | 2007 | Breast cancer | 1 | 0 | 1 | 0 | 13 | 13 | 1 | ||||||
Agrawal | Manish | M | USA | 2014 | 2017 | Bladder cancer | 1 | 0 | 0 | 1 | 17 | 17 | 1 | |||||
Agrawal | Rajiv K. | M | United Kingdom | 1996 | 2019 | NEAT Investigators and the SCTBG; tAnGo trial collaborators | Breast cancer | 5 | 0 | 5 | 0 | 120 | 71 | 1 | ||||
Agrawal | Samir | M | 2006 | 2012 | NCRI | Chronic lymphocytic leukemia; Multiple myeloma; Stem cell mobilization | 2 | 0 | 0 | 0 | 34 | 34 | 1 | |||||
Agrawal | Shruti | F | USA | 2006 | 2021 | Chronic myeloid leukemia pediatric; Non-small cell lung cancer nonsquamous; Non-small cell lung cancer squamous | 2 | 0 | 1 | 2 | 42 | 42 | 1 | |||||
Agresta | Samuel V. | M | USA | 2013 | 2019 | Acute myeloid leukemia | 4 | 0 | 0 | 2 | 109 | 54 | 1 | |||||
Agricola | Karen | F | USA | 2007 | 2015 | Subependymal giant cell astrocytoma | 3 | 0 | 0 | 1 | 23 | 14 | 1 | |||||
Aguado Fraile | Elia | F | USA | 2017 | 2021 | Cholangiocarcinoma | 1 | 0 | 1 | 1 | 26 | 26 | 1 | |||||
Aguado | M. Jose | M | 1999 | 1999 | Hodgkin lymphoma | 1 | 0 | 0 | 0 | 5 | 5 | 1 | ||||||
Aguggini | S. | CBD | 1997 | 2005 | Breast cancer | 1 | 0 | 1 | 0 | 13 | 13 | 1 | ||||||
Aguiar | Melanie | Not yet determined | United Kingdom | 2012 | 2022 | B-cell acute lymphoblastic leukemia | 1 | 0 | 1 | 0 | 25 | 25 | 1 | |||||
Aguiar | Ricardo C. T. | M | USA | 2014 | 2014 | Hypereosinophilic syndrome | 1 | 0 | 0 | 0 | 18 | 18 | 1 | |||||
Aguilera | Nadia | F | Cuba | 2006 | 2016 | Non-small cell lung cancer | 1 | 0 | 1 | 0 | 33 | 33 | 1 | |||||
Aguilo | Rafael | M | 2000 | 2010 | Spanish Lung Cancer Group | Non-small cell lung cancer | 1 | 0 | 1 | 0 | 19 | 19 | 1 | |||||
Agulnik | Jason | M | Canada | 2008 | 2016 | Non-small cell lung cancer nonsquamous | 1 | 0 | 1 | 0 | 14 | 14 | 1 | |||||
Agulnik | Mark B. | M | USA | 2004 | 2020 | Epithelioid sarcoma; Head and neck cancer; Osteosarcoma; Soft tissue sarcoma; Vascular sarcoma | 7 | 1 | 3 | 2 | 132 | 100 | 1 | |||||
Agunwamba | Blessing U. | F | USA | 2009 | 2013 | Melanoma | 1 | 0 | 0 | 0 | 23 | 23 | 1 | |||||
Agura | Edward | M | USA | 1997 | 2018 | Acute myeloid leukemia; Allogeneic HSCT; Chronic lymphocytic leukemia; Hodgkin lymphoma | 8 | 1 | 1 | 1 | 131 | 83 | 1 | |||||
Agus | David B. | M | USA | 1993 | 2015 | Diffuse large B-cell lymphoma; Prostate cancer | 2 | 0 | 1 | 0 | 38 | 38 | 1 | |||||
Aguzzi | Rasha | Not yet determined | USA | 2018 | 2018 | Paroxysmal nocturnal hemoglobinuria | 1 | 0 | 1 | 1 | 13 | 13 | 1 | |||||
Ah See | Antoinne K. | M | 2002 | 2002 | Breast cancer | 1 | 0 | 1 | 0 | 11 | 11 | 1 | ||||||
Ah See | Mei Lin | Not yet determined | United Kingdom | 2007 | 2019 | Breast cancer | 1 | 0 | 1 | 0 | 31 | 31 | 1 | |||||
Ahern | Charlotte | F | USA | 2009 | 2013 | COG | Anaplastic large cell lymphoma pediatric | 1 | 0 | 0 | 1 | 13 | 13 | 1 | ||||
Ahlberg | Lucia | F | 2002 | 2013 | Multiple myeloma | 2 | 0 | 2 | 0 | 48 | 37 | 1 | ||||||
Ahlborn | Miriam | F | Germany | 2012 | 2021 | GHSG | Hodgkin lymphoma | 1 | 0 | 2 | 0 | 35 | 35 | 1 | ||||
Ahlgren | Goeran M. | M | Sweden | 2005 | 2018 | SPCG | Prostate cancer | 2 | 1 | 2 | 0 | 30 | 29 | 1 | ||||
Ahlgren | James D. | M | 1984 | 1989 | MAOP | Colorectal cancer | 1 | 0 | 1 | 0 | 4 | 4 | 1 | |||||
Ahlgren | Johan | M | Sweden | 2004 | 2022 | Breast cancer | 3 | 0 | 1 | 0 | 57 | 27 | 1 | |||||
Ahlgren | Tomas | M | Sweden | 2002 | 2015 | Nordic Lymphoma Group | Follicular lymphoma | 1 | 0 | 1 | 0 | 12 | 12 | 1 | ||||
Ahlman | Hakan | M | 1979 | 2010 | Adrenocortical carcinoma | 1 | 1 | 0 | 0 | 8 | 8 | 1 | ||||||
Ahlmann | Martina | F | Germany | 2020 | 2020 | Hemophagocytic lymphohistiocytosis | 1 | 0 | 0 | 1 | 19 | 19 | 1 | |||||
Ahluwalia | Manmeet S. | M | USA | 2009 | 2020 | Glioblastoma | 2 | 0 | 2 | 0 | 47 | 46 | 1 | |||||
Ahmad | Chaudhary E. | Not yet determined | Canada | 2016 | 2020 | NCIC-CTG | Colorectal cancer | 1 | 0 | 0 | 0 | 20 | 20 | 1 | ||||
Ahmad | Rizvana | F | United Kingdom | 2009 | 2015 | Breast cancer | 1 | 0 | 1 | 0 | 20 | 20 | 1 | |||||
Ahmad | Shaharyar | UNMATCHED | 2013 | 2013 | Hodgkin lymphoma | 1 | 0 | 0 | 0 | 3 | 3 | 1 | ||||||
Ahmadi | Jamshid | M | USA | 1992 | 2015 | SWOG | Meningioma | 1 | 0 | 1 | 0 | 12 | 12 | 1 | ||||
Ahmadi | Tahamtan | M | USA | 2008 | 2021 | Follicular lymphoma; Light-chain (AL) amyloidosis; Mantle cell lymphoma; Multiple myeloma | 16 | 1 | 6 | 9 | 409 | 214 | 1 | |||||
Ahmann | David L. | M | USA | 1977 | 1995 | Breast cancer; Melanoma | 7 | 2 | 7 | 1 | 54 | 30 | 1 | |||||
Ahmann | Frederick R. | M | 2002 | 2007 | Prostate cancer | 1 | 0 | 1 | 0 | 18 | 18 | 1 | ||||||
Ahmann | Gregory J. | M | USA | 2004 | 2018 | ECOG | Multiple myeloma | 2 | 0 | 1 | 1 | 42 | 39 | 1 | ||||
Ahmed | Asra | F | 2005 | 2012 | Multiple myeloma | 2 | 0 | 0 | 0 | 28 | 25 | 1 | ||||||
Ahmed | Atif A. | Not yet determined | USA | 2010 | 2021 | COG | Ewing sarcoma | 1 | 0 | 1 | 0 | 23 | 23 | 1 | ||||
Ahmed | Ikhlaaq | Not yet determined | United Kingdom | 1998 | 2019 | Breast cancer | 1 | 0 | 1 | 0 | 19 | 19 | 1 | |||||
Ahmed | Nazma | F | Switzerland | 2006 | 2015 | Head and neck cancer | 1 | 0 | 1 | 0 | 24 | 24 | 1 | |||||
Ahmed | Sairah | F | USA | 2009 | 2014 | Allogeneic HSCT; Mantle cell lymphoma; Transformed lymphoma | 1 | 0 | 0 | 0 | 13 | 13 | 1 | |||||
Ahn | Chul | M | USA | 2013 | 2014 | Blastic plasmacytoid dendritic cell neoplasm | 1 | 0 | 0 | 0 | 14 | 14 | 1 | |||||
Ahn | Daniel H. | M | USA | 2015 | 2019 | Cholangiocarcinoma; Colorectal cancer; Gallbladder cancer | 2 | 0 | 0 | 0 | 31 | 30 | 1 | |||||
Ahn | Hanjong | Not yet determined | South Korea | 2014 | 2022 | Prostate cancer | 1 | 0 | 1 | 0 | 8 | 8 | 1 | |||||
Ahn | Inhye E. | Not yet determined | USA | 2015 | 2020 | Chronic lymphocytic leukemia | 1 | 1 | 0 | 0 | 16 | 16 | 1 | |||||
Ahn | Jae Sook | M | South Korea | 2009 | 2015 | Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology | B-cell acute lymphoblastic leukemia; CNS leukemia | 1 | 0 | 0 | 0 | 36 | 36 | 1 | ||||
Ahn | Jin Hee | F | South Korea | 2007 | 2022 | KCSG | Breast cancer | 4 | 0 | 4 | 1 | 79 | 66 | 1 | ||||
Ahn | Jin Seok | M | South Korea | 2002 | 2020 | KCSG | Breast cancer; CNS carcinoma; Non-small cell lung cancer; Non-small cell lung cancer nonsquamous; Small cell lung cancer | 15 | 1 | 10 | 4 | 230 | 152 | 1 | ||||
Ahn | Joong Bae | M | South Korea | 2008 | 2019 | Colorectal cancer; Rectal cancer | 6 | 0 | 3 | 1 | 103 | 65 | 1 | |||||
Ahn | Myung Ju | F | South Korea | 2002 | 2021 | KCSG | CNS carcinoma; Esophageal squamous cell carcinoma; Head and neck cancer; Non-small cell lung cancer; Non-small cell lung cancer nonsquamous; Non-small cell lung cancer squamous; NTRK; Small cell lung cancer | 41 | 4 | 20 | 11 | 735 | 423 | 1 | ||||
Ahn | Sei Hyun | Not yet determined | South Korea | 2012 | 2020 | Breast cancer | 1 | 1 | 1 | 0 | 9 | 8 | 1 | |||||
Ahn | Sung Ja | Not yet determined | 2005 | 2013 | Non-small cell lung cancer | 1 | 1 | 1 | 0 | 11 | 11 | 1 | ||||||
Ahn | Yeon S. | Not yet determined | 1983 | 1983 | Immune thrombocytopenia | 1 | 1 | 0 | 0 | 5 | 5 | 1 | ||||||
Ahn | Yong Chan | M | South Korea | 2003 | 2015 | Consortium for Improving Survival of Lymphoma; KCSG | Extranodal NK- and T-cell lymphoma nasal type; Gastric cancer; Non-small cell lung cancer; Small cell lung cancer | 4 | 1 | 3 | 0 | 69 | 60 | 1 | ||||
Ahren | Bo | M | 1991 | 2003 | Neuroendocrine tumor | 1 | 1 | 0 | 0 | 3 | 3 | 1 | ||||||
Ahrens | S. | CBD | 2001 | 2001 | Ewing sarcoma | 1 | 0 | 0 | 0 | 18 | 18 | 1 | ||||||
Ahsan | S. | Not yet determined | USA | 2011 | 2019 | Melanoma | 1 | 0 | 0 | 0 | 19 | 19 | 1 | |||||
Ahsan | Sama | F | United Kingdom; USA | 2015 | 2022 | SWOG | Melanoma | 2 | 0 | 2 | 1 | 57 | 54 | 1 | ||||
Ahuja | Harish | M | 2005 | 2005 | Esophageal cancer | 1 | 0 | 0 | 0 | 10 | 10 | 1 | ||||||
Ai | Ping | F | China | 2011 | 2019 | Nasopharyngeal carcinoma | 2 | 0 | 2 | 0 | 67 | 34 | 1 | |||||
Ai | Weiyun | F | USA | 2018 | 2021 | Diffuse large B-cell lymphoma; Transformed lymphoma | 1 | 0 | 0 | 1 | 17 | 17 | 1 | |||||
Ai | Xinghao | Not yet determined | China | 2018 | 2021 | Non-small cell lung cancer nonsquamous; Small cell lung cancer | 2 | 1 | 2 | 0 | 57 | 51 | 1 | |||||
Aiba | Keisuke | Not yet determined | Japan | 2010 | 2021 | Colon cancer | 2 | 0 | 1 | 0 | 41 | 30 | 1 | |||||
Aiello | Maria | F | USA | 2012 | 2014 | Chronic lymphocytic leukemia | 1 | 0 | 1 | 1 | 26 | 26 | 1 | |||||
Aieta | Michele | M | Italy | 2007 | 2018 | Reader study level-I and level-II Groups | Breast cancer; Testicular cancer | 2 | 0 | 1 | 0 | 40 | 40 | 1 | ||||
Aihara | Satomi | Not yet determined | Japan | 2015 | 2021 | Ovarian cancer | 1 | 0 | 1 | 0 | 41 | 41 | 1 | |||||
Aihara | Tomohiko | M | Japan | 2002 | 2010 | Breast cancer | 1 | 1 | 1 | 0 | 20 | 20 | 1 | |||||
Aikata | Hiroshi | M | Japan | 2008 | 2018 | Hepatocellular carcinoma | 2 | 0 | 2 | 0 | 35 | 32 | 1 | |||||
Aikawa | Keiko | Not yet determined | Japan | 1995 | 2010 | JCOG | Adult T-cell leukemia-lymphoma; Diffuse large B-cell lymphoma | 2 | 0 | 1 | 0 | 32 | 25 | 1 | ||||
Aiken | Robert | Not yet determined | USA | 2007 | 2018 | Glioblastoma | 1 | 0 | 1 | 0 | 68 | 68 | 1 | |||||
Ailawadhi | Sikander | M | USA | 2012 | 2018 | Chronic myeloid leukemia; Multiple myeloma | 3 | 0 | 0 | 1 | 70 | 51 | 1 | |||||
Aimone | Paola | F | Switzerland | 2007 | 2021 | Chronic myeloid leukemia; Chronic myeloid leukemia pediatric; Head and neck cancer; Renal cell carcinoma | 7 | 0 | 3 | 4 | 146 | 116 | 1 | |||||
Airatovich Gafanov | Rustem | M | Russian Federation | 2016 | 2021 | Clear cell renal cell carcinoma; Non-clear cell renal cell carcinoma; Prostate cancer; Renal cell carcinoma | 5 | 0 | 2 | 1 | 107 | 78 | 1 | |||||
Aird | William | M | 1990 | 2000 | Acute myeloid leukemia | 1 | 0 | 0 | 0 | 6 | 6 | 1 | ||||||
Airewele | Gladstone | Not yet determined | USA | 2004 | 2014 | Acute myeloid leukemia pediatric; Sickle cell anemia | 2 | 0 | 1 | 0 | 56 | 56 | 1 | |||||
Airoma | G. | CBD | 1990 | 1996 | GOSCI | Non-small cell lung cancer | 1 | 0 | 1 | 0 | 18 | 18 | 1 | |||||
Aisa | Yoshinobu | M | 2015 | 2015 | Follicular lymphoma | 1 | 0 | 0 | 0 | 18 | 18 | 1 | ||||||
Aisner | D. L. | CBD | USA | 2011 | 2015 | Pancreatic cancer | 1 | 0 | 0 | 0 | 30 | 30 | 1 | |||||
Aisner | Joseph A. | M | USA | 1976 | 2003 | CALGB | Breast cancer; Head and neck cancer; Soft tissue sarcoma; Thymoma | 9 | 3 | 6 | 0 | 93 | 65 | 1 | ||||
Aisner | Seena C. | F | USA | 1982 | 2017 | ECOG; ECOG-ACRIN; SECSG; SWOG | Non-small cell lung cancer; Small cell lung cancer; Thymoma | 8 | 0 | 3 | 0 | 72 | 56 | 1 | ||||
Aitchison | Michael A. | M | United Kingdom | 1998 | 2018 | EORTC; MRC | Renal cell carcinoma | 3 | 1 | 3 | 0 | 48 | 47 | 1 | ||||
Aitini | Enrico | M | Italy | 1987 | 2014 | GERCOR; GISCAD; Italian Group for the Study of Digestive Tract Cancer; Mammella InterGruppo | Breast cancer; Colorectal cancer; Diffuse large B-cell lymphoma; Gastric cancer; Malignant pleural mesothelioma; Non-small cell lung cancer; Ovarian cancer; Pancreatic cancer | 13 | 0 | 10 | 0 | 216 | 176 | 1 | ||||
Aitken | Casey N. | UNMATCHED | USA | 2017 | 2017 | Transformed lymphoma | 1 | 0 | 0 | 0 | 34 | 34 | 1 | |||||
Aivado | Manuel | M | 2010 | 2010 | Immune thrombocytopenia | 1 | 0 | 1 | 0 | 8 | 8 | 1 | ||||||
Aix | Santiago Ponce | Not yet determined | Spain | 2014 | 2020 | Non-small cell lung cancer | 1 | 0 | 1 | 0 | 19 | 19 | 1 | |||||
Aizawa | Masataka | Not yet determined | 2005 | 2013 | Bladder cancer; Upper tract urothelial carcinoma | 1 | 0 | 0 | 0 | 22 | 22 | 1 | ||||||
Ajani | Jaffer A. | M | USA | 1990 | 2022 | RTOG; USA Intergroup | Anal cancer; Esophageal adenocarcinoma; Esophageal cancer; Esophageal squamous cell carcinoma; Gastric cancer | 21 | 11 | 13 | 5 | 316 | 237 | 1 | ||||
Ajaz | Mazhar | Not yet determined | United Kingdom | 2016 | 2019 | Melanoma | 1 | 0 | 0 | 0 | 18 | 18 | 1 | |||||
Akabane | Hiromitsu | M | Japan | 2006 | 2021 | Breast cancer | 2 | 0 | 2 | 0 | 21 | 19 | 1 | |||||
Akaike | Makoto | M | Japan | 2003 | 2014 | JCOG | Colorectal cancer | 1 | 0 | 1 | 0 | 17 | 17 | 1 | ||||
Akaike | Tomoko | F | USA | 2015 | 2021 | Merkel cell carcinoma | 1 | 0 | 0 | 1 | 28 | 28 | 1 | |||||
Akamaru | Yusuke | M | Japan | 2007 | 2015 | Gastric cancer | 1 | 0 | 1 | 0 | 16 | 16 | 1 | |||||
Akamatsu | Hiroaki | M | Japan | 2014 | 2021 | CNS carcinoma; Non-small cell lung cancer; Non-small cell lung cancer nonsquamous | 3 | 0 | 2 | 1 | 53 | 42 | 1 | |||||
Akamatsu | Hiroki | Not yet determined | Japan | 2011 | 2017 | Rectal cancer | 1 | 0 | 1 | 0 | 12 | 12 | 1 | |||||
Akapame | Sydney | M | USA | 2015 | 2022 | Bladder cancer | 1 | 0 | 0 | 1 | 18 | 18 | 1 | |||||
Akard | Luke | M | USA | 2006 | 2015 | Chronic myeloid leukemia; Testicular cancer | 3 | 0 | 0 | 2 | 40 | 34 | 1 | |||||
Akaza | Hideyuki | M | Japan | 2000 | 2020 | Study Group for the Combined Androgen Blockade Therapy of Prostate Cancer | Prostate cancer | 6 | 3 | 5 | 1 | 66 | 57 | 1 | ||||
Akazawa | Kohei | M | Japan | 2010 | 2018 | Hepatocellular carcinoma | 1 | 0 | 1 | 0 | 21 | 21 | 1 | |||||
Akazawa | Rio | F | Japan | 2013 | 2018 | Prostate cancer | 1 | 0 | 1 | 0 | 11 | 11 | 1 | |||||
Akbulut | Hakan | M | 1992 | 2005 | Turkish Oncology Group | Breast cancer | 2 | 0 | 2 | 0 | 25 | 21 | 1 | |||||
Akdas | Atif | M | Turkey | 1997 | 2009 | EORTC | Prostate cancer | 1 | 0 | 1 | 0 | 15 | 15 | 1 | ||||
Aker | Memet | M | 1998 | 1998 | Allogeneic HSCT; Chronic lymphocytic leukemia | 1 | 0 | 0 | 0 | 14 | 14 | 1 | ||||||
Akerley | Wallace | M | USA | 1998 | 2016 | CALGB | Melanoma; Non-small cell lung cancer; Small cell lung cancer | 4 | 0 | 4 | 1 | 74 | 72 | 1 | ||||
Akerman | Maans | M | 1989 | 2008 | Nordic Lymphoma Group | Autologous HSCT; Diffuse large B-cell lymphoma; Mantle cell lymphoma | 2 | 1 | 1 | 0 | 30 | 28 | 1 | |||||
Akewanlop | Charuwan | F | Thailand | 2015 | 2020 | Non-small cell lung cancer | 1 | 0 | 1 | 1 | 23 | 23 | 1 | |||||
Akhter | Chameli | Not yet determined | Bangladesh | 2004 | 2016 | Breast cancer | 1 | 0 | 1 | 0 | 29 | 29 | 1 | |||||
Akilov | Oleg E. | M | USA | 2012 | 2021 | Cutaneous T-cell lymphoma | 2 | 0 | 1 | 1 | 57 | 37 | 1 | |||||
Akimasa | Nakao | UNMATCHED | 2003 | 2007 | Chubu Clinical Cancer Group | Gastric cancer | 1 | 1 | 0 | 0 | 12 | 12 | 1 | |||||
Akimov | Mikhail | M | Switzerland | 2020 | 2020 | Non-small cell lung cancer | 1 | 0 | 0 | 1 | 31 | 31 | 1 | |||||
Akin | Cem | M | USA | 2003 | 2016 | Hypereosinophilic syndrome; Systemic mastocytosis | 3 | 0 | 0 | 1 | 34 | 34 | 1 | |||||
Akinaga | Shiro | M | Japan | 2010 | 2015 | Adult T-cell leukemia-lymphoma; CNS leukemia; Cutaneous T-cell lymphoma; Non-small cell lung cancer; Peripheral T-cell lymphoma | 3 | 0 | 1 | 0 | 54 | 47 | 1 | |||||
Akita | Hirotoshi | M | 1992 | 1992 | Small cell lung cancer | 1 | 0 | 1 | 0 | 10 | 10 | 1 | ||||||
Akiya | Toshikazu | M | 2002 | 2008 | Gastric cancer | 1 | 0 | 1 | 0 | 16 | 16 | 1 | ||||||
Akiyama | Hideki | M | 1993 | 2013 | JALSG | B-cell acute lymphoblastic leukemia; Chronic myeloid leukemia | 2 | 0 | 1 | 1 | 35 | 35 | 1 | |||||
Akiyoshi | Kohei | Not yet determined | Japan | 2019 | 2019 | Carcinoma of unknown primary | 1 | 0 | 0 | 0 | 20 | 20 | 1 | |||||
Akkermans Vogelaar | Janine M. | F | Netherlands | 2013 | 2022 | Dutch Pancreatic Cancer Group | Pancreatic cancer | 2 | 0 | 1 | 0 | 60 | 31 | 1 | ||||
Akopov | Audrey | F | Russian Federation | 2015 | 2021 | Non-small cell lung cancer | 1 | 0 | 1 | 1 | 20 | 20 | 1 | |||||
Akpek | Gorgun | UNMATCHED | USA | 2016 | 2016 | BMT CTN | Autologous HSCT; HIV-associated lymphoma | 1 | 0 | 0 | 0 | 21 | 21 | 1 | ||||
Akram Hussain | Syed Md | Not yet determined | Bangladesh | 2004 | 2016 | Breast cancer | 1 | 0 | 1 | 0 | 29 | 29 | 1 | |||||
Akram | Muhammed | M | USA | 2018 | 2021 | Multiple myeloma | 1 | 0 | 0 | 1 | 35 | 35 | 1 | |||||
Aksnes | Anne Kirsti | F | Norway | 2008 | 2014 | Prostate cancer | 1 | 0 | 1 | 1 | 12 | 12 | 1 | |||||
Aktan | Gursel | M | USA | 2005 | 2022 | NeoALTTO Study Team | Breast cancer | 6 | 0 | 5 | 2 | 123 | 95 | 1 | ||||
Aktan | Melih | M | Turkey | 2010 | 2018 | Chronic lymphocytic leukemia | 1 | 0 | 1 | 0 | 16 | 16 | 1 | |||||
Aktas | Bahriye | F | Germany | 2000 | 2019 | GBG | Breast cancer | 7 | 0 | 5 | 0 | 144 | 87 | 1 | ||||
Akusawa | Hiroshi | M | 1987 | 1996 | Non-small cell lung cancer | 1 | 0 | 1 | 0 | 7 | 7 | 1 | ||||||
Al Akash | Samhar I. | Not yet determined | USA | 2016 | 2016 | Atypical hemolytic uremic syndrome | 1 | 0 | 0 | 0 | 14 | 14 | 1 | |||||
Al Ali | Haifa Kathrin | F | Germany | 1997 | 2017 | OSHO | Acute myeloid leukemia; Allogeneic HSCT; Autologous HSCT; Chronic lymphocytic leukemia; CNS lymphoma; Follicular lymphoma; Myelofibrosis | 10 | 1 | 5 | 1 | 165 | 117 | 1 | ||||
Al Batran | Salah Eddin | M | Germany | 2000 | 2020 | AIO | Breast cancer; Colorectal cancer; Esophageal adenocarcinoma; Esophageal squamous cell carcinoma; Follicular lymphoma; Gastric cancer; Gastrointestinal stromal tumor; Mantle cell lymphoma; Marginal zone lymphoma; MSI-H or dMMR; Waldenstroem macroglobulinemia | 19 | 6 | 10 | 2 | 415 | 280 | 1 | ||||
Al Booz | Hoda | F | United Kingdom | 2012 | 2018 | De-ESCALaTE HPV Trial Group | Oropharyngeal cancer | 1 | 0 | 1 | 0 | 30 | 30 | 1 | ||||
Al Dewik | Nader | M | Qatar | 2015 | 2015 | Essential thrombocythemia | 1 | 0 | 0 | 0 | 13 | 13 | 1 | |||||
Al Fayoumi | Suliman | M | USA | 2014 | 2018 | Myelofibrosis | 1 | 0 | 1 | 1 | 18 | 18 | 1 | |||||
Al Ghuzlan | Abir | Not yet determined | France | 2013 | 2022 | Thyroid cancer differentiated | 1 | 0 | 1 | 0 | 33 | 33 | 1 | |||||
Al Kali | Aref | M | USA | 2010 | 2016 | Myelodysplastic syndrome | 1 | 0 | 1 | 0 | 20 | 20 | 1 | |||||
Al Kateb | Hussam | Not yet determined | USA | 2013 | 2017 | Breast cancer | 1 | 0 | 0 | 0 | 33 | 33 | 1 | |||||
Al Rajabi | Raed | M | USA | 2015 | 2020 | Cholangiocarcinoma; Esophageal cancer; Esophageal squamous cell carcinoma | 2 | 0 | 1 | 2 | 44 | 44 | 1 | |||||
Al Sakaff | Nedal | M | Switzerland | 2001 | 2019 | Herceptin Adjuvant (HERA) Trial Study Team | Breast cancer | 2 | 0 | 2 | 2 | 26 | 25 | 1 | ||||
al Sarraf | Muhyi | M | USA | 1977 | 1999 | Radiation Therapy Oncology Group; RTOG; SWOG | Esophageal cancer; Glioblastoma; Melanoma; Nasopharyngeal carcinoma; Prostate cancer | 7 | 2 | 6 | 1 | 70 | 53 | 1 | ||||
Al Sawaf | Othman | M | Germany | 2005 | 2022 | GCLLSG | Chronic lymphocytic leukemia | 6 | 2 | 4 | 1 | 148 | 80 | 1 | ||||
Al Shukri | Salman | M | Russian Federation | 2010 | 2016 | Renal cell carcinoma | 2 | 0 | 1 | 0 | 17 | 11 | 1 | |||||
Al Toubah | Taymeyah E. | Not yet determined | USA | 2016 | 2020 | Cholangiocarcinoma | 1 | 0 | 0 | 0 | 10 | 10 | 1 | |||||
Al Tweigeri | Taher | M | Canada | 1997 | 2005 | BCIRG | Breast cancer | 1 | 0 | 1 | 1 | 31 | 31 | 1 | ||||
Al Zoubi | Ammar | M | 2005 | 2012 | Multiple myeloma | 2 | 0 | 0 | 0 | 28 | 25 | 1 | ||||||
Alabiso | O. | CBD | 2007 | 2007 | Malignant pleural mesothelioma | 1 | 0 | 0 | 0 | 14 | 14 | 1 | ||||||
Alakel | N. | CBD | Germany | 2012 | 2015 | Acute myeloid leukemia; Allogeneic HSCT | 1 | 0 | 0 | 0 | 25 | 25 | 1 | |||||
Alakl | May | F | France | 1994 | 2010 | EORTC | Breast cancer; Colorectal cancer; Light-chain (AL) amyloidosis | 5 | 0 | 3 | 3 | 82 | 81 | 1 | ||||
Alam | A. | CBD | 2005 | 2005 | Follicular lymphoma | 1 | 0 | 0 | 0 | 18 | 18 | 1 | ||||||
Alam | Rafeul | M | USA | 2001 | 2003 | Hypereosinophilic syndrome | 1 | 0 | 0 | 0 | 25 | 25 | 1 | |||||
Alam | Yasmin | F | Italy | 2006 | 2012 | Non-small cell lung cancer | 3 | 0 | 1 | 0 | 70 | 47 | 1 | |||||
Alama | A. | CBD | 1983 | 1987 | Breast cancer | 1 | 0 | 1 | 0 | 15 | 15 | 1 | ||||||
Alamoudi | Sameer | M | Canada | 2003 | 2015 | NCIC-CTG | Transformed lymphoma | 1 | 0 | 1 | 0 | 18 | 18 | 1 | ||||
Alamouti | Sepideh | F | Canada | 2010 | 2016 | Diffuse large B-cell lymphoma | 1 | 0 | 0 | 0 | 23 | 23 | 1 | |||||
Alanko | Tuomo | M | Finland | 2000 | 2009 | Breast cancer | 3 | 0 | 2 | 0 | 56 | 34 | 1 | |||||
Alao | Hawwa | Not yet determined | USA | 2014 | 2019 | Hypereosinophilic syndrome | 1 | 0 | 0 | 0 | 24 | 24 | 1 | |||||
Alapi | Krisztina Zuborne | Not yet determined | United Kingdom | 2012 | 2022 | B-cell acute lymphoblastic leukemia | 1 | 0 | 1 | 0 | 25 | 25 | 1 | |||||
Alarcon | Jesus | M | 2007 | 2007 | Diffuse large B-cell lymphoma | 1 | 0 | 0 | 0 | 9 | 9 | 1 | ||||||
Alashkar | Ferras | Not yet determined | Germany | 2021 | 2021 | Paroxysmal nocturnal hemoglobinuria | 1 | 0 | 0 | 0 | 14 | 14 | 1 | |||||
Alatorre Alexander | Jorge | M | Mexico | 2016 | 2021 | Small cell lung cancer | 1 | 0 | 1 | 1 | 19 | 19 | 1 | |||||
Alattar | Mona Lisa | F | 2011 | 2013 | Acute myeloid leukemia | 1 | 0 | 0 | 0 | 19 | 19 | 1 | ||||||
Alavi | Jane | F | 2003 | 2003 | CNS lymphoma | 1 | 0 | 0 | 0 | 7 | 7 | 1 | ||||||
Alba | Emilio | M | Spain | 1995 | 2021 | GEICAM | Breast cancer | 13 | 3 | 12 | 1 | 280 | 186 | 1 | ||||
Albain | Kathy S. | F | USA | 1989 | 2021 | Breast Cancer Intergroup of North America; NCIC-CTG; NSABP; RTOG; SWOG | Breast cancer; Non-small cell lung cancer | 19 | 4 | 12 | 3 | 361 | 250 | 1 | ||||
Albala | Maurice M. | M | 1968 | 1968 | Head and neck cancer | 1 | 0 | 0 | 0 | 2 | 2 | 1 | ||||||
Albanell | Juan | M | Spain | 1987 | 2014 | GEICAM | Breast cancer | 3 | 0 | 2 | 0 | 38 | 38 | 1 | ||||
Albano | Edythe | F | USA | 2002 | 2006 | B-cell acute lymphoblastic leukemia pediatric | 1 | 0 | 0 | 1 | 19 | 19 | 1 | |||||
Albano | Francesco | M | Italy | 2004 | 2019 | GIMEMA | Acute promyelocytic leukemia; Chronic myeloid leukemia | 3 | 0 | 3 | 1 | 113 | 69 | 1 | ||||
Alberici | Federico | M | Italy | 1994 | 2015 | GOIRC; POLAR-01 Trial Investigators | Erdheim-Chester disease; Renal cell carcinoma | 2 | 0 | 1 | 0 | 34 | 32 | 1 | ||||
Alberola | Vincente | M | Spain | 1989 | 2012 | Spanish Lung Cancer Group | Non-small cell lung cancer; Non-small cell lung cancer nonsquamous | 6 | 1 | 6 | 2 | 109 | 85 | 1 | ||||
Albers | Gregory W. | M | USA | 2018 | 2018 | Venous thromboembolism | 1 | 0 | 1 | 0 | 12 | 12 | 1 | |||||
Albers | Mary E. | F | USA | 1990 | 1998 | Head and neck cancer | 1 | 0 | 1 | 0 | 8 | 8 | 1 | |||||
Albers | Peter | M | Germany | 1994 | 2021 | AUO; EORTC; German Association of Urologic Oncology; Groupe d'Etude des Tumeurs Urogenitales; National Cancer Institute of Canada Clinical Trials Group; National Cancer Research Institute Bladder Cancer Study Group | Bladder cancer; Prostate cancer; Testicular cancer | 9 | 3 | 8 | 0 | 156 | 127 | 1 | ||||
Albert | Catherine M. | F | USA | 2015 | 2020 | NTRK | 1 | 0 | 0 | 3 | 28 | 28 | 1 | |||||
Albert | Donald | M | 2002 | 2008 | Non-small cell lung cancer | 1 | 0 | 1 | 0 | 7 | 7 | 1 | ||||||
Albert | Istvan | M | Hungary | 2006 | 2019 | Non-small cell lung cancer | 4 | 0 | 4 | 1 | 74 | 64 | 1 | |||||
Albert | Michael H. | M | Germany | 2003 | 2015 | Allogeneic HSCT; B-cell acute lymphoblastic leukemia pediatric; T-cell acute lymphoblastic leukemia pediatric | 1 | 0 | 0 | 0 | 22 | 22 | 1 | |||||
Albert | Paul S. | M | USA | 2006 | 2008 | Glioblastoma | 1 | 0 | 0 | 1 | 12 | 12 | 1 | |||||
Albert | Ute Susann | F | 1998 | 2009 | Breast cancer | 1 | 0 | 1 | 0 | 19 | 19 | 1 | ||||||
Alberti | Daniele | UNMATCHED | 1996 | 2002 | Breast cancer | 1 | 0 | 1 | 0 | 9 | 9 | 1 | ||||||
Albertini | Mark R. | M | USA | 1998 | 2019 | ECOG | Melanoma; Uveal melanoma | 3 | 0 | 2 | 0 | 67 | 58 | 1 | ||||
Alberto | Pierre | M | 1979 | 1994 | SAKK | Breast cancer | 2 | 1 | 2 | 0 | 22 | 19 | 1 | |||||
Alberts | David S. | M | USA | 1974 | 2019 | GOG; GRACES Clinical Trial Consortium; Gynecologic Cancer Intergroup; SWOG | Cervical cancer; Multiple myeloma; Ovarian cancer | 16 | 13 | 11 | 1 | 144 | 105 | 1 | ||||
Alberts | Steven R. | M | USA | 1997 | 2017 | CALGB; ECOG; NCCTG; SWOG | Cholangiocarcinoma; Colon cancer; Colorectal cancer; Gallbladder cancer; Gastric cancer; Pancreatic cancer | 10 | 2 | 8 | 2 | 121 | 97 | 1 | ||||
Albertsen | Birgitte Klug | F | Denmark | 2008 | 2019 | B-cell acute lymphoblastic leukemia pediatric | 1 | 1 | 1 | 0 | 9 | 9 | 1 | |||||
Albertson | Tina M. | F | USA | 2016 | 2020 | Diffuse large B-cell lymphoma; Primary mediastinal B-cell lymphoma; Transformed lymphoma | 1 | 0 | 0 | 1 | 21 | 21 | 1 | |||||
Albertsson | Maria | F | Sweden | 1991 | 2015 | Nordic Gastrointestinal Tumour Adjuvant Therapy Group | Colon cancer; Colorectal cancer; Esophageal cancer; Esophageal squamous cell carcinoma | 4 | 1 | 3 | 0 | 34 | 30 | 1 | ||||
Albiges | Laurence | M | France; USA | 2004 | 2022 | GETUG | Non-clear cell renal cell carcinoma; Papillary renal cell carcinoma; Prostate cancer; Renal cell carcinoma | 9 | 3 | 7 | 2 | 187 | 143 | 1 | ||||
Albitar | Maher | M | USA | 1998 | 2009 | Acute myeloid leukemia; B-cell acute lymphoblastic leukemia; Chronic lymphocytic leukemia; Chronic myeloid leukemia; CNS leukemia; Hypereosinophilic syndrome; Myelodysplastic syndrome; Systemic mastocytosis | 7 | 0 | 2 | 3 | 98 | 74 | 1 | |||||
Albo | Vincent C. | M | 1988 | 1988 | CCG | T-cell acute lymphoblastic leukemia pediatric | 1 | 0 | 0 | 0 | 11 | 11 | 1 | |||||
Albright | A. L. | Not yet determined | 1999 | 1999 | CCG | Medulloblastoma | 1 | 0 | 0 | 0 | 15 | 15 | 1 | |||||
Albright | Robert E. | M | USA | 1999 | 2000 | Temodal Brain Tumor Group | Anaplastic glioma; Glioblastoma | 2 | 0 | 0 | 1 | 36 | 27 | 1 | ||||
Albritton | Karen | F | 2004 | 2004 | Ewing sarcoma | 1 | 0 | 0 | 0 | 9 | 9 | 1 | ||||||
Albuquerque | Marco | M | Canada | 2010 | 2016 | Diffuse large B-cell lymphoma | 1 | 0 | 0 | 0 | 23 | 23 | 1 | |||||
Alcaide | Julia | F | Spain | 2010 | 2018 | TTD | Colorectal cancer | 1 | 0 | 0 | 0 | 26 | 26 | 1 | ||||
Alcaide | Miguel | M | Canada | 2010 | 2016 | Diffuse large B-cell lymphoma | 1 | 0 | 0 | 0 | 23 | 23 | 1 | |||||
Alcaraz | Antonio | M | Spain | 2011 | 2022 | Prostate cancer | 3 | 0 | 2 | 1 | 50 | 38 | 1 | |||||
Alcedo | Juan Carlos | M | Panama | 2002 | 2016 | Breast cancer; Cervical cancer | 2 | 0 | 3 | 0 | 26 | 26 | 1 | |||||
Alcindor | Thierry | M | Canada | 2003 | 2019 | EORTC | Gastric cancer; Liposarcoma; Soft tissue sarcoma; Tenosynovial giant cell tumor | 7 | 0 | 6 | 2 | 138 | 107 | 1 | ||||
Aldaoud | Ali | M | Germany | 1996 | 2017 | European Mantle Cell Lymphoma Network; GCLLSG; GLSG | Autologous HSCT; Chronic lymphocytic leukemia; Follicular lymphoma; Mantle cell lymphoma; Stem cell mobilization | 6 | 0 | 6 | 1 | 111 | 75 | 1 | ||||
Aldape | Kenneth D. | M | Canada; USA | 2002 | 2017 | Canadian Brain Tumor Consortium; CENTRIC study team; EORTC; RTOG | Anaplastic glioma; Glioblastoma | 5 | 0 | 6 | 0 | 137 | 102 | 1 | ||||
Alderdice | M. | CBD | 1995 | 2002 | Breast cancer | 1 | 0 | 1 | 0 | 16 | 16 | 1 | ||||||
Alderete | Daniel | M | 1987 | 1997 | Hodgkin lymphoma | 1 | 0 | 1 | 0 | 9 | 9 | 1 | ||||||
Alderson | Derek | M | United Kingdom | 1989 | 2017 | MRC | Colorectal cancer; Esophageal adenocarcinoma | 3 | 1 | 4 | 0 | 42 | 33 | 1 | ||||
Alderuccio | Juan Pablo | M | USA | 2018 | 2021 | Diffuse large B-cell lymphoma; Transformed lymphoma | 1 | 0 | 0 | 1 | 17 | 17 | 1 | |||||
Aldrighetti | Daniela | F | 1996 | 2004 | GONO | Breast cancer | 1 | 0 | 1 | 0 | 14 | 14 | 1 | |||||
Aldrighetti | Luca | M | 2000 | 2005 | Pancreatic cancer | 1 | 0 | 1 | 0 | 16 | 16 | 1 | ||||||
Aledo | Alexander | M | USA | 2002 | 2014 | COG | B-cell acute lymphoblastic leukemia pediatric | 2 | 0 | 0 | 1 | 37 | 20 | 1 | ||||
Aledort | Louis M. | M | 1991 | 2008 | Immune thrombocytopenia | 2 | 1 | 2 | 0 | 35 | 34 | 1 | ||||||
Alegakis | Athanasios | M | 2004 | 2004 | Non-small cell lung cancer | 1 | 1 | 1 | 0 | 14 | 14 | 1 | ||||||
Alegre | Adrian | M | Spain | 2004 | 2021 | GEM; PETHEMA | Multiple myeloma | 8 | 0 | 3 | 2 | 199 | 112 | 1 | ||||
Aleinikova | Olga | F | Belarus | 2001 | 2020 | EBMT Paediatric Diseases Working Party; I-BFM SCT Study Group; IBFM Study Group; IntReALL Study Group | Acute myeloid leukemia; Acute myeloid leukemia pediatric; Allogeneic HSCT | 2 | 0 | 3 | 0 | 49 | 49 | 1 | ||||
Alekar | Shilpa | F | USA | 2014 | 2014 | B-cell acute lymphoblastic leukemia | 1 | 0 | 0 | 0 | 19 | 19 | 1 | |||||
Aleksandrovic | Jasna | F | 1991 | 2000 | Head and neck cancer | 1 | 0 | 1 | 0 | 7 | 7 | 1 | ||||||
Alekseev | Boris Yakovlevich | M | Russian Federation | 2010 | 2022 | Bladder cancer; Non-clear cell renal cell carcinoma; Prostate cancer; Renal cell carcinoma | 22 | 0 | 15 | 8 | 482 | 310 | 1 | |||||
Alekseev | Sergey | M | Russian Federation | 2012 | 2021 | Hodgkin lymphoma | 3 | 0 | 1 | 1 | 79 | 38 | 1 | |||||
Alekseeva | Yulia | F | Russian Federation | 2017 | 2022 | Multiple myeloma | 1 | 0 | 1 | 0 | 27 | 27 | 1 | |||||
Aleman | Berthe M. P. | F | Netherlands | 1988 | 2017 | EORTC; GELA | Hodgkin lymphoma | 3 | 1 | 5 | 0 | 75 | 56 | 1 | ||||
Aleman | Karen | F | USA | 2012 | 2016 | Kaposi sarcoma | 2 | 0 | 0 | 1 | 27 | 20 | 1 | |||||
Alencar | Alvaro | Not yet determined | USA | 2014 | 2019 | Blood Cancer Research Partnership of the Leukemia and Lymphoma Society | Chronic lymphocytic leukemia | 1 | 0 | 0 | 0 | 22 | 22 | 1 | ||||
Alese | Olatunji B. | Not yet determined | USA | 2016 | 2020 | Cholangiocarcinoma | 1 | 0 | 0 | 0 | 10 | 10 | 1 | |||||
Alessandri | S. | CBD | 1982 | 1986 | Ovarian cancer | 1 | 0 | 1 | 0 | 33 | 33 | 1 | ||||||
Alessandrino | Emilio Paolo | M | Italy | 1996 | 2015 | Acute myeloid leukemia; Allogeneic HSCT; Multiple myeloma; Stem cell mobilization | 3 | 0 | 1 | 0 | 77 | 60 | 1 | |||||
Alessandroni | Paolo | M | 2006 | 2012 | Colorectal cancer | 1 | 0 | 1 | 0 | 10 | 10 | 1 | ||||||
Alexander | Eben | M | USA | 1969 | 1980 | BTSG | Glioblastoma | 2 | 0 | 2 | 0 | 27 | 18 | 1 | ||||
Alexander | Sarah | F | Canada | 2011 | 2021 | Children's Oncology Group; COG; European Intergroup for Childhood Non-Hodgkin Lymphoma | Anaplastic large cell lymphoma pediatric; Non-Hodgkin lymphoma pediatric | 3 | 1 | 1 | 1 | 38 | 33 | 1 | ||||
Alexandre | Jerome | M | Canada | 2006 | 2016 | JGOG | Ovarian cancer | 1 | 0 | 1 | 0 | 23 | 23 | 1 | ||||
Alexandris | Ekaterine | F | USA | 2010 | 2014 | Non-small cell lung cancer | 1 | 0 | 1 | 1 | 25 | 25 | 1 | |||||
Alexandru | Aurelia | F | Romania | 2015 | 2021 | Non-small cell lung cancer; Non-small cell lung cancer nonsquamous; Non-small cell lung cancer squamous | 3 | 0 | 2 | 2 | 77 | 52 | 1 | |||||
Alexanian | Raymond | M | USA | 1965 | 2008 | SWOG | Multiple myeloma | 14 | 10 | 3 | 2 | 90 | 48 | 1 | ||||
Alexeeva | Julia A. | F | Russian Federation | 2004 | 2016 | SPRINT trial investigators and in collaboration with the European Mantle Cell Lymphoma Network | Acute myeloid leukemia; Mantle cell lymphoma | 3 | 0 | 2 | 1 | 65 | 63 | 1 | ||||
Alexis Vigier | Magda | F | France | 1990 | 2021 | France Intergroupe des Leucemies Myeloides Chroniques; GOELAMS | Chronic myeloid leukemia; Diffuse large B-cell lymphoma; Hodgkin lymphoma; Mantle cell lymphoma | 4 | 0 | 2 | 0 | 106 | 96 | 1 | ||||
Alexopoulos | Athanasios | M | 1997 | 2003 | Greek Oncology Cooperative Group (GOCG) for Lung Cancer; HORG | Non-small cell lung cancer | 2 | 0 | 2 | 0 | 19 | 18 | 1 | |||||
Alexopoulos | Constantinos G. | M | 1990 | 2007 | ELCWP | Non-small cell lung cancer | 4 | 0 | 4 | 0 | 51 | 23 | 1 | |||||
Alfaro | Elizabeth | F | 1987 | 1997 | Hodgkin lymphoma | 1 | 0 | 1 | 0 | 9 | 9 | 1 | ||||||
Alfaro | Vicente | M | Spain | 2008 | 2021 | Multiple myeloma; Ovarian cancer; Small cell lung cancer; Soft tissue sarcoma | 4 | 0 | 3 | 1 | 84 | 76 | 1 | |||||
Alfieri | Sergio | M | Italy | 2005 | 2019 | Rectal cancer | 1 | 0 | 1 | 0 | 27 | 27 | 1 | |||||
Alfonsi | Marc | M | France | 1994 | 2020 | GORTEC | Head and neck cancer | 9 | 0 | 8 | 0 | 162 | 84 | 1 | ||||
Algarra | Lorenzo | M | Spain | 2014 | 2021 | PETHEMA Group | Acute myeloid leukemia | 1 | 0 | 1 | 0 | 32 | 32 | 1 | ||||
Algazi | Alain P. | M | USA | 2010 | 2021 | CNS melanoma; Melanoma | 7 | 0 | 0 | 1 | 166 | 91 | 1 | |||||
Algeri | Renato | M | 1991 | 2000 | Breast cancer | 1 | 0 | 1 | 0 | 9 | 9 | 1 | ||||||
Algul | Hana | F | Germany | 2015 | 2019 | Pancreatic cancer | 1 | 0 | 1 | 1 | 18 | 18 | 1 | |||||
Ali | Adnan | Not yet determined | United Kingdom | 2005 | 2019 | Prostate cancer | 1 | 0 | 1 | 0 | 49 | 49 | 1 | |||||
Ali | Arif N. | M | USA | 1990 | 2018 | RTOG | Glioblastoma | 1 | 1 | 1 | 0 | 17 | 17 | 1 | ||||
Ali | Haris | M | USA | 2016 | 2020 | Graft versus host disease | 1 | 0 | 0 | 1 | 12 | 12 | 1 | |||||
Ali | Haythem | M | USA | 2008 | 2017 | Thyroid cancer medullary | 2 | 0 | 1 | 1 | 36 | 21 | 1 | |||||
Ali | Kulsam | M | 2003 | 2009 | Small cell lung cancer | 1 | 0 | 1 | 0 | 10 | 10 | 1 | ||||||
Ali | Marco | M | Italy | 2017 | 2017 | Thymoma | 1 | 0 | 0 | 0 | 23 | 23 | 1 | |||||
Ali | Nasim | M | United Kingdom | 2010 | 2020 | Gastrointestinal stromal tumor; Leiomyosarcoma; Soft tissue sarcoma | 2 | 0 | 1 | 0 | 38 | 37 | 1 | |||||
Ali | Ridvan | M | 2006 | 2010 | Multiple myeloma | 1 | 0 | 1 | 0 | 14 | 14 | 1 | ||||||
Ali | Saad | M | United Kingdom | 2015 | 2018 | Endometrial cancer | 1 | 0 | 1 | 0 | 13 | 13 | 1 | |||||
Ali | Sahra | F | United Kingdom | 2006 | 2017 | MRC; UK NCRI | Acute myeloid leukemia; Essential thrombocythemia; Myelofibrosis | 4 | 0 | 1 | 0 | 53 | 42 | 1 | ||||
Ali | Shamshad | M | USA | 1992 | 2014 | GOG | Cervical cancer; Vulvar cancer | 3 | 0 | 2 | 0 | 24 | 24 | 1 | ||||
Ali | Shyanne | F | USA | 2009 | 2014 | Breast cancer | 1 | 0 | 1 | 0 | 22 | 22 | 1 | |||||
Ali | Siraj M. | M | USA | 2017 | 2022 | Bladder cancer; Non-small cell lung cancer | 4 | 0 | 1 | 0 | 121 | 106 | 1 | |||||
Aliberti | Camillo | M | 2006 | 2012 | Colorectal cancer | 1 | 0 | 1 | 0 | 10 | 10 | 1 | ||||||
Aliberti | Sandra | F | 2009 | 2009 | Osteosarcoma | 1 | 0 | 0 | 0 | 8 | 8 | 1 | ||||||
Alietti | Alessandra | F | 2008 | 2014 | Chronic lymphocytic leukemia | 1 | 0 | 0 | 0 | 39 | 39 | 1 | ||||||
Alimam | Samah | F | United Kingdom | 2012 | 2017 | Essential thrombocythemia | 1 | 0 | 0 | 0 | 20 | 20 | 1 | |||||
Alimena | Giuliana | F | Italy | 2001 | 2016 | EORTC; GIMEMA; GIMEMA CML Working Party | Acute myeloid leukemia; Chronic myeloid leukemia | 8 | 0 | 3 | 2 | 171 | 108 | 1 | ||||
Alinari | Lapo | M | 1996 | 2010 | Diffuse large B-cell lymphoma; Follicular lymphoma; Mantle cell lymphoma | 3 | 0 | 2 | 0 | 51 | 39 | 1 | ||||||
Aljijakli | Ahmad | M | France | 2008 | 2012 | ALFA | Acute myeloid leukemia | 1 | 0 | 1 | 1 | 21 | 21 | 1 | ||||
Aljitawi | Omar S. | M | 2011 | 2011 | BMT CTN | Allogeneic HSCT | 1 | 0 | 0 | 0 | 13 | 13 | 1 | |||||
Aljumaily | Raid | M | USA | 2014 | 2017 | Bladder cancer | 1 | 0 | 0 | 1 | 17 | 17 | 1 | |||||
Alkan | Serhan | M | 2008 | 2008 | Acute myeloid leukemia | 1 | 0 | 0 | 0 | 9 | 9 | 1 | ||||||
Alkhouri | Naim | Not yet determined | USA | 2013 | 2020 | Thrombocytopenia in liver disease | 1 | 1 | 2 | 0 | 7 | 7 | 1 | |||||
Alkindi | Salam | Not yet determined | Oman | 2017 | 2019 | Sickle cell anemia | 1 | 0 | 1 | 0 | 21 | 21 | 1 | |||||
Alkuzweny | Baha | M | 2004 | 2004 | Follicular lymphoma | 1 | 0 | 0 | 0 | 4 | 4 | 1 | ||||||
Allaham | Wassim | M | France | 2011 | 2017 | SARAH Trial Group | Hepatocellular carcinoma | 1 | 0 | 1 | 0 | 36 | 36 | 1 | ||||
Allal | Abdelkarim S. | M | 1994 | 2011 | SAKK | Head and neck cancer | 2 | 0 | 1 | 0 | 28 | 24 | 1 | |||||
Allan | John N. | M | USA | 2021 | 2021 | Waldenstroem macroglobulinemia | 1 | 0 | 0 | 0 | 22 | 22 | 1 | |||||
Allan | Karen | F | United Kingdom | 2008 | 2018 | Colorectal cancer | 1 | 0 | 1 | 0 | 35 | 35 | 1 | |||||
Allan | Norman C. | M | United Kingdom | 1986 | 1995 | MRC | Chronic myeloid leukemia | 1 | 1 | 1 | 0 | 2 | 2 | 1 | ||||
Alland | Leila | F | USA | 1998 | 2006 | B-cell acute lymphoblastic leukemia; Breast cancer; Chronic myeloid leukemia; Hypereosinophilic syndrome; Systemic mastocytosis | 3 | 0 | 2 | 1 | 43 | 41 | 1 | |||||
Allangba | Olivier | M | France | 2013 | 2018 | IFM | Multiple myeloma | 2 | 0 | 1 | 0 | 77 | 54 | 1 | ||||
Allard | Christian | M | France | 2003 | 2010 | Intergroupe Francais des Leucemies Myeloides Chroniques; SPIRIT Investigators | Chronic myeloid leukemia | 1 | 0 | 1 | 0 | 22 | 22 | 1 | ||||
Allegra | Carmen J. | M | USA | 1991 | 2020 | NSABP; SWOG | Colon cancer; Colorectal cancer; Rectal cancer | 11 | 6 | 6 | 1 | 153 | 82 | 1 | ||||
Allegrini | Giacomo | M | Italy | 2001 | 2015 | GONO | Colorectal cancer | 4 | 0 | 3 | 0 | 75 | 48 | 1 | ||||
Allen Mersh | T. G. | Not yet determined | United Kingdom | 1988 | 1994 | Colorectal cancer | 1 | 1 | 1 | 0 | 4 | 4 | 1 | |||||
Allen | Aaron M. | M | Israel | 2008 | 2022 | Prostate cancer | 1 | 0 | 1 | 0 | 21 | 21 | 1 | |||||
Allen | Andrew R. | M | USA | 2013 | 2016 | Ovarian cancer | 1 | 0 | 0 | 1 | 30 | 30 | 1 | |||||
Allen | Carl | M | USA | 2020 | 2020 | Hemophagocytic lymphohistiocytosis | 1 | 0 | 0 | 1 | 19 | 19 | 1 | |||||
Allen | Jeffrey C. | M | 1985 | 1999 | CCG | High-grade glioma pediatric; Low-grade glioma; Medulloblastoma | 3 | 0 | 1 | 0 | 47 | 36 | 1 | |||||
Allen | Jennifer L. | F | United Kingdom | 2015 | 2018 | Endometrial cancer | 1 | 0 | 1 | 0 | 13 | 13 | 1 | |||||
Allen | Jill N. | F | USA | 2006 | 2018 | Cholangiocarcinoma; Gallbladder cancer; Hepatocellular carcinoma; Pancreatic cancer | 3 | 0 | 0 | 0 | 56 | 44 | 1 | |||||
Allen | John | M | USA | 1995 | 2014 | Hodgkin lymphoma; Hodgkin lymphoma nodular lymphocyte-predominant | 2 | 0 | 0 | 0 | 14 | 10 | 1 | |||||
Allen | L. | CBD | United Kingdom | 1984 | 1985 | Prostate cancer | 1 | 0 | 1 | 0 | 5 | 5 | 1 | |||||
Allen | Lee F. | M | USA | 2006 | 2018 | Cutaneous T-cell lymphoma; Immune thrombocytopenia; Peripheral T-cell lymphoma; Thrombocytopenia in liver disease | 4 | 1 | 3 | 1 | 47 | 42 | 1 | |||||
Allen | Mary S. | F | USA | 2014 | 2014 | Autologous HSCT | 1 | 0 | 0 | 0 | 6 | 6 | 1 | |||||
Allen | Peter J. | M | USA | 2007 | 2016 | Hepatocellular carcinoma | 1 | 0 | 0 | 0 | 19 | 19 | 1 | |||||
Allen | Roberta S. | F | USA | 1998 | 2002 | Follicular lymphoma | 1 | 0 | 0 | 1 | 11 | 11 | 1 | |||||
Allen | Steven L. | M | USA | 1977 | 2015 | CALGB | Acute myeloid leukemia; Acute promyelocytic leukemia; Adult T-cell leukemia-lymphoma; Breast cancer; Cutaneous T-cell lymphoma; Diffuse large B-cell lymphoma; Peripheral T-cell lymphoma | 9 | 0 | 3 | 1 | 128 | 100 | 1 | ||||
Allepuz | Alex | M | Switzerland | 2013 | 2021 | Chronic myeloid leukemia; Chronic myeloid leukemia pediatric | 3 | 0 | 1 | 2 | 63 | 45 | 1 | |||||
Allerton | Rozenn | F | United Kingdom | 2009 | 2015 | Breast cancer; CNS carcinoma | 1 | 0 | 1 | 0 | 20 | 20 | 1 | |||||
Allevi | G. | CBD | 1997 | 2005 | Breast cancer | 1 | 0 | 1 | 0 | 13 | 13 | 1 | ||||||
Allewelt | Heather | F | USA | 2014 | 2022 | Marginal zone lymphoma | 1 | 0 | 0 | 1 | 13 | 13 | 1 | |||||
Allgeier | Anouk | F | Belgium | 1988 | 2012 | EORTC; NCIC-CTG | Anaplastic glioma; Glioblastoma | 5 | 0 | 3 | 1 | 84 | 43 | 1 | ||||
Allietta | Nathalie | F | France | 2006 | 2013 | Multiple myeloma | 2 | 0 | 0 | 1 | 20 | 17 | 1 | |||||
Allione | Bernardino | M | Italy | 1993 | 2020 | EORTC | Acute myeloid leukemia; Chronic myelomonocytic leukemia; HIV-associated lymphoma; Multiple myeloma | 4 | 0 | 2 | 0 | 81 | 80 | 1 | ||||
Allis | Simona | F | 1992 | 2010 | Head and neck cancer | 1 | 0 | 1 | 0 | 13 | 13 | 1 | ||||||
Allison | James | M | USA | 2015 | 2017 | Anal cancer | 1 | 0 | 0 | 0 | 28 | 28 | 1 | |||||
Allison | Mary Ann K. | F | USA | 2007 | 2013 | Breast cancer | 1 | 0 | 0 | 0 | 18 | 18 | 1 | |||||
Allman | David | M | France | 1996 | 2001 | Colorectal cancer | 1 | 0 | 1 | 1 | 20 | 20 | 1 | |||||
Allmark | Christine | F | 2014 | 2021 | Gastric cancer | 1 | 0 | 1 | 0 | 33 | 33 | 1 | ||||||
Allmer | Christine | F | 2004 | 2008 | NCCTG | Mantle cell lymphoma | 1 | 0 | 0 | 0 | 11 | 11 | 1 | |||||
Alloisio | M. | CBD | 1998 | 2002 | Bladder cancer | 1 | 0 | 0 | 0 | 9 | 9 | 1 | ||||||
Allolio | Bruno | M | Germany | 2004 | 2012 | Adrenocortical carcinoma | 1 | 0 | 1 | 0 | 36 | 36 | 1 | |||||
Allotey | David | M | United Kingdom | 2011 | 2021 | UK NCRI | Multiple myeloma | 1 | 0 | 1 | 0 | 22 | 22 | 1 | ||||
Allouache | Djelila | F | France | 1999 | 2022 | GINECO; Trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01) | Breast cancer; Carcinoma of unknown primary | 3 | 0 | 1 | 0 | 58 | 55 | 1 | ||||
Allouache | Nedla | Not yet determined | France | 2006 | 2019 | GETUG | Prostate cancer | 1 | 0 | 1 | 0 | 21 | 21 | 1 | ||||
Allred | Alicia J. | F | USA | 2010 | 2021 | Melanoma; Multiple myeloma | 2 | 0 | 0 | 1 | 60 | 59 | 1 | |||||
Allred | D. Craig | M | USA | 1989 | 2011 | ACOSOG | Breast cancer | 3 | 0 | 1 | 0 | 38 | 38 | 1 | ||||
Allred | Jacob B. | M | USA | 2004 | 2012 | Light-chain (AL) amyloidosis; Multiple myeloma; Myelofibrosis | 7 | 0 | 0 | 0 | 126 | 40 | 1 | |||||
Allsup | David J. | M | United Kingdom | 2006 | 2017 | NCRI | Chronic lymphocytic leukemia | 2 | 0 | 0 | 0 | 38 | 35 | 1 | ||||
Allum | William H. | M | United Kingdom | 1976 | 2017 | British Stomach Cancer Group; MAGIC Trial Participants; MRC | Esophageal adenocarcinoma; Esophageal cancer; Gastric cancer | 5 | 3 | 5 | 0 | 40 | 33 | 1 | ||||
Ally | Mina S. | F | USA | 2009 | 2016 | Cutaneous basal cell carcinoma | 1 | 0 | 0 | 0 | 12 | 12 | 1 | |||||
Alm | Gunnar | M | Sweden | 1983 | 1983 | Neuroendocrine tumor | 1 | 1 | 0 | 0 | 2 | 2 | 1 | |||||
Almeida | Antonio | M | Portugal | 2010 | 2021 | Myelodysplastic syndrome | 2 | 0 | 2 | 0 | 48 | 39 | 1 | |||||
Almeida | M. S. S. | Not yet determined | Brazil | 2006 | 2015 | Multiple myeloma | 1 | 0 | 1 | 0 | 11 | 11 | 1 | |||||
Almenar | Daniel | M | 2000 | 2005 | Spanish Germ Cell Cancer Cooperative Group; Spanish Lung Cancer Group | Non-small cell lung cancer; Testicular cancer | 2 | 0 | 1 | 0 | 38 | 38 | 1 | |||||
Almenar | Sergio | M | Spain | 1999 | 2010 | GEICAM | Breast cancer | 2 | 0 | 2 | 0 | 64 | 49 | 1 | ||||
Almond | Jennifer P. | F | 1994 | 2001 | European Study Group for Pancreatic Cancer | Pancreatic cancer | 1 | 0 | 1 | 0 | 16 | 16 | 1 | |||||
Aloe | Alessandra | Not yet determined | 1996 | 2009 | Breast cancer | 1 | 0 | 1 | 0 | 10 | 10 | 1 | ||||||
Aloj | Luigi | M | 2014 | 2014 | Hodgkin lymphoma | 1 | 0 | 0 | 0 | 16 | 16 | 1 | ||||||
Alonso Carrion | Lorenzo | M | Spain | 2021 | 2021 | Uveal melanoma | 1 | 0 | 0 | 0 | 13 | 13 | 1 | |||||
Alonso Garcia | Miriam | M | Spain | 1995 | 2021 | Non-small cell lung cancer; Non-small cell lung cancer nonsquamous; Non-small cell lung cancer squamous | 2 | 0 | 3 | 3 | 44 | 44 | 1 | |||||
Alonso Gordoa | Teresa | F | Spain | 2016 | 2021 | Clear cell renal cell carcinoma; Renal cell carcinoma | 2 | 0 | 1 | 1 | 56 | 55 | 1 | |||||
Alonso Orduna | Vicente | M | Spain | 2006 | 2012 | TTD | Colorectal cancer; Esophageal adenocarcinoma | 2 | 0 | 1 | 1 | 33 | 33 | 1 | ||||
Alonso | Carmen | F | Spain | 1994 | 2004 | Small cell lung cancer | 1 | 0 | 1 | 0 | 16 | 16 | 1 | |||||
Alonso | Guillermo | M | 2000 | 2010 | Spanish Lung Cancer Group | Non-small cell lung cancer | 1 | 0 | 1 | 0 | 19 | 19 | 1 | |||||
Alonso | Liuba | F | Cuba | 2006 | 2016 | Non-small cell lung cancer | 1 | 0 | 1 | 0 | 33 | 33 | 1 | |||||
Alonso | Maria Carmen | F | Spain | 1978 | 1995 | Breast cancer | 2 | 1 | 2 | 0 | 13 | 12 | 1 | |||||
Alonso | Mirta Garcia | F | Spain | 2009 | 2020 | Breast cancer | 1 | 0 | 1 | 1 | 30 | 30 | 1 | |||||
Alonso | Natalia | F | 2013 | 2013 | Burkitt lymphoma; HIV-associated lymphoma | 1 | 0 | 0 | 0 | 19 | 19 | 1 | ||||||
Alonso | Silvia | F | 2003 | 2009 | Bladder cancer | 1 | 0 | 0 | 0 | 8 | 8 | 1 | ||||||
Alonzo | Todd A. | M | USA | 1979 | 2014 | CCG; COG | Acute myeloid leukemia; Acute myeloid leukemia pediatric; Chronic myeloid leukemia pediatric | 4 | 1 | 4 | 1 | 46 | 37 | 1 | ||||
Alousi | Amin M. | M | USA | 2009 | 2020 | BMT CTN | Acute myeloid leukemia; Allogeneic HSCT; Follicular lymphoma; Graft versus host disease; Mantle cell lymphoma; Transformed lymphoma | 5 | 0 | 1 | 0 | 84 | 60 | 1 | ||||
Alpen | B. | Not yet determined | 1997 | 1997 | MALT lymphoma | 1 | 0 | 0 | 0 | 9 | 9 | 1 | ||||||
Alquati | Palmiro | M | 1991 | 2005 | Epirubicin-Lonidamine Group | Breast cancer | 3 | 0 | 3 | 0 | 46 | 37 | 1 | |||||
Alsayed | Yazan | M | 1998 | 2010 | Multiple myeloma | 4 | 0 | 0 | 0 | 59 | 28 | 1 | ||||||
Alsina Maqueda | Maria | F | Spain | 2011 | 2021 | Colorectal cancer; Esophageal cancer; Esophageal squamous cell carcinoma; Gastric cancer | 8 | 0 | 8 | 2 | 161 | 129 | 1 | |||||
Alsina | Melissa | F | USA | 2001 | 2022 | Multiple myeloma | 14 | 0 | 2 | 4 | 279 | 159 | 1 | |||||
Altavilla | Giuseppe | M | Italy | 1983 | 2012 | Associazione Italiana Oncologia Toracica; Groupe Francais de Pneumo-Cancerologie; Italian Lung Cancer Project; Italian Lung Cancer Task Force; Italian Multicentre Breast Study with Epirubicin; Spanish Lung Cancer Group | Breast cancer; Non-small cell lung cancer | 4 | 0 | 4 | 1 | 157 | 151 | 1 | ||||
Altenhofer | Petra | F | Austria | 2010 | 2016 | AGMT | Chronic lymphocytic leukemia | 1 | 0 | 1 | 0 | 34 | 34 | 1 | ||||
Alter | Robert S. | M | USA | 2015 | 2020 | Bladder cancer | 1 | 0 | 0 | 0 | 20 | 20 | 1 | |||||
Alterio | D. | CBD | Italy | 2008 | 2017 | GSTTC | Head and neck cancer | 1 | 0 | 0 | 0 | 36 | 36 | 1 | ||||
Altermatt | Hans J. | M | 1998 | 2007 | BIG | Breast cancer | 1 | 0 | 1 | 1 | 18 | 18 | 1 | |||||
Altes | Albert | M | 2001 | 2008 | Chronic lymphocytic leukemia | 1 | 0 | 0 | 0 | 19 | 19 | 1 | ||||||
Althaus | Betsy L. | F | USA | 2009 | 2020 | Breast cancer; Gastric cancer | 3 | 0 | 1 | 0 | 42 | 42 | 1 | |||||
Althausen | Alex F. | M | USA | 1993 | 1993 | Bladder cancer | 1 | 0 | 0 | 0 | 5 | 5 | 1 | |||||
Altieri | Vincenzo | M | 2011 | 2011 | Penile cancer | 1 | 0 | 0 | 0 | 15 | 15 | 1 | ||||||
Altinbas | M. | CBD | 1997 | 2005 | Turkish Oncology Group | Breast cancer | 1 | 0 | 1 | 0 | 16 | 16 | 1 | |||||
Altinmakas | Emre | M | USA | 2010 | 2015 | Non-clear cell renal cell carcinoma | 1 | 0 | 0 | 0 | 15 | 15 | 1 | |||||
Altintas | Sevilay | F | Belgium | 2011 | 2016 | Ovarian cancer | 1 | 0 | 1 | 0 | 23 | 23 | 1 | |||||
Altman | Arnold | M | USA | 2002 | 2006 | B-cell acute lymphoblastic leukemia pediatric | 1 | 0 | 0 | 1 | 19 | 19 | 1 | |||||
Altman | Jessica K. | F | USA | 2007 | 2022 | ECOG | Acute myeloid leukemia; Acute promyelocytic leukemia; Hairy cell leukemia; Myelodysplastic syndrome | 10 | 0 | 4 | 2 | 248 | 176 | 1 | ||||
Altman | Stanley J. | M | USA | 1979 | 1993 | COG; SWOG | Breast cancer; Soft tissue sarcoma; Testicular cancer | 3 | 0 | 3 | 0 | 26 | 26 | 1 | ||||
Altmann | Bettina | F | Germany | 2003 | 2021 | DSHNHL; FLYER Trial Investigators; German Lymphoma Alliance | Autologous HSCT; Diffuse large B-cell lymphoma; Peripheral T-cell lymphoma | 4 | 1 | 4 | 0 | 130 | 90 | 1 | ||||
Altorjai | Gabriela | F | 2004 | 2007 | Breast cancer | 1 | 0 | 0 | 0 | 8 | 8 | 1 | ||||||
Altorki | Nasser K. | M | USA | 2007 | 2021 | Non-small cell lung cancer | 2 | 0 | 2 | 1 | 35 | 35 | 1 | |||||
Altug | Sedat | M | Turkey | 2009 | 2014 | Non-small cell lung cancer nonsquamous | 1 | 0 | 1 | 0 | 11 | 11 | 1 | |||||
Altwein | Jens Erik | M | 1986 | 1991 | Prostate cancer | 2 | 0 | 2 | 0 | 12 | 12 | 1 | ||||||
Alu | Massimiliano | M | 1996 | 2002 | Breast cancer | 1 | 0 | 1 | 0 | 9 | 9 | 1 | ||||||
Alumkal | Joshi J. | M | USA | 2007 | 2017 | Prostate Cancer Foundation/Department of Defense Prostate Cancer Clinical Trials Consortium | Prostate cancer | 3 | 0 | 0 | 0 | 40 | 35 | 1 | ||||
Alva | Ajjai S. | M | USA | 2012 | 2021 | SWOG | Bladder cancer; Clear cell renal cell carcinoma; Papillary renal cell carcinoma; Renal cell carcinoma | 4 | 1 | 3 | 2 | 100 | 92 | 1 | ||||
Alvarado | Gladys | F | 1995 | 2009 | Melanoma | 1 | 0 | 1 | 0 | 20 | 20 | 1 | ||||||
Alvarado | Yesid | M | USA | 2011 | 2020 | Acute myeloid leukemia; B-cell acute lymphoblastic leukemia; Chronic lymphocytic leukemia; Myelodysplastic syndrome | 4 | 0 | 0 | 0 | 115 | 66 | 1 | |||||
Alvarez Cabellos | Ruth | F | 2013 | 2013 | GOTEL | Follicular lymphoma | 1 | 0 | 0 | 0 | 11 | 11 | 1 | |||||
Alvarez de Celis | Isabel | F | Italy | 2004 | 2013 | Follicular lymphoma | 1 | 0 | 2 | 0 | 20 | 20 | 1 | |||||
Alvarez Larran | Alberto | M | 2005 | 2005 | Myelofibrosis | 1 | 0 | 0 | 0 | 4 | 4 | 1 | ||||||
Alvarez Secord | Angeles | F | USA | 1999 | 2022 | GOG | Endometrial cancer; Gestational trophoblastic neoplasia; Low-grade serous ovarian cancer; Ovarian cancer | 8 | 1 | 7 | 2 | 149 | 122 | 1 | ||||
Alvarez Twose | Ivan | M | Spain | 2018 | 2021 | Systemic mastocytosis | 1 | 0 | 0 | 1 | 23 | 23 | 1 | |||||
Alvarez Vicent | J. J. | CBD | 1996 | 2002 | Head and neck cancer | 1 | 0 | 0 | 0 | 10 | 10 | 1 | ||||||
Alvarez | Ana | F | Spain | 2005 | 2015 | Prostate cancer | 1 | 0 | 1 | 0 | 14 | 14 | 1 | |||||
Alvarez | Axxx | CBD | Argentina | 1991 | 1999 | Breast cancer | 1 | 0 | 1 | 0 | 9 | 9 | 1 | |||||
Alvarez | Elena | F | 1987 | 1999 | Breast cancer | 1 | 1 | 1 | 0 | 9 | 9 | 1 | ||||||
Alvarez | Isabel | F | Spain | 1995 | 2020 | ANZ BCTG; GEICAM; Intergroup Exemestane Study | Breast cancer; Diffuse large B-cell lymphoma | 9 | 0 | 9 | 1 | 230 | 159 | 1 | ||||
Alvarez | Ivan | M | Spain | 2006 | 2006 | Allogeneic HSCT; Hodgkin lymphoma | 1 | 1 | 0 | 0 | 17 | 17 | 1 | |||||
Alvarez | Jose Valero | M | 1999 | 2008 | GEICAM | Breast cancer | 1 | 0 | 1 | 0 | 34 | 34 | 1 | |||||
Alvarez | Ofelia A. | F | USA | 2013 | 2016 | Sickle cell anemia | 1 | 0 | 0 | 1 | 15 | 15 | 1 | |||||
Alvarez | Pablo | M | United Kingdom | 2007 | 2012 | Thyroid cancer differentiated | 1 | 0 | 1 | 0 | 27 | 27 | 1 | |||||
Alvarez | Ronald D. | M | 1985 | 2008 | GOG; GRACES Clinical Trial Consortium; SWOG | Cervical cancer; Endometrial cancer; Ovarian cancer | 5 | 1 | 4 | 0 | 39 | 36 | 1 | |||||
Alvarnas | Joseph C. | M | USA | 2016 | 2016 | BMT CTN | Autologous HSCT; HIV-associated lymphoma | 1 | 1 | 0 | 0 | 21 | 21 | 1 | ||||
Alvegaard | Thor | M | Sweden | 2004 | 2020 | Gastrointestinal stromal tumor | 3 | 0 | 1 | 1 | 58 | 29 | 1 | |||||
Aly | Abdalla | M | USA | 2009 | 2018 | Pancreatic cancer | 1 | 0 | 1 | 1 | 11 | 11 | 1 | |||||
Alyasova | Anna | F | Russian Federation | 2010 | 2021 | Head and neck cancer; Renal cell carcinoma | 4 | 0 | 2 | 1 | 95 | 89 | 1 | |||||
Alyea | Edwin P. | M | USA | 2003 | 2017 | BMT CTN; CALGB | Acute myeloid leukemia; Allogeneic HSCT; Multiple myeloma | 3 | 1 | 2 | 0 | 60 | 51 | 1 | ||||
Alzate | Stefanie | F | USA | 2012 | 2017 | Multiple myeloma | 1 | 0 | 0 | 0 | 20 | 20 | 1 | |||||
Alzieu | Claude | M | 1984 | 2006 | FNCLCC | Head and neck cancer | 2 | 0 | 2 | 0 | 25 | 25 | 1 | |||||
Alzouebi | Mymoona | F | United Kingdom | 2005 | 2015 | Prostate cancer | 1 | 0 | 1 | 0 | 46 | 46 | 1 | |||||
Amabile | Marilina | F | 1994 | 2009 | GIMEMA; GIMEMA CML Working Party; Italian Cooperative Study Group on Myeloid Leukemia | Chronic myeloid leukemia | 3 | 0 | 1 | 0 | 51 | 32 | 1 | |||||
Amado | Rafael G. | M | USA | 2004 | 2008 | Colorectal cancer | 2 | 2 | 2 | 1 | 23 | 23 | 1 | |||||
Amador Barciela | Maria L. | F | Spain | 2014 | 2021 | PETHEMA Group | Acute myeloid leukemia | 1 | 0 | 1 | 0 | 32 | 32 | 1 | ||||
Amador | Rosa M. | F | Cuba | 2006 | 2016 | Non-small cell lung cancer | 1 | 0 | 1 | 0 | 33 | 33 | 1 | |||||
Amadori | Dino | M | Italy | 1981 | 2017 | GONO; International Collaborative Cancer Group | Bladder cancer; Breast cancer; Colorectal cancer; Gastric cancer; Hepatocellular carcinoma | 14 | 4 | 11 | 0 | 196 | 155 | 1 | ||||
Amadori | Sergio | M | Italy | 1984 | 2020 | AIEOP; EORTC; German-Austrian Acute Myeloid Leukemia Study Group; GIMEMA; Study Alliance Leukemia | Acute myeloid leukemia; Acute promyelocytic leukemia; B-cell acute lymphoblastic leukemia; Chronic myeloid leukemia; CNS leukemia; Diffuse large B-cell lymphoma; Multiple myeloma; Myelodysplastic syndrome | 30 | 7 | 21 | 3 | 594 | 249 | 1 | ||||
Amaducci | Laura | F | Italy | 1997 | 2021 | GIM; Reader study level-I and level-II Groups | Breast cancer | 3 | 0 | 3 | 0 | 77 | 71 | 1 | ||||
Amagai | Kenji | M | Japan | 2008 | 2018 | Tokyo Cooperative Oncology Group | Gastric cancer | 4 | 0 | 4 | 0 | 70 | 61 | 1 | ||||
Amam | Josif | M | Germany | 2005 | 2019 | FLYER Trial Investigators; German Lymphoma Alliance | Diffuse large B-cell lymphoma | 1 | 0 | 1 | 0 | 43 | 43 | 1 | ||||
Amann | G. | CBD | 2001 | 2001 | Ewing sarcoma | 1 | 0 | 0 | 0 | 18 | 18 | 1 | ||||||
Amano | Hodaka | UNMATCHED | 1986 | 2002 | Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract | Periampullary adenocarcinoma | 1 | 0 | 1 | 0 | 7 | 7 | 1 | |||||
Amant | Frederic | M | Belgium | 1998 | 2010 | EORTC; NCIC-CTG | Breast cancer; Ovarian cancer | 2 | 0 | 2 | 0 | 32 | 32 | 1 | ||||
Amar | Avraham | M | 1998 | 1998 | Allogeneic HSCT; Chronic lymphocytic leukemia | 1 | 0 | 0 | 0 | 14 | 14 | 1 | ||||||
Amaravadi | Ravi K. | M | USA | 2009 | 2012 | Melanoma | 1 | 0 | 0 | 1 | 24 | 24 | 1 | |||||
Amare | Mammo | Not yet determined | 1977 | 1983 | SWOG | Multiple myeloma | 1 | 0 | 1 | 0 | 0 | 0 | 1 | |||||
Amato | Giovanni | M | Italy | 2013 | 2021 | CNS melanoma | 1 | 0 | 1 | 0 | 16 | 16 | 1 | |||||
Amato | Robert J. | M | USA | 1985 | 2010 | Bladder cancer; Penile cancer; Prostate cancer; Renal cell carcinoma; Testicular cancer | 5 | 2 | 3 | 0 | 39 | 35 | 1 | |||||
Amato | S. | CBD | Argentina | 1995 | 1999 | Breast cancer | 1 | 0 | 0 | 0 | 14 | 14 | 1 | |||||
Amatruda | Thomas T. | M | USA | 2006 | 2015 | NCCTG | Melanoma | 3 | 0 | 1 | 1 | 48 | 43 | 1 | ||||
Amatu | Alessio | M | Italy | 2012 | 2017 | Colorectal cancer; Non-small cell lung cancer; NTRK | 2 | 0 | 0 | 2 | 63 | 57 | 1 | |||||
Ambarkhane | Sumeet | M | Germany | 2016 | 2021 | Diffuse large B-cell lymphoma; Transformed lymphoma | 2 | 0 | 0 | 1 | 36 | 21 | 1 | |||||
Ambinder | Richard F. | M | USA | 1998 | 2018 | A5264/AMC-067 REACT-KS Team; AIDS Malignancy Consortium; BMT CTN | Autologous HSCT; Burkitt lymphoma; Diffuse large B-cell lymphoma; Graft versus host disease; HIV-associated lymphoma; Hodgkin lymphoma; Kaposi sarcoma | 9 | 2 | 4 | 0 | 136 | 109 | 1 | ||||
Ambo | Y. | CBD | Japan | 2007 | 2018 | Cholangiocarcinoma | 1 | 0 | 1 | 0 | 14 | 14 | 1 | |||||
Ambros | Peter F. | M | Austria | 2002 | 2018 | SIOP Europe Neuroblastoma Group (SIOPEN) | Neuroblastoma | 2 | 0 | 1 | 0 | 50 | 32 | 1 | ||||
Ambrose | David | M | USA | 2015 | 2015 | Chronic lymphocytic leukemia | 1 | 0 | 0 | 0 | 17 | 17 | 1 | |||||
Ambrosetti | Achille | M | Italy | 1995 | 2017 | FIL; IELSG | Chronic lymphocytic leukemia; CNS lymphoma; Hairy cell leukemia; Hodgkin lymphoma; MALT lymphoma; Mantle cell lymphoma | 7 | 0 | 1 | 0 | 211 | 166 | 1 | ||||
Ambrosini | Giovanni | M | Italy | 1983 | 2011 | Italian Multicentre Breast Study with Epirubicin | Breast cancer; Rectal cancer | 3 | 2 | 2 | 0 | 97 | 96 | 1 | ||||
Ambrosini | Grazia | F | USA | 2010 | 2014 | Uveal melanoma | 1 | 0 | 0 | 0 | 27 | 27 | 1 | |||||
Ambrosini | Maria Teresa | F | 2002 | 2007 | GIMEMA--Italian Multiple Myeloma Network; Gruppo Italiano Malattie Ematologicche dell'Adulto; Italian Multiple Myeloma Network | Multiple myeloma | 3 | 0 | 1 | 0 | 52 | 36 | 1 | |||||
Ambrosio | Francesca | F | Italy | 2009 | 2017 | GOIRC | Small cell lung cancer | 1 | 0 | 1 | 0 | 18 | 18 | 1 | ||||
Ambrun | Alexis | Not yet determined | France | 2016 | 2016 | Hereditary hemorrhagic telangiectasia | 1 | 0 | 0 | 0 | 18 | 18 | 1 | |||||
Amellal | Nadia | F | Germany; USA | 1999 | 2008 | Head and neck cancer | 4 | 0 | 2 | 3 | 53 | 40 | 1 | |||||
Amendola | Angela | F | 2006 | 2006 | GIMEMA | Immune thrombocytopenia | 1 | 0 | 0 | 0 | 15 | 15 | 1 | |||||
Amenedo Gancedo | Margarita | F | Spain | 1999 | 2020 | GEICAM | Breast cancer; Ovarian cancer | 4 | 0 | 2 | 1 | 93 | 48 | 1 | ||||
Ames | Frederick C. | M | USA | 1977 | 2004 | Breast cancer | 5 | 0 | 5 | 0 | 65 | 36 | 1 | |||||
Ames | Patricia | F | 1998 | 2002 | Melanoma | 1 | 0 | 0 | 0 | 11 | 11 | 1 | ||||||
Ameye | Lieveke | F | Belgium | 1998 | 2015 | BIG | Breast cancer | 1 | 0 | 1 | 0 | 17 | 17 | 1 | ||||
Amiel | Jean Louis | M | 1969 | 1969 | B-cell acute lymphoblastic leukemia | 1 | 0 | 0 | 0 | 7 | 7 | 1 | ||||||
Amillano | Kepa | Not yet determined | Spain | 2015 | 2021 | Breast cancer | 1 | 0 | 1 | 0 | 39 | 39 | 1 | |||||
Amin | Amanda L. | F | USA | 2010 | 2016 | Breast cancer | 1 | 0 | 0 | 0 | 33 | 33 | 1 | |||||
Amin | Asim | M | USA | 2013 | 2020 | Renal cell carcinoma; Small cell lung cancer | 4 | 0 | 1 | 2 | 107 | 74 | 1 | |||||
Amin | Bipinkumar | UNMATCHED | 2008 | 2011 | Follicular lymphoma | 1 | 0 | 0 | 0 | 14 | 14 | 1 | ||||||
Amin | Himal | M | USA | 2014 | 2021 | Multiple myeloma | 4 | 0 | 2 | 2 | 92 | 61 | 1 | |||||
Amin | Mahul B. | M | Canada; USA | 1994 | 2020 | RTOG | Prostate cancer; Upper tract urothelial carcinoma | 3 | 0 | 2 | 0 | 61 | 57 | 1 | ||||
Aminossadati | Behnaz | F | 2001 | 2009 | Neuroendocrine tumor; Pancreatic NET | 1 | 0 | 1 | 0 | 13 | 13 | 1 | ||||||
Amiot | Martine | Not yet determined | France | 2012 | 2017 | Multiple myeloma | 1 | 0 | 0 | 0 | 20 | 20 | 1 | |||||
Amista | P. | CBD | 2004 | 2004 | Glioblastoma | 1 | 0 | 0 | 0 | 6 | 6 | 1 | ||||||
Amler | Susanne | F | Germany | 2000 | 2018 | AML-CG | Acute myeloid leukemia; Autologous HSCT; Ewing sarcoma | 2 | 0 | 2 | 0 | 84 | 84 | 1 | ||||
Ammassari | Adriana | F | 2002 | 2002 | HIV-associated lymphoma | 1 | 0 | 0 | 0 | 12 | 12 | 1 | ||||||
Amonkar | Mayur | M | USA | 2006 | 2021 | Colorectal cancer; Head and neck cancer | 2 | 0 | 2 | 1 | 43 | 43 | 1 | |||||
Amorim | Gilberto | M | 2006 | 2019 | CIBOMA; GEICAM; LACOG (Latin American Cooperative Oncology Group) | Breast cancer | 1 | 0 | 1 | 0 | 37 | 37 | 1 | |||||
Amoroso | Domenico | M | Italy | 2007 | 2018 | GOIRC | Breast cancer; Colorectal cancer; Non-small cell lung cancer | 5 | 0 | 3 | 0 | 105 | 85 | 1 | ||||
Amoroso | Mariangela | F | 1990 | 2002 | Cervical cancer | 1 | 0 | 1 | 0 | 10 | 10 | 1 | ||||||
Amoroso | Vito | M | Italy | 2014 | 2021 | Breast cancer | 1 | 0 | 1 | 0 | 25 | 25 | 1 | |||||
Amos | Claire L. | F | United Kingdom | 2005 | 2019 | Prostate cancer | 3 | 0 | 1 | 0 | 141 | 83 | 1 | |||||
Amott | S. J. | Not yet determined | 1984 | 1996 | MRC | Rectal cancer | 1 | 1 | 1 | 0 | 2 | 2 | 1 | |||||
Amoura | Zahir | M | France | 2014 | 2014 | Erdheim-Chester disease | 1 | 1 | 0 | 0 | 20 | 20 | 1 | |||||
Amrein | Philip C. | M | 1990 | 2004 | CALGB | Acute myeloid leukemia | 2 | 0 | 1 | 0 | 16 | 16 | 1 | |||||
Amthauer | Holger | M | 2003 | 2012 | Arbeitsgemeinschaft Medikamentoese Tumortherapie; GHSG; SAKK | Hodgkin lymphoma | 1 | 0 | 1 | 0 | 30 | 30 | 1 | |||||
Amundsen | Tore | M | 2005 | 2012 | Non-small cell lung cancer | 2 | 0 | 2 | 0 | 21 | 15 | 1 | ||||||
Amunni | Gianni | M | 1990 | 2002 | Cervical cancer | 1 | 0 | 1 | 0 | 10 | 10 | 1 | ||||||
Amutio | Elena | F | 1996 | 2003 | Programa de Estudio y Traitmiento de las Hemopatias Malignas | Acute promyelocytic leukemia | 1 | 0 | 0 | 0 | 18 | 18 | 1 | |||||
Amylon | Michael D. | M | USA | 1987 | 1999 | POG | B-cell acute lymphoblastic leukemia; B-cell acute lymphoblastic leukemia pediatric; Graft versus host disease; T-cell acute lymphoblastic leukemia pediatric | 3 | 1 | 2 | 0 | 36 | 35 | 1 | ||||
Amzal | Billy | M | United Kingdom | 2011 | 2016 | Prostate cancer | 1 | 0 | 1 | 0 | 21 | 21 | 1 | |||||
An | Gang | Not yet determined | China | 2017 | 2021 | Multiple myeloma | 1 | 0 | 1 | 0 | 19 | 19 | 1 | |||||
An | J. Y. | Not yet determined | South Korea | 2013 | 2020 | Gastric cancer | 1 | 0 | 1 | 0 | 22 | 22 | 1 | |||||
An | Ruifang | Not yet determined | China | 2017 | 2022 | Ovarian cancer | 2 | 0 | 2 | 0 | 70 | 60 | 1 | |||||
An | Xin | Not yet determined | China | 2010 | 2022 | South China Breast Cancer Group (SCBCG) | Breast cancer | 2 | 0 | 2 | 0 | 58 | 40 | 1 | ||||
An | Xuebei | CBD | USA | 2016 | 2020 | Breast cancer; CNS carcinoma | 1 | 0 | 1 | 1 | 28 | 28 | 1 | |||||
Anagnostopoulos | Achilles | M | Greece | 2007 | 2022 | HORG | Acute myeloid leukemia; Chronic myelomonocytic leukemia; Colon cancer; Myelodysplastic syndrome | 5 | 0 | 4 | 1 | 104 | 80 | 1 | ||||
Anagnostopoulos | Athanasios | M | 1999 | 2007 | Multiple myeloma; Waldenstroem macroglobulinemia | 5 | 2 | 1 | 0 | 58 | 40 | 1 | ||||||
Anagnostopoulos | Ioannis | M | Germany | 1999 | 2016 | European PTLD Network; German PTLD Study Group. | Post-transplant lymphoproliferative disorder | 3 | 0 | 0 | 0 | 51 | 38 | 1 | ||||
Anagnostopoulos | Nikolaos | M | 1999 | 2007 | Multiple myeloma; Waldenstroem macroglobulinemia | 5 | 1 | 1 | 0 | 59 | 35 | 1 | ||||||
Anagnostopoulou | Ourania | F | 1999 | 2005 | Non-small cell lung cancer | 1 | 0 | 1 | 0 | 16 | 16 | 1 | ||||||
Anaissie | Elias | M | USA | 1990 | 2010 | Multiple myeloma | 9 | 0 | 0 | 0 | 122 | 54 | 1 | |||||
Anak | Oezlem | F | Switzerland; USA | 1999 | 2021 | EORTC | Autologous HSCT; Colorectal cancer; Diffuse large B-cell lymphoma; Follicular lymphoma; Hepatocellular carcinoma; Renal cell carcinoma; Subependymal giant cell astrocytoma; Transformed lymphoma | 7 | 0 | 3 | 3 | 147 | 139 | 1 | ||||
Anand | Aseem | M | 2007 | 2010 | Prostate Cancer Foundation/Department of Defense Prostate Cancer Clinical Trials Consortium | Prostate cancer | 1 | 0 | 0 | 0 | 18 | 18 | 1 | |||||
Anand | Palka | UNMATCHED | USA | 2012 | 2016 | Multiple myeloma | 1 | 0 | 0 | 0 | 8 | 8 | 1 | |||||
Ananthakrishnan | Revathi | F | USA | 2016 | 2016 | Follicular lymphoma | 1 | 0 | 0 | 0 | 9 | 9 | 1 | |||||
Anasetti | Claudio | M | USA | 1985 | 2003 | Allogeneic HSCT; Chronic myeloid leukemia | 2 | 1 | 0 | 0 | 28 | 25 | 1 | |||||
Anastasi | John | M | 1998 | 2008 | CALGB | Acute myeloid leukemia | 2 | 0 | 1 | 0 | 23 | 16 | 1 | |||||
Anastasia | Antonella | F | Italy | 2008 | 2021 | FIL; Rete Ematologica Lombarda–CLL Workgroup | Chronic lymphocytic leukemia; Follicular lymphoma; Hairy cell leukemia; Hodgkin lymphoma | 5 | 0 | 1 | 0 | 136 | 121 | 1 | ||||
Anastasopoulou | Anastasia | F | 2001 | 2001 | EORTC | Cervical cancer | 1 | 0 | 0 | 0 | 12 | 12 | 1 | |||||
Ancell | Kristin | F | USA | 2010 | 2014 | Uveal melanoma | 1 | 0 | 0 | 0 | 27 | 27 | 1 | |||||
Anchisi | Sandro | Not yet determined | Switzerland | 2007 | 2016 | SAKK | Breast cancer; Colorectal cancer | 2 | 0 | 2 | 0 | 39 | 36 | 1 | ||||
Anciaux | Nicole | F | 1998 | 2006 | EORTC | Colorectal cancer | 1 | 0 | 1 | 0 | 19 | 19 | 1 | |||||
Ancliff | Philip | M | 2003 | 2010 | B-cell acute lymphoblastic leukemia pediatric; T-cell acute lymphoblastic leukemia pediatric | 1 | 0 | 1 | 0 | 14 | 14 | 1 | ||||||
Ancona | Ermanno | M | Italy | 1992 | 2001 | Esophageal cancer | 1 | 1 | 1 | 0 | 8 | 8 | 1 | |||||
Ancukiewicz | Marek | M | 2006 | 2009 | Hepatocellular carcinoma | 1 | 0 | 0 | 0 | 20 | 20 | 1 | ||||||
Andel | Johannes | M | Austria | 2007 | 2016 | AGMT | Chronic lymphocytic leukemia; Diffuse large B-cell lymphoma | 2 | 0 | 2 | 0 | 45 | 40 | 1 | ||||
Andergassen | Ulrich | M | Germany | 2005 | 2020 | Breast cancer | 1 | 0 | 1 | 0 | 24 | 24 | 1 | |||||
Anderl | Janet | F | USA | 2012 | 2016 | Multiple myeloma | 1 | 0 | 0 | 0 | 16 | 16 | 1 | |||||
Anderlini | Paolo | M | USA | 2009 | 2014 | Allogeneic HSCT; Diffuse large B-cell lymphoma; Follicular lymphoma; Hodgkin lymphoma; Mantle cell lymphoma; Transformed lymphoma | 6 | 1 | 0 | 0 | 101 | 55 | 1 | |||||
Anders | Carey K. | F | USA | 2008 | 2022 | CALGB | Breast cancer; CNS carcinoma | 4 | 0 | 3 | 1 | 90 | 68 | 1 | ||||
Anders | Robert A. | M | USA | 2013 | 2017 | Cholangiocarcinoma; Colorectal cancer; Endometrial cancer; MSI-H or dMMR | 2 | 0 | 0 | 1 | 79 | 57 | 1 | |||||
Andersen | Barbara L. | F | USA | 2015 | 2020 | Chronic lymphocytic leukemia | 1 | 0 | 0 | 0 | 18 | 18 | 1 | |||||
Andersen | E. | CBD | 1983 | 1990 | Breast cancer | 1 | 0 | 1 | 0 | 6 | 6 | 1 | ||||||
Andersen | J. C. | Not yet determined | USA | 1994 | 1994 | Immune thrombocytopenia | 1 | 1 | 0 | 0 | 0 | 0 | 1 | |||||
Andersen | James S. | M | USA | 1992 | 1996 | Pancreatic cancer | 1 | 0 | 0 | 1 | 11 | 11 | 1 | |||||
Andersen | Janet W. | F | USA | 1977 | 2002 | ECOG | Acute promyelocytic leukemia; Breast cancer; Chronic lymphocytic leukemia; Diffuse large B-cell lymphoma; Follicular lymphoma | 6 | 0 | 5 | 0 | 56 | 43 | 1 | ||||
Andersen | Jay C. | M | USA | 2017 | 2022 | Breast cancer | 1 | 0 | 1 | 1 | 29 | 29 | 1 | |||||
Andersen | Joern Erik | M | Denmark | 1994 | 2000 | Ovarian cancer | 1 | 0 | 1 | 1 | 27 | 27 | 1 | |||||
Andersen | John | M | USA | 1992 | 1997 | Pancreatic cancer | 1 | 0 | 1 | 1 | 13 | 13 | 1 | |||||
Andersen | Jorn | M | Denmark | 1977 | 2013 | DBCG; Intergroup Exemestane Study; Scandinavian Breast Group | Breast cancer; Diffuse large B-cell lymphoma | 10 | 2 | 8 | 1 | 126 | 76 | 1 | ||||
Andersen | Knud West | M | 1977 | 1983 | DBCG | Breast cancer | 2 | 1 | 2 | 0 | 12 | 10 | 1 | |||||
Andersen | Niels Frost | M | Denmark | 2005 | 2020 | Multiple myeloma | 3 | 0 | 3 | 0 | 101 | 92 | 1 | |||||
Andersen | Niels S. | M | Denmark | 2000 | 2016 | Nordic Lymphoma Group | Autologous HSCT; Mantle cell lymphoma | 3 | 0 | 0 | 0 | 67 | 30 | 1 | ||||
Andersen | Willie A. | M | 1993 | 2004 | GOG | Cervical cancer; Endometrial cancer | 4 | 4 | 1 | 0 | 22 | 18 | 1 | |||||
Anderson | Abraham | M | USA | 2009 | 2021 | Esophageal adenocarcinoma; Non-small cell lung cancer | 2 | 0 | 0 | 1 | 40 | 40 | 1 | |||||
Anderson | Barrie | Not yet determined | 1990 | 1997 | GOG | Cervical cancer | 1 | 1 | 1 | 0 | 6 | 6 | 1 | |||||
Anderson | Barry | M | USA | 2001 | 2010 | CCG; COG | Ewing sarcoma; Neuroblastoma; Osteosarcoma | 2 | 0 | 1 | 1 | 26 | 26 | 1 | ||||
Anderson | Cathy | F | 1980 | 1987 | Autologous HSCT; Diffuse large B-cell lymphoma | 1 | 0 | 0 | 0 | 18 | 18 | 1 | ||||||
Anderson | Charles K. | M | USA | 2016 | 2021 | Ovarian cancer | 2 | 0 | 2 | 0 | 47 | 47 | 1 | |||||
Anderson | Clay M. | M | USA | 1995 | 2022 | RTOG | Esophageal cancer; Melanoma | 2 | 0 | 2 | 0 | 41 | 41 | 1 | ||||
Anderson | Daniel M. | M | USA | 2011 | 2021 | ECOG | Breast cancer; Follicular lymphoma; Multiple myeloma | 3 | 0 | 2 | 0 | 74 | 74 | 1 | ||||
Anderson | David R. | M | Canada | 2003 | 2018 | Antiphospholipid antibody syndrome; Venous thromboembolism | 3 | 2 | 3 | 0 | 65 | 44 | 1 | |||||
Anderson | Harald | M | Sweden | 1978 | 2016 | Nordic Lymphoma Group; Scandinavian Breast Group | Autologous HSCT; Breast cancer; CNS lymphoma; Diffuse large B-cell lymphoma; Peripheral T-cell lymphoma | 7 | 0 | 5 | 0 | 92 | 76 | 1 | ||||
Anderson | Heather A. | F | 1995 | 2006 | BTOG | Esophageal cancer; Gastric cancer; Non-small cell lung cancer | 4 | 0 | 4 | 0 | 47 | 40 | 1 | |||||
Anderson | J. | Not yet determined | USA | 2008 | 2008 | Anaplastic glioma | 1 | 0 | 0 | 0 | 9 | 9 | 1 | |||||
Anderson | James R. | M | USA | 1972 | 2019 | CALGB; CCG; COG; ECOG | Acute myeloid leukemia; B-cell acute lymphoblastic leukemia; Diffuse large B-cell lymphoma; Hodgkin lymphoma; Melanoma; Rhabdomyosarcoma; Soft tissue sarcoma | 14 | 2 | 11 | 1 | 164 | 124 | 1 | ||||
Anderson | Jeanne E. | F | USA | 1995 | 2002 | SWOG | Acute myeloid leukemia | 1 | 1 | 1 | 0 | 10 | 10 | 1 | ||||
Anderson | Jeffrey | M | USA | 2012 | 2020 | Hepatocellular carcinoma | 2 | 0 | 0 | 1 | 40 | 31 | 1 | |||||
Anderson | Jennifer J. | F | 1976 | 2004 | Autologous HSCT; Light-chain (AL) amyloidosis | 2 | 0 | 0 | 0 | 19 | 17 | 1 | ||||||
Anderson | John B. | M | United Kingdom | 1995 | 2012 | MRC; NCIC | Prostate cancer | 4 | 0 | 3 | 0 | 52 | 43 | 1 | ||||
Anderson | Karen S. | F | USA | 2013 | 2017 | Breast cancer | 1 | 0 | 0 | 0 | 33 | 33 | 1 | |||||
Anderson | Kenneth C. | M | USA | 1982 | 2022 | CALGB; FIRST Trial Team; IFM; SWOG; Waldenstroem's Macroglobulinemia Clinical Trials Group | Autologous HSCT; Diffuse large B-cell lymphoma; Multiple myeloma; Waldenstroem macroglobulinemia | 38 | 18 | 13 | 9 | 818 | 389 | 1 | ||||
Anderson | Larry D. | M | USA | 2010 | 2022 | Multiple myeloma | 4 | 1 | 2 | 2 | 167 | 151 | 1 | |||||
Anderson | Lisa | F | USA | 2017 | 2019 | Colorectal cancer | 1 | 0 | 1 | 1 | 34 | 34 | 1 | |||||
Anderson | Lxxx | Not yet determined | 1983 | 1994 | BNLI | Hodgkin lymphoma | 2 | 0 | 2 | 0 | 12 | 7 | 1 | |||||
Anderson | Mary Ann | F | Australia | 2011 | 2018 | Chronic lymphocytic leukemia; Mantle cell lymphoma | 2 | 0 | 0 | 1 | 34 | 32 | 1 | |||||
Anderson | Michael J. | M | Denmark; USA | 1979 | 2015 | BIG | Breast cancer; Cutaneous T-cell lymphoma | 2 | 0 | 2 | 0 | 29 | 29 | 1 | ||||
Anderson | Nancy | Not yet determined | USA | 2012 | 2020 | GOG | Gestational trophoblastic neoplasia | 1 | 0 | 1 | 0 | 12 | 12 | 1 | ||||
Anderson | Nicole D. | F | 2003 | 2003 | Autologous HSCT; CNS lymphoma; Stem cell mobilization | 1 | 0 | 0 | 0 | 12 | 12 | 1 | ||||||
Anderson | Patricia | F | USA | 1985 | 1992 | SWOG | Ovarian cancer | 1 | 0 | 1 | 1 | 9 | 9 | 1 | ||||
Anderson | Peter M. | M | USA | 2002 | 2002 | Osteosarcoma | 1 | 1 | 0 | 0 | 7 | 7 | 1 | |||||
Anderson | Richard T. | M | 1979 | 1991 | NCCTG | Non-small cell lung cancer; Small cell lung cancer | 2 | 2 | 2 | 0 | 24 | 19 | 1 | |||||
Anderson | Russell D. | M | 2009 | 2009 | Multiple myeloma | 1 | 0 | 0 | 0 | 15 | 15 | 1 | ||||||
Anderson | Sibyl | F | USA | 2003 | 2010 | Sorafenib TARGET Clinical Trial Group | Clear cell renal cell carcinoma; Renal cell carcinoma | 2 | 0 | 1 | 1 | 27 | 21 | 1 | ||||
Anderson | Stewart J. | M | USA | 1982 | 2018 | BOOG Dutch Breast Cancer Trialists' Group; Breast International Group; GEICAM Spanish Breast Cancer Group; International Breast Cancer Study Group; NRG Oncology; NSABP | Breast cancer | 11 | 0 | 11 | 2 | 153 | 81 | 1 | ||||
Anderson | Sxxx | Not yet determined | United Kingdom | 1996 | 2004 | Multiple myeloma | 1 | 0 | 1 | 0 | 7 | 7 | 1 | |||||
Anderson | Tara | F | 2009 | 2012 | Multiple myeloma | 1 | 0 | 0 | 0 | 18 | 18 | 1 | ||||||
Anderson | Thomas | M | USA | 1972 | 2008 | ECOG; Hoosier Oncology Group; US Oncology | Colorectal cancer; Non-small cell lung cancer; Ovarian cancer | 3 | 0 | 3 | 0 | 34 | 34 | 1 | ||||
Andersson | Borje S. | M | USA | 1990 | 2019 | Acute myeloid leukemia; Allogeneic HSCT; Breast cancer; Diffuse large B-cell lymphoma; Hodgkin lymphoma; Multiple myeloma | 8 | 3 | 2 | 0 | 125 | 99 | 1 | |||||
Andersson | Haakan | Not yet determined | 1995 | 2010 | EORTC | Endometrial cancer; Ovarian cancer | 3 | 0 | 3 | 0 | 29 | 23 | 1 | |||||
Andersson | Michael | M | Denmark | 1977 | 2021 | BIG; DBCG; EORTC; GBG; Herceptin Adjuvant (HERA) Trial Study Team; monarchE Committee Members | Breast cancer | 17 | 2 | 13 | 3 | 299 | 203 | 1 | ||||
Andersson | Per-Ola | Not yet determined | Sweden | 2011 | 2016 | Chronic lymphocytic leukemia | 1 | 0 | 1 | 0 | 18 | 18 | 1 | |||||
Andersson | Ronny | M | 1998 | 1998 | Melanoma | 1 | 0 | 1 | 0 | 12 | 12 | 1 | ||||||
Andersson | Swen Olof | M | Sweden | 1989 | 2018 | SPCG | Prostate cancer | 6 | 0 | 1 | 0 | 78 | 22 | 1 | ||||
Ando | Jiro | M | 1994 | 2014 | JCOG | Breast cancer | 1 | 0 | 1 | 0 | 10 | 10 | 1 | |||||
Ando | Kiyoshi | M | Japan | 2002 | 2021 | JCOG | Acute myeloid leukemia; Cutaneous T-cell lymphoma; Diffuse large B-cell lymphoma; Follicular lymphoma; Multiple myeloma; Peripheral T-cell lymphoma | 12 | 1 | 5 | 1 | 229 | 166 | 1 | ||||
Ando | Masahiko | M | Japan | 2000 | 2021 | JCOG; WJOG; WJTOG | Cholangiocarcinoma; Colorectal cancer; Non-small cell lung cancer; Non-small cell lung cancer squamous; Small cell lung cancer | 14 | 0 | 13 | 0 | 260 | 168 | 1 | ||||
Ando | Masahiro | M | Japan | 2006 | 2010 | Non-small cell lung cancer | 1 | 0 | 1 | 0 | 22 | 22 | 1 | |||||
Ando | Masashi | M | 2004 | 2009 | Breast cancer | 1 | 0 | 1 | 0 | 15 | 15 | 1 | ||||||
Ando | Nobutoshi | M | Japan | 1988 | 2011 | JCOG | Esophageal cancer | 3 | 3 | 3 | 0 | 43 | 32 | 1 | ||||
Ando | Yuichi | M | Japan | 2012 | 2018 | Colorectal cancer | 1 | 0 | 0 | 0 | 23 | 23 | 1 | |||||
Andoh | J. | CBD | 1999 | 2009 | JCOG | Breast cancer | 1 | 0 | 1 | 0 | 10 | 10 | 1 | |||||
Andorsky | David | M | USA | 2011 | 2019 | Chronic myeloid leukemia; Diffuse large B-cell lymphoma | 2 | 0 | 2 | 0 | 35 | 35 | 1 | |||||
Andrade | Luciana | F | Brazil | 2017 | 2021 | Breast cancer | 1 | 0 | 1 | 0 | 18 | 18 | 1 | |||||
Andre | Fabrice | M | France | 2006 | 2022 | Breast cancer | 16 | 4 | 9 | 4 | 336 | 223 | 1 | |||||
Andre | Marc P. E. | M | Belgium | 1996 | 2021 | EORTC; European Mantle Cell Lymphoma Network; FIL; GELA; Lymphoma Study Association; LYSA; SFGM | Autologous HSCT; Diffuse large B-cell lymphoma; Follicular lymphoma; Hodgkin lymphoma; Mantle cell lymphoma; Peripheral T-cell lymphoma; Transformed lymphoma | 14 | 1 | 14 | 1 | 340 | 212 | 1 | ||||
Andre | Niko | M | Switzerland | 2007 | 2013 | Colorectal cancer | 1 | 0 | 1 | 0 | 10 | 10 | 1 | |||||
Andre | Thierry | M | France | 1996 | 2022 | AERO; FFCD; FNCLCC; GERCOR; GISCAD; Group Cooperateur Multidisciplinaire en Oncologie; HORG; PRODIGE investigators, GERCOR, Federation Francaise de Cancerologie Digestive, UNICANCER | Anal cancer; Colon cancer; Colorectal cancer; Desmoid tumor; Esophageal adenocarcinoma; Gastric cancer; MSI-H or dMMR; Pancreatic cancer; Rectal cancer | 35 | 16 | 20 | 5 | 612 | 348 | 1 | ||||
Andre | Valerie A. M. | F | USA | 2017 | 2021 | monarchE Committee Members | Breast cancer | 1 | 0 | 1 | 1 | 34 | 34 | 1 | ||||
Andreadis | Charalambos | M | USA | 1998 | 2021 | Autologous HSCT; Diffuse large B-cell lymphoma; Follicular lymphoma; Ovarian cancer; Primary mediastinal B-cell lymphoma; Transformed lymphoma | 5 | 0 | 2 | 3 | 124 | 101 | 1 | |||||
Andreas | Stefan | M | Germany | 2005 | 2016 | Non-small cell lung cancer | 1 | 0 | 1 | 0 | 10 | 10 | 1 | |||||
Andreasson | Bjoern | M | 2007 | 2012 | Multiple myeloma | 1 | 0 | 1 | 0 | 18 | 18 | 1 | ||||||
Andreeff | Michael | M | USA | 1984 | 2020 | Acute myeloid leukemia; Acute promyelocytic leukemia; B-cell acute lymphoblastic leukemia; Chronic lymphocytic leukemia; CNS leukemia; Hypereosinophilic syndrome | 15 | 1 | 2 | 1 | 273 | 130 | 1 | |||||
Andreescu | Astrid C. | F | USA | 2010 | 2022 | Multiple myeloma | 1 | 0 | 1 | 0 | 55 | 55 | 1 | |||||
Andreesen | Reinhard | M | 1992 | 2012 | Arbeitsgemeinschaft Medikamentoese Tumortherapie; GHSG; SAKK | Breast cancer; Hodgkin lymphoma | 2 | 0 | 2 | 0 | 44 | 44 | 1 | |||||
Andreetta | Claudia | F | Italy | 2014 | 2021 | Breast cancer | 1 | 0 | 1 | 0 | 25 | 25 | 1 | |||||
Andren | Ove | Not yet determined | Sweden | 1989 | 2018 | SPCG | Prostate cancer | 2 | 0 | 1 | 0 | 25 | 14 | 1 | ||||
Andreola | Giovanna | F | Switzerland | 2019 | 2021 | Diffuse large B-cell lymphoma; Waldenstroem macroglobulinemia | 2 | 0 | 1 | 0 | 53 | 53 | 1 | |||||
Andreoli | Laura | F | Italy | 2018 | 2018 | Antiphospholipid antibody syndrome | 1 | 0 | 1 | 0 | 21 | 21 | 1 | |||||
Andreopoulos | Demetrios | M | Cyprus | 2001 | 2021 | EORTC | Prostate cancer | 1 | 0 | 1 | 0 | 21 | 21 | 1 | ||||
Andreou | Cal | M | Canada | 2006 | 2008 | Prostate cancer | 1 | 0 | 1 | 1 | 8 | 8 | 1 | |||||
Andreou | Pantelis | Not yet determined | Canada | 2013 | 2018 | Venous thromboembolism | 2 | 0 | 2 | 0 | 47 | 28 | 1 | |||||
Andresen Daniil | Corina | F | USA | 2013 | 2018 | PLATO collaborators | Prostate cancer | 1 | 0 | 1 | 0 | 7 | 7 | 1 | ||||
Andreuccetti | Michele | M | 2001 | 2010 | GONO | Colorectal cancer | 2 | 0 | 1 | 0 | 34 | 30 | 1 | |||||
Andrews | Chris | M | United Kingdom | 2012 | 2015 | Myelofibrosis | 1 | 0 | 0 | 0 | 11 | 11 | 1 | |||||
Andrews | Glen I. | M | USA | 2010 | 2016 | Renal cell carcinoma | 1 | 0 | 1 | 0 | 8 | 8 | 1 | |||||
Andrews | Michael B. | M | 2000 | 2005 | Follicular lymphoma | 1 | 0 | 0 | 0 | 6 | 6 | 1 | ||||||
Andrews | Stephen | M | United Kingdom | 2007 | 2018 | Bladder cancer | 1 | 0 | 1 | 0 | 17 | 17 | 1 | |||||
Andrews | Vivienne E. | F | United Kingdom | 2008 | 2019 | National Cancer Research Institute Haemato-oncology Clinical Studies Group | Multiple myeloma | 1 | 0 | 2 | 0 | 21 | 21 | 1 | ||||
Andric | Zoran | M | Serbia | 2015 | 2021 | Non-small cell lung cancer nonsquamous; Non-small cell lung cancer squamous | 2 | 0 | 1 | 1 | 39 | 25 | 1 | |||||
Andrien | J. M. | CBD | 1985 | 1993 | Breast cancer | 1 | 0 | 1 | 0 | 9 | 9 | 1 | ||||||
Andrieu | Jean Marie | M | 1990 | 2003 | Hodgkin lymphoma | 1 | 1 | 1 | 0 | 15 | 15 | 1 | ||||||
Andriole | Gerald L. | M | USA | 1994 | 2017 | Prostate cancer | 2 | 0 | 1 | 0 | 27 | 20 | 1 | |||||
Andritsos | Leslie A. | UNMATCHED | USA | 2011 | 2015 | Chronic lymphocytic leukemia | 1 | 0 | 0 | 0 | 20 | 20 | 1 | |||||
Androulakis | Ioannis | M | 1993 | 2002 | HeCOG | Colorectal cancer | 1 | 0 | 1 | 0 | 13 | 13 | 1 | |||||
Androulakis | Nikolaos | M | Greece | 1999 | 2019 | HORG | Colon cancer; Colorectal cancer; Non-small cell lung cancer; Pancreatic cancer; Small cell lung cancer | 7 | 0 | 6 | 0 | 108 | 59 | 1 | ||||
Andrulis | Irene L. | F | Canada | 1989 | 2006 | NCIC-CTG | Breast cancer | 1 | 0 | 1 | 1 | 6 | 6 | 1 | ||||
Andtbacka | Robert H. I. | M | USA | 2009 | 2019 | Melanoma | 2 | 2 | 1 | 1 | 34 | 30 | 1 | |||||
Ang | Agnes | F | USA | 2012 | 2021 | Gastric cancer; Non-small cell lung cancer | 2 | 0 | 0 | 1 | 45 | 45 | 1 | |||||
Ang | Kie Kian | M | USA | 1994 | 2015 | EORTC; RTOG | Head and neck cancer | 9 | 5 | 5 | 1 | 120 | 73 | 0 | ||||
Ang | Mei Kim | F | Singapore | 2004 | 2015 | Nasopharyngeal carcinoma | 1 | 0 | 0 | 0 | 13 | 13 | 1 | |||||
Ang | Peng Tiam | M | 1990 | 1994 | Nasopharyngeal carcinoma | 1 | 1 | 0 | 0 | 1 | 1 | 1 | ||||||
Angchaisuksiri | Pantep | Not yet determined | Thailand | 2016 | 2016 | Venous thromboembolism | 1 | 0 | 1 | 0 | 13 | 13 | 1 | |||||
Angele | Martin | M | Germany | 1997 | 2018 | EORTC; European Society for Hyperthermic Oncology | Soft tissue sarcoma | 1 | 0 | 1 | 0 | 21 | 21 | 1 | ||||
Angeli | Alberto | M | 1993 | 2005 | Italian Group for the Study of Adrenal Cancer | Adrenocortical carcinoma | 2 | 0 | 0 | 0 | 16 | 12 | 1 | |||||
Angelopoulou | Maria K. | F | 2010 | 2010 | Mantle cell lymphoma | 1 | 1 | 0 | 0 | 16 | 16 | 1 | ||||||
Angelot Delettre | Fanny | F | France | 2013 | 2014 | Blastic plasmacytoid dendritic cell neoplasm | 1 | 0 | 0 | 0 | 14 | 14 | 1 | |||||
Angelsen | Anders | M | Norway | 1995 | 2018 | Scandinavian Prostate Cancer Group; SPCG; Swedish Association for Urological Oncology | Prostate cancer | 3 | 0 | 3 | 0 | 25 | 24 | 1 | ||||
Angelucci | Emanuele | M | Italy | 1995 | 2022 | CYTO-PV Collaborative Group; FIL; GIMEMA; Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation | Aplastic anemia; Chronic lymphocytic leukemia; Chronic myelomonocytic leukemia; Diffuse large B-cell lymphoma; Follicular lymphoma; Hodgkin lymphoma; Polycythemia vera | 9 | 0 | 6 | 0 | 221 | 188 | 1 | ||||
Angermund | Ralf | M | Germany | 2006 | 2013 | Multiple myeloma | 2 | 0 | 0 | 1 | 20 | 17 | 1 | |||||
Anghel | Rodica | F | Romania | 2008 | 2016 | Breast cancer | 1 | 0 | 1 | 0 | 18 | 18 | 1 | |||||
Angiolillo | Anne L. | F | USA | 2000 | 2021 | CCG; COG | B-cell acute lymphoblastic leukemia pediatric; Ewing sarcoma; Osteosarcoma | 4 | 2 | 3 | 1 | 63 | 43 | 1 | ||||
Anglaret | Bruno | M | 1995 | 2012 | GELA; IFM | Diffuse large B-cell lymphoma; Multiple myeloma | 3 | 0 | 3 | 0 | 78 | 61 | 1 | |||||
Anglin | Peter | M | Canada | 2003 | 2015 | NCIC-CTG | Multiple myeloma; Transformed lymphoma | 2 | 0 | 1 | 0 | 26 | 26 | 1 | ||||
Angra | Natasha | F | USA | 2015 | 2020 | Bladder cancer | 1 | 0 | 1 | 0 | 28 | 28 | 1 | |||||
Angrilli | Francesco | M | Italy | 2000 | 2017 | FIL; IELSG | CNS lymphoma; Follicular lymphoma; Hodgkin lymphoma; Mantle cell lymphoma | 6 | 0 | 2 | 0 | 132 | 92 | 1 | ||||
Angyalfi | Steve J. | M | Canada | 1999 | 2022 | NCIC-CTG | Prostate cancer | 2 | 0 | 2 | 0 | 41 | 41 | 1 | ||||
Anichini | Andrea | Not yet determined | Italy | 2017 | 2018 | Bladder cancer | 1 | 0 | 0 | 0 | 22 | 22 | 1 | |||||
Anker | Christopher J. | M | USA | 2008 | 2017 | RTOG | Esophageal cancer | 1 | 0 | 1 | 0 | 18 | 18 | 1 | ||||
Anker | Gun | F | 1994 | 2000 | Scandinavian Breast Group | Breast cancer | 1 | 0 | 1 | 0 | 17 | 17 | 1 | |||||
Annamalai | Lakshmanan | M | USA | 2015 | 2016 | Merkel cell carcinoma | 1 | 0 | 0 | 1 | 30 | 30 | 1 | |||||
Anne | P. Rani | F | 1999 | 2006 | RTOG | Esophageal adenocarcinoma | 1 | 0 | 0 | 0 | 10 | 10 | 1 | |||||
Annechini | Giorgia | F | Italy | 2016 | 2016 | Hodgkin lymphoma | 1 | 0 | 0 | 0 | 17 | 17 | 1 | |||||
Annecke | K. | CBD | Germany | 2001 | 2016 | Breast cancer | 1 | 0 | 1 | 0 | 11 | 11 | 1 | |||||
Annett | Robert D. | M | USA | 2014 | 2022 | COG | T-cell acute lymphoblastic leukemia pediatric | 1 | 0 | 1 | 0 | 35 | 35 | 1 | ||||
Annibali | Ombretta | F | Italy | 2007 | 2019 | Acute promyelocytic leukemia | 1 | 0 | 2 | 1 | 45 | 45 | 1 | |||||
Annino | Luciana | F | Italy | 1988 | 2016 | EORTC; GIMEMA | Acute myeloid leukemia; B-cell acute lymphoblastic leukemia; Multiple myeloma | 3 | 1 | 3 | 1 | 67 | 66 | 1 | ||||
Annunziata | Annalisa | F | 2003 | 2006 | MITO | Ovarian cancer | 1 | 0 | 1 | 0 | 19 | 19 | 1 | |||||
Annunziata | Mario | M | Italy | 2017 | 2021 | Chronic myeloid leukemia; Thrombotic thrombocytopenic purpura | 2 | 0 | 1 | 1 | 32 | 32 | 1 | |||||
Anota | Amelie | F | France | 2014 | 2018 | Anal cancer | 1 | 0 | 0 | 0 | 26 | 26 | 1 | |||||
Ansari | Hassan | M | 1983 | 1994 | Chronic myeloid leukemia | 1 | 1 | 1 | 0 | 43 | 42 | 1 | ||||||
Ansari | Marc | M | Switzerland | 2007 | 2020 | EBMT Paediatric Diseases Working Party; I-BFM SCT Study Group; IBFM Study Group; IntReALL Study Group; SIOPEL | Allogeneic HSCT; Hepatoblastoma | 2 | 0 | 2 | 0 | 53 | 53 | 1 | ||||
Ansari | Rafat H. | M | USA | 1984 | 2013 | Alpha Oncology Research Network; CALGB; Fox Chase Network; Hoosier Oncology Group; NCIC-CTG; US Oncology | Breast cancer; Colorectal cancer; Non-small cell lung cancer; Prostate cancer; Small cell lung cancer | 16 | 0 | 15 | 1 | 186 | 151 | 1 | ||||
Ansell | Peter J. | M | USA | 2012 | 2021 | Non-small cell lung cancer; Non-small cell lung cancer squamous; Ovarian cancer | 3 | 0 | 2 | 0 | 70 | 67 | 1 | |||||
Ansell | Stephen M. | M | USA | 2002 | 2022 | NCCTG | Diffuse large B-cell lymphoma; Follicular lymphoma; Hodgkin lymphoma; Mantle cell lymphoma; Transformed lymphoma; Waldenstroem macroglobulinemia | 26 | 7 | 1 | 4 | 410 | 217 | 1 | ||||
Anselmo | Anna Paola | F | 1988 | 2004 | FIL; GHSG | Diffuse large B-cell lymphoma; Hodgkin lymphoma | 4 | 0 | 1 | 0 | 57 | 50 | 1 | |||||
Ansfield | Fred J. | M | 1961 | 1985 | Cooperative Breast Cancer Group | Breast cancer; Head and neck cancer | 4 | 0 | 3 | 0 | 23 | 17 | 1 | |||||
Ansstas | George | M | USA | 2016 | 2022 | Glioblastoma | 1 | 0 | 1 | 0 | 23 | 23 | 1 | |||||
Antal | Joyce | F | USA | 2014 | 2017 | Bladder cancer | 1 | 0 | 0 | 1 | 18 | 18 | 1 | |||||
Anter | A. H. | CBD | 2006 | 2013 | Breast cancer | 1 | 0 | 1 | 0 | 3 | 3 | 1 | ||||||
Anthes | M. | Not yet determined | 1996 | 2004 | Glioblastoma | 1 | 0 | 0 | 0 | 17 | 17 | 1 | ||||||
Anthoney | Alan | M | United Kingdom | 2000 | 2021 | Advanced Biliary Cancer Working Group; European Study Group for Pancreatic Cancer | Cholangiocarcinoma; Gallbladder cancer; Pancreatic cancer; Periampullary adenocarcinoma | 5 | 0 | 5 | 0 | 119 | 84 | 1 | ||||
Anthony | Alan | M | United Kingdom | 2006 | 2022 | Cholangiocarcinoma; Gallbladder cancer | 2 | 0 | 1 | 0 | 52 | 29 | 1 | |||||
Anthony | Stephen P. | M | 1997 | 2006 | Breast cancer | 1 | 0 | 1 | 0 | 19 | 19 | 1 | ||||||
Antimi | Mauro | M | 1991 | 2003 | Italian Co-operative Group on Bladder Cancer | Bladder cancer; Breast cancer | 2 | 0 | 1 | 0 | 27 | 27 | 1 | |||||
Antin | Joseph H. | M | USA | 2003 | 2016 | BMT CTN | Allogeneic HSCT; Chronic myeloid leukemia; Graft versus host disease; Multiple myeloma | 4 | 1 | 3 | 0 | 79 | 76 | 1 | ||||
Antinori | Andrea | UNMATCHED | 2002 | 2002 | HIV-associated lymphoma | 1 | 0 | 0 | 0 | 12 | 12 | 1 | ||||||
Antman | Karen | F | USA | 1987 | 1993 | Autologous HSCT; Breast cancer; Soft tissue sarcoma | 2 | 2 | 1 | 0 | 26 | 25 | 1 | |||||
Antolin Novoa | Silvia | F | Spain | 2008 | 2021 | GEICAM | Breast cancer | 2 | 0 | 2 | 0 | 63 | 61 | 1 | ||||
Anton Torres | A. | CBD | 1994 | 1998 | TTD | Colorectal cancer | 1 | 0 | 1 | 0 | 12 | 12 | 1 | |||||
Anton | Antonio | M | Spain | 1990 | 2020 | CIBOMA; GEICAM; LACOG (Latin American Cooperative Oncology Group); Spanish Lung Cancer Group; TTD | Breast cancer; Colorectal cancer; Esophageal adenocarcinoma; Head and neck cancer; Non-small cell lung cancer; Small cell lung cancer | 17 | 0 | 17 | 2 | 380 | 273 | 1 | ||||
Antonarakis | Emmanuel S. | M | USA | 2011 | 2021 | Prostate cancer | 2 | 1 | 0 | 0 | 39 | 38 | 1 | |||||
Antonelli | G. | CBD | 1998 | 2002 | Bladder cancer | 1 | 0 | 0 | 0 | 9 | 9 | 1 | ||||||
Antonescu | Cristina R. | F | USA | 2002 | 2011 | ACOSOG | Gastrointestinal stromal tumor; Melanoma | 2 | 0 | 1 | 1 | 31 | 31 | 1 | ||||
Antonia | Scott J. | M | USA | 2007 | 2022 | Malignant pleural mesothelioma; Non-small cell lung cancer; Non-small cell lung cancer nonsquamous; Non-small cell lung cancer squamous; Small cell lung cancer | 17 | 6 | 7 | 5 | 408 | 222 | 1 | |||||
Antonini | Ninja F. | F | Netherlands | 2003 | 2009 | Dutch Colorectal Cancer Group | Colorectal cancer | 2 | 0 | 2 | 0 | 36 | 28 | 1 | ||||
Antonioli | Elisabetta | F | Italy | 2014 | 2021 | Multiple myeloma; Paroxysmal nocturnal hemoglobinuria | 2 | 0 | 1 | 1 | 37 | 37 | 1 | |||||
Antoniotti | Carlotta | F | Italy | 2008 | 2022 | Colorectal cancer | 3 | 0 | 2 | 0 | 70 | 54 | 1 | |||||
Antoniou | Dimosthenis | M | Greece | 2000 | 2010 | Non-small cell lung cancer | 2 | 0 | 2 | 0 | 33 | 27 | 1 | |||||
Antoniou | Nicos | M | Greece | 2000 | 2013 | SEUG | Prostate cancer | 1 | 0 | 1 | 0 | 10 | 9 | 1 | ||||
Antonuzzo | Lorenzo | M | Italy | 2008 | 2022 | Colorectal cancer | 2 | 0 | 2 | 0 | 45 | 42 | 1 | |||||
Antonyan | Igor | Not yet determined | Ukraine | 2017 | 2022 | Renal cell carcinoma | 1 | 0 | 1 | 0 | 20 | 20 | 1 | |||||
Anttila | Pekka | M | Finland | 2012 | 2016 | Multiple myeloma | 1 | 0 | 0 | 0 | 30 | 30 | 1 | |||||
Antunes | Luis | M | Brazil | 2017 | 2021 | Esophageal cancer | 1 | 0 | 1 | 1 | 24 | 24 | 1 | |||||
Antunovic | Petar | M | 2004 | 2010 | Acute myeloid leukemia; Chronic myelomonocytic leukemia; Myelodysplastic syndrome | 1 | 0 | 0 | 0 | 19 | 19 | 1 | ||||||
Anz | Bertrand | M | USA | 2014 | 2018 | Chronic lymphocytic leukemia | 1 | 0 | 1 | 1 | 19 | 19 | 1 | |||||
Aogi | Kenjiro | M | Japan | 1994 | 2021 | JCOG; NSAS | Breast cancer | 9 | 0 | 8 | 1 | 140 | 103 | 1 | ||||
Aokage | Keiju | Not yet determined | Japan | 2013 | 2020 | JCOG | Small cell lung cancer | 1 | 0 | 1 | 0 | 19 | 19 | 1 | ||||
Aoki | Daisuke | M | Japan | 2003 | 2021 | JGOG | Cervical cancer; Endometrial cancer; Ovarian cancer | 6 | 1 | 5 | 0 | 121 | 89 | 1 | ||||
Aoki | Hiroshi | M | 2005 | 2013 | Bladder cancer; Upper tract urothelial carcinoma | 1 | 0 | 0 | 0 | 22 | 22 | 1 | ||||||
Aoki | Takuya | Not yet determined | Japan | 2001 | 2021 | WJTOG | Non-small cell lung cancer | 1 | 0 | 1 | 0 | 20 | 20 | 1 | ||||
Aoki | Yoichi | M | Japan | 2008 | 2021 | Cervical cancer; Ovarian cancer | 2 | 1 | 2 | 0 | 60 | 57 | 1 | |||||
Aondio | Gian Marco | M | 2004 | 2009 | IELSG | CNS lymphoma | 1 | 0 | 0 | 0 | 31 | 31 | 1 | |||||
Aotani | Eriko | F | Japan | 2006 | 2016 | JGOG | Ovarian cancer | 1 | 0 | 1 | 0 | 23 | 23 | 1 | ||||
Aoudjhane | A. | CBD | France | 2003 | 2014 | Lymphoma Study Association | Hodgkin lymphoma | 1 | 0 | 1 | 0 | 17 | 17 | 1 | ||||
Aoudjhane | Malek | M | France | 1989 | 2003 | EORTC | Hodgkin lymphoma | 1 | 0 | 2 | 0 | 28 | 28 | 1 | ||||
Aoyama | H. | CBD | 1993 | 1996 | Breast cancer | 1 | 0 | 0 | 0 | 6 | 6 | 1 | ||||||
Aoyama | Norio | M | 1992 | 2011 | JCOG | Esophageal cancer | 2 | 0 | 2 | 0 | 32 | 29 | 1 | |||||
Aoyama | Toru | Not yet determined | Japan; USA | 2011 | 2017 | Gastric cancer; Rectal cancer | 2 | 1 | 2 | 0 | 30 | 30 | 1 | |||||
Aozasa | Katsuyuki | Not yet determined | 2005 | 2005 | Castleman disease | 1 | 0 | 0 | 0 | 20 | 20 | 1 | ||||||
Apanovitch | Anne Marie | F | USA | 2005 | 2007 | B-cell acute lymphoblastic leukemia | 1 | 0 | 0 | 1 | 11 | 11 | 1 | |||||
Aparicio | Jorge | M | Spain | 1994 | 2011 | Spanish Germ Cell Cancer Cooperative Group; TTD | Colorectal cancer; Hodgkin lymphoma; Testicular cancer | 6 | 3 | 2 | 0 | 81 | 68 | 1 | ||||
Aparicio | Samuel | M | Canada | 2008 | 2015 | NCIC-CTG | Breast cancer | 1 | 0 | 1 | 0 | 26 | 26 | 1 | ||||
Aparicio | Thomas | M | France | 2000 | 2018 | FFCD; SFRO; UNICANCER | Colorectal cancer; Esophageal adenocarcinoma; Gastric cancer; Hepatocellular carcinoma; Pancreatic cancer | 5 | 2 | 5 | 0 | 89 | 71 | 1 | ||||
Apfelbeck | Ute | F | Austria | 1994 | 2003 | Chronic myeloid leukemia | 1 | 0 | 1 | 0 | 25 | 25 | 1 | |||||
Apffelstaedt | Justus | M | South Africa | 1996 | 2003 | Breast cancer | 3 | 0 | 2 | 1 | 51 | 32 | 1 | |||||
Aplenc | Richard | M | USA | 2011 | 2014 | COG | Acute myeloid leukemia pediatric; B-cell acute lymphoblastic leukemia; B-cell acute lymphoblastic leukemia pediatric | 3 | 1 | 0 | 0 | 44 | 36 | 1 | ||||
Apolo | Andrea B. | M | USA | 2014 | 2022 | Bladder cancer; Renal cell carcinoma | 4 | 2 | 1 | 2 | 81 | 59 | 1 | |||||
Apolone | Giovanni | M | 1987 | 1998 | EORTC; Gruppo Interdisciplinare Valutazione Interventi in Oncologia; Japanese Foundation for Cancer Research | Colon cancer | 1 | 0 | 1 | 0 | 14 | 14 | 1 | |||||
Aponte | John | M | 1996 | 2002 | Barcelona Liver Cancer Group | Hepatocellular carcinoma | 1 | 0 | 1 | 0 | 11 | 11 | 1 | |||||
Apostolou | Theofanis | M | 2008 | 2012 | Light-chain (AL) amyloidosis | 1 | 0 | 0 | 0 | 12 | 12 | 1 | ||||||
Appel | Tabea | F | 2006 | 2006 | Non-small cell lung cancer | 1 | 0 | 1 | 0 | 10 | 10 | 1 | ||||||
Appel | Wiebke | F | United Kingdom | 2008 | 2017 | CONVERT Study Team | Small cell lung cancer | 1 | 0 | 1 | 0 | 19 | 19 | 1 | ||||
Appelbaum | Frederick R. | M | USA | 1971 | 2021 | CALGB; ECOG; SWOG | Acute myeloid leukemia; Acute promyelocytic leukemia; Allogeneic HSCT; B-cell acute lymphoblastic leukemia; Chronic lymphocytic leukemia; Chronic myeloid leukemia; Chronic myelomonocytic leukemia; Follicular lymphoma; Graft versus host disease; Hairy cell leukemia; Myelodysplastic syndrome; T-cell acute lymphoblastic leukemia | 36 | 11 | 16 | 4 | 477 | 273 | 1 | ||||
Appenzeller | Christina | Not yet determined | Switzerland | 2017 | 2021 | Small cell lung cancer | 1 | 0 | 1 | 0 | 21 | 21 | 1 | |||||
Apperley | Jane F. | F | United Kingdom | 1981 | 2021 | B-cell acute lymphoblastic leukemia; Chronic myeloid leukemia; Hypereosinophilic syndrome | 12 | 1 | 1 | 4 | 227 | 140 | 1 | |||||
Appiani | Carlos | M | USA | 2008 | 2018 | Mantle cell lymphoma | 1 | 0 | 1 | 1 | 15 | 15 | 1 | |||||
Appleman | Leonard J. | M | USA | 2008 | 2014 | Bladder cancer | 1 | 0 | 0 | 0 | 18 | 18 | 1 | |||||
Aprea | Pasquale | M | 2002 | 2013 | SICOG | Melanoma | 1 | 0 | 1 | 0 | 17 | 17 | 1 | |||||
Aprile | Giuseppe | M | Italy | 2005 | 2022 | Colorectal cancer; Esophageal adenocarcinoma; Esophageal cancer; Gastric cancer | 4 | 0 | 3 | 2 | 89 | 81 | 1 | |||||
Apte | Ron N. | M | Israel | 2014 | 2017 | Colorectal cancer | 1 | 0 | 1 | 0 | 14 | 14 | 1 | |||||
Aqui | Nicole A. | F | USA | 2008 | 2015 | Follicular lymphoma; Mantle cell lymphoma | 2 | 0 | 0 | 0 | 14 | 8 | 1 | |||||
Aquino | Sara | Not yet determined | Italy | 2011 | 2021 | Multiple myeloma | 3 | 0 | 1 | 0 | 123 | 78 | 1 | |||||
Arachchillage | Deepa R. J. | Not yet determined | United Kingdom | 2016 | 2016 | Antiphospholipid antibody syndrome | 1 | 0 | 0 | 0 | 13 | 13 | 1 | |||||
Aracil | Miguel | Not yet determined | Spain | 2015 | 2021 | Ovarian cancer | 1 | 0 | 1 | 0 | 19 | 19 | 1 | |||||
Aragon Ching | Jeanny B. | F | USA | 2011 | 2020 | Bladder cancer | 3 | 0 | 2 | 1 | 91 | 82 | 1 | |||||
Arahmani | Amal | F | Belgium | 2011 | 2021 | Breast cancer | 2 | 0 | 2 | 2 | 55 | 51 | 1 | |||||
Arai | Gaku | Not yet determined | Japan | 2001 | 2020 | Prostate cancer | 2 | 0 | 2 | 0 | 48 | 45 | 1 | |||||
Arai | Kuniyoshi | M | Japan | 1993 | 2011 | ACTS-GC Group; JCOG | Gastric cancer | 2 | 2 | 2 | 0 | 21 | 16 | 1 | ||||
Arai | Makoto | Not yet determined | Japan | 2019 | 2019 | Carcinoma of unknown primary | 1 | 0 | 0 | 0 | 20 | 20 | 1 | |||||
Arai | Masahide | Not yet determined | Japan | 2006 | 2019 | JGOG | Endometrial cancer | 1 | 0 | 1 | 0 | 16 | 16 | 1 | ||||
Arai | Sally | F | USA | 2006 | 2016 | Allogeneic HSCT | 2 | 0 | 1 | 0 | 45 | 45 | 1 | |||||
Arai | Yasuaki | M | Japan | 2010 | 2018 | Hepatocellular carcinoma | 2 | 2 | 2 | 0 | 34 | 32 | 1 | |||||
Arai | Yoichi | M | 2000 | 2013 | Study Group for the Combined Androgen Blockade Therapy of Prostate Cancer | Bladder cancer; Prostate cancer; Upper tract urothelial carcinoma | 3 | 1 | 1 | 0 | 38 | 34 | 1 | |||||
Arakelyan | Nina | F | 1994 | 2013 | GOELAMS | Diffuse large B-cell lymphoma; Follicular lymphoma; Mantle cell lymphoma | 3 | 0 | 1 | 0 | 57 | 46 | 1 | |||||
Araki | K. | CBD | 1994 | 2001 | JCOG | Adult T-cell leukemia-lymphoma | 1 | 0 | 0 | 0 | 15 | 15 | 1 | |||||
Araki | Nobuhito | M | Japan | 2008 | 2016 | Soft tissue sarcoma | 3 | 0 | 1 | 1 | 45 | 40 | 1 | |||||
Arana Yi | C. | CBD | USA | 2007 | 2014 | Acute myeloid leukemia | 1 | 0 | 0 | 0 | 17 | 17 | 1 | |||||
Arance | Ana M. | F | Spain | 2009 | 2022 | CheckMate 238 Collaborators | CNS melanoma; Melanoma | 24 | 1 | 11 | 8 | 562 | 205 | 1 | ||||
Aranda | Enrique | M | Spain | 1994 | 2020 | GEICAM; TTD | Breast cancer; Colon cancer; Colorectal cancer; Esophageal adenocarcinoma | 9 | 7 | 7 | 0 | 179 | 127 | 1 | ||||
Aranda | Ignacio | M | Spain | 1999 | 2010 | GEICAM | Breast cancer | 1 | 0 | 1 | 0 | 30 | 30 | 1 | ||||
Aranda | J. | CBD | Spain | 1987 | 2003 | GEICAM | Breast cancer | 1 | 0 | 1 | 0 | 14 | 14 | 1 | ||||
Arango Hisijara | Israel | M | USA | 2013 | 2021 | Marginal zone lymphoma; Waldenstroem macroglobulinemia | 2 | 0 | 1 | 2 | 37 | 36 | 1 | |||||
Arango Ossa | Juan E. | Not yet determined | USA | 2011 | 2022 | Polycythemia vera | 1 | 0 | 1 | 0 | 42 | 42 | 1 | |||||
Arasteh | Keikawus | M | 1993 | 1998 | Kaposi sarcoma | 1 | 0 | 1 | 0 | 8 | 8 | 1 | ||||||
Araujo | Carla | F | France | 2008 | 2022 | IFM | Autologous HSCT; Multiple myeloma | 6 | 0 | 4 | 1 | 217 | 121 | 1 | ||||
Araujo | John C. | M | USA | 2008 | 2013 | Prostate cancer | 1 | 1 | 1 | 0 | 24 | 24 | 1 | |||||
Aravantinos | Gerasimos | M | Greece | 1989 | 2012 | HCOG; HeCOG | Bladder cancer; Breast cancer; Colon cancer; Colorectal cancer; Endometrial cancer; Ovarian cancer; Pancreatic cancer; Testicular cancer | 13 | 2 | 11 | 0 | 212 | 101 | 1 | ||||
Arazy | Melina | F | USA | 2017 | 2020 | Multiple myeloma | 1 | 0 | 1 | 1 | 57 | 57 | 1 | |||||
Arbogast | Daria | F | 2010 | 2010 | Thyroid cancer medullary | 1 | 0 | 0 | 0 | 18 | 18 | 1 | ||||||
Arbuck | Susan G. | F | 1992 | 2003 | Cervical cancer; Ovarian cancer | 2 | 1 | 1 | 0 | 22 | 21 | 1 | ||||||
Arbushites | Michael C. | M | USA | 2004 | 2020 | Breast cancer; Graft versus host disease | 2 | 0 | 1 | 1 | 25 | 25 | 1 | |||||
Arcaini | Luca | M | Italy | 2006 | 2021 | FIL; SPRINT trial investigators and in collaboration with the European Mantle Cell Lymphoma Network | Follicular lymphoma; Mantle cell lymphoma | 7 | 1 | 3 | 0 | 164 | 132 | 1 | ||||
Arcamone | Manuela | F | 2012 | 2012 | Follicular lymphoma | 1 | 0 | 0 | 0 | 14 | 14 | 1 | ||||||
Arcangeli | Annarosa | F | 1995 | 2008 | Italian Oncology Group for Cancer Research | Gastric cancer | 1 | 0 | 1 | 0 | 15 | 15 | 1 | |||||
Arcangeli | Giuseppina | F | 1995 | 1995 | Hepatocellular carcinoma | 1 | 1 | 0 | 0 | 3 | 3 | 1 | ||||||
Arcangeli | Valentina | F | Italy | 2010 | 2015 | MITO | Ovarian cancer | 1 | 0 | 0 | 0 | 22 | 22 | 1 | ||||
Arcari | Annalisa | F | Italy | 2003 | 2021 | ANZ BCTG; FIL | Diffuse large B-cell lymphoma; Follicular lymphoma; Mantle cell lymphoma | 4 | 0 | 2 | 0 | 93 | 78 | 1 | ||||
Arcasoy | Murat O. | M | USA | 2009 | 2022 | Myelofibrosis; Polycythemia vera | 6 | 0 | 2 | 1 | 161 | 74 | 1 | |||||
Arce Lara | Carlos | M | USA | 2015 | 2019 | Multiple myeloma | 1 | 0 | 0 | 0 | 10 | 10 | 1 | |||||
Arce Salinas | Claudia H. | F | Mexico | 2011 | 2021 | Breast cancer | 2 | 0 | 2 | 1 | 61 | 60 | 1 | |||||
Arceci | Robert J. | M | USA | 1979 | 2011 | CCG; COG | Acute myeloid leukemia; B-cell acute lymphoblastic leukemia pediatric; Chronic myeloid leukemia pediatric; Langerhans cell histiocytosis | 5 | 2 | 4 | 2 | 60 | 53 | 1 | ||||
Arcenas | Anthony | M | 2000 | 2000 | Non-small cell lung cancer | 1 | 0 | 1 | 0 | 18 | 18 | 1 | ||||||
Arcese | William | M | Italy | 1988 | 2015 | Acute myeloid leukemia; Allogeneic HSCT | 2 | 0 | 1 | 0 | 40 | 40 | 1 | |||||
Archambaud | Baptiste | Not yet determined | France | 2017 | 2022 | French Sarcoma Group | Leiomyosarcoma | 1 | 0 | 1 | 0 | 19 | 19 | 1 | ||||
Archambault | Robert | M | Canada | 2000 | 2020 | Prostate cancer | 2 | 0 | 2 | 0 | 23 | 17 | 1 | |||||
Archer | Caroline | F | United Kingdom | 2007 | 2014 | Pancreatic cancer | 1 | 0 | 1 | 0 | 32 | 32 | 1 | |||||
Archer | J. Hunter | Not yet determined | USA | 2014 | 2022 | COG | T-cell acute lymphoblastic leukemia pediatric | 1 | 0 | 1 | 0 | 35 | 35 | 1 | ||||
Archer | Laura | F | 2003 | 2010 | CALGB | Renal cell carcinoma | 2 | 0 | 1 | 0 | 21 | 11 | 1 | |||||
Archer | Venice | F | United Kingdom | 2005 | 2019 | Non-small cell lung cancer; Non-small cell lung cancer nonsquamous | 4 | 0 | 3 | 2 | 49 | 38 | 1 | |||||
Archimbaud | Eric | M | 1980 | 2004 | ALFA; EAPLG; EORTC; European APL Group; GELA; HOVON | Acute myeloid leukemia; Acute promyelocytic leukemia; Diffuse large B-cell lymphoma | 6 | 0 | 5 | 0 | 110 | 83 | 1 | |||||
Arcila | Maria E. | F | USA | 2012 | 2021 | ERBB2 (HER2); Erdheim-Chester disease; Multiple myeloma | 3 | 1 | 0 | 1 | 88 | 85 | 1 | |||||
Arcusa | Angels | F | Spain | 1988 | 2010 | GEICAM | Breast cancer; Gastric cancer | 3 | 0 | 3 | 0 | 59 | 52 | 1 |